<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cns70378" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id><journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id><journal-id journal-id-type="publisher-id">CNS</journal-id><journal-title-group><journal-title>CNS Neuroscience &#x00026; Therapeutics</journal-title></journal-title-group><issn pub-type="ppub">1755-5930</issn><issn pub-type="epub">1755-5949</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40406921</article-id><article-id pub-id-type="pmc">PMC12099310</article-id><article-id pub-id-type="doi">10.1111/cns.70378</article-id><article-id pub-id-type="publisher-id">CNS70378</article-id><article-id pub-id-type="other">CNSNT-2024-2691.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Mitochondria&#x02010;Associated Membranes: A Key Point of Neurodegenerative Diseases</article-title></title-group><contrib-group><contrib id="cns70378-cr-0001" contrib-type="author"><name><surname>Zhang</surname><given-names>Yiwei</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0005-0849-9621</contrib-id><xref rid="cns70378-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cns70378-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cns70378-cr-0002" contrib-type="author"><name><surname>Rao</surname><given-names>Xiuqin</given-names></name><xref rid="cns70378-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cns70378-cr-0003" contrib-type="author"><name><surname>Wang</surname><given-names>Jiayi</given-names></name><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cns70378-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cns70378-cr-0004" contrib-type="author"><name><surname>Liu</surname><given-names>Hantian</given-names></name><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cns70378-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cns70378-cr-0005" contrib-type="author"><name><surname>Wang</surname><given-names>Qixian</given-names></name><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cns70378-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cns70378-cr-0006" contrib-type="author"><name><surname>Wang</surname><given-names>Xifeng</given-names></name><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cns70378-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cns70378-cr-0007" contrib-type="author"><name><surname>Hua</surname><given-names>Fuzhou</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0005-6307-2778</contrib-id><xref rid="cns70378-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cns70378-cr-0008" contrib-type="author" corresp="yes"><name><surname>Guan</surname><given-names>Xilong</given-names></name><xref rid="cns70378-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>xilongguan24@163.com</email></address></contrib><contrib id="cns70378-cr-0009" contrib-type="author" corresp="yes"><name><surname>Lin</surname><given-names>Yue</given-names></name><xref rid="cns70378-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cns70378-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>linyue0101@163.com</email></address></contrib></contrib-group><aff id="cns70378-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College</named-content>
<institution>Nanchang University</institution>
<city>Nanchang</city>
<named-content content-type="country-part">Jiangxi Province</named-content>
<country country="CN">China</country>
</aff><aff id="cns70378-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Jiangxi Provincial Key Laboratory of Anesthesiology</institution>
<city>Nanchang</city>
<named-content content-type="country-part">Jiangxi Province</named-content>
<country country="CN">China</country>
</aff><aff id="cns70378-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Queen Mary College</named-content>
<institution>Nanchang University</institution>
<city>Nanchang</city>
<named-content content-type="country-part">Jiangxi Province</named-content>
<country country="CN">China</country>
</aff><aff id="cns70378-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College</named-content>
<institution>Nanchang University</institution>
<city>Nanchang</city>
<named-content content-type="country-part">Jiangxi Province</named-content>
<country country="CN">China</country>
</aff><aff id="cns70378-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Anesthesiology</named-content>
<institution>Yingtan City People's Hospital</institution>
<city>Yingtan City</city>
<named-content content-type="country-part">Jiangxi Province</named-content>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Xilong Guan (<email>xilongguan24@163.com</email>)<break/>
Yue Lin (<email>linyue0101@163.com</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>31</volume><issue seq="80">5</issue><issue-id pub-id-type="doi">10.1111/cns.v31.5</issue-id><elocation-id>e70378</elocation-id><history>
<date date-type="rev-recd"><day>12</day><month>3</month><year>2025</year></date>
<date date-type="received"><day>11</day><month>12</month><year>2024</year></date>
<date date-type="accepted"><day>29</day><month>3</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">CNS Neuroscience &#x00026; Therapeutics</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CNS-31-e70378.pdf"/><abstract><title>ABSTRACT</title><sec id="cns70378-sec-1001"><title>Background</title><p>Neurodegenerative diseases pose significant health challenges in the 21st century, with increasing morbidity and mortality, particularly among the elderly population. One of the key factors contributing to the pathogenesis of these diseases is the disrupted crosstalk between mitochondria and the endoplasmic reticulum. Mitochondria&#x02010;associated membranes (MAMs), which are regions where the ER interfaces with mitochondria, serve as crucial platforms facilitating communication between these organelles.</p></sec><sec id="cns70378-sec-1002"><title>Objectives</title><p>This review focuses on the structural composition and functions of MAMs and highlights their roles. Additionally, in this review, we summarize the relationship between MAM dysfunction and various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and others. The involvement of key proteins such as Sig&#x02010;1R, IP3R, and VAPB in maintaining ER&#x02010;mitochondrial communication and their dysfunction in neurodegenerative diseases is emphasized.</p></sec><sec id="cns70378-sec-1003"><title>Conclusion</title><p>Through analyzing the effects of MAM on neurodegenerative diseases, we provide the newest insights and potential therapeutic targets for the treatment of these debilitating conditions.</p></sec></abstract><abstract abstract-type="graphical"><p>
<boxed-text position="anchor" content-type="graphic" id="cns70378-blkfxd-0001"><graphic xlink:href="CNS-31-e70378-g002.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cns70378-kwd-0001">Alzheimers' disease</kwd><kwd id="cns70378-kwd-0002">Ca<sup>2+</sup> homeostasis</kwd><kwd id="cns70378-kwd-0003">IP3R</kwd><kwd id="cns70378-kwd-0004">mitochondria&#x02010;associated membranes</kwd><kwd id="cns70378-kwd-0005">neurodegenerative disease</kwd><kwd id="cns70378-kwd-0006">Parkinson's disease</kwd><kwd id="cns70378-kwd-0007">Sig&#x02010;1R</kwd><kwd id="cns70378-kwd-0008">VAPB</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Jiangxi Provincial Natural Science Foundation
</institution><institution-id institution-id-type="doi">10.13039/501100004479</institution-id></institution-wrap></funding-source><award-id>20242BAB26133</award-id><award-id>20243BCE51077</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Jiangxi Province Double Thousand Plan
</institution><institution-id institution-id-type="doi">10.13039/100022957</institution-id></institution-wrap></funding-source><award-id>jxsq2019201023</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82271234</award-id><award-id>82401426</award-id><award-id>82460231</award-id></award-group><award-group id="funding-0004"><funding-source>Jiangxi Province Key Laboratory of Anesthesiology</funding-source><award-id>2024SSY06161</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="0"/><page-count count="20"/><word-count count="17700"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="cns70378-ntgp-0001"><fn fn-type="funding" id="cns70378-note-0001"><p>
<bold>Funding:</bold> This work was supported by grants from the National Natural Science Foundation of China (82401426; 82460231; 82271234); Jiangxi Provincial Natural Science Foundation (20242BAB26133, 20243<sc>bce</sc>51077); Jiangxi Province Double Thousand Plan (jxsq2019201023); and Jiangxi Province Key Laboratory of Anesthesiology (2024SSY06161).</p></fn></fn-group></notes></front><body id="cns70378-body-0001"><def-list list-content="abbreviations" id="cns70378-dl-0001"><title>Abbreviations</title><def-item><term id="cns70378-li-0001">ACAT</term><def id="cns70378-li-0002"><p>acyl coenzyme A: cholesterol acyltransferase</p></def></def-item><def-item><term id="cns70378-li-0003">AD</term><def id="cns70378-li-0004"><p>Alzheimer's disease</p></def></def-item><def-item><term id="cns70378-li-0005">ALS</term><def id="cns70378-li-0006"><p>amyotrophic lateral sclerosis</p></def></def-item><def-item><term id="cns70378-li-0007">Apo&#x02010;E</term><def id="cns70378-li-0008"><p>apolipoprotein E</p></def></def-item><def-item><term id="cns70378-li-0009">APP</term><def id="cns70378-li-0010"><p>amyloid precursor protein</p></def></def-item><def-item><term id="cns70378-li-0011">ASC</term><def id="cns70378-li-0012"><p>apoptosis&#x02010;associated speck&#x02010;like protein containing a CARD</p></def></def-item><def-item><term id="cns70378-li-0013">ATAD3A</term><def id="cns70378-li-0014"><p>AAA ATPase domain&#x02010;containing protein 3A</p></def></def-item><def-item><term id="cns70378-li-0015">ATF6</term><def id="cns70378-li-0016"><p>activating transcription factor 6</p></def></def-item><def-item><term id="cns70378-li-0017">ATG14</term><def id="cns70378-li-0018"><p>autophagy&#x02010;related gene 14</p></def></def-item><def-item><term id="cns70378-li-0019">ATP</term><def id="cns70378-li-0020"><p>adenosine triphosphate</p></def></def-item><def-item><term id="cns70378-li-0021">AUTOTAC</term><def id="cns70378-li-0022"><p>autophagy&#x02010;targeting chimera</p></def></def-item><def-item><term id="cns70378-li-0023">A&#x003b2;</term><def id="cns70378-li-0024"><p>&#x003b2;&#x02010;amyloid</p></def></def-item><def-item><term id="cns70378-li-0025">BACE1</term><def id="cns70378-li-0026"><p>&#x003b2;&#x02010;site amyloid precursor protein cleaving enzyme 1</p></def></def-item><def-item><term id="cns70378-li-0027">BAP31</term><def id="cns70378-li-0028"><p>B&#x02010;cell receptor associated protein 31</p></def></def-item><def-item><term id="cns70378-li-0029">BECN1</term><def id="cns70378-li-0030"><p>recombinant beclin 1</p></def></def-item><def-item><term id="cns70378-li-0031">BiP</term><def id="cns70378-li-0032"><p>binding immunoglobulin protein</p></def></def-item><def-item><term id="cns70378-li-0033">CAV1</term><def id="cns70378-li-0034"><p>caveolin&#x02010;1</p></def></def-item><def-item><term id="cns70378-li-0035">CDS2</term><def id="cns70378-li-0036"><p>CDP&#x02010;diacylglycerol synthase&#x02010;2</p></def></def-item><def-item><term id="cns70378-li-0037">CHOP</term><def id="cns70378-li-0038"><p>C/EBP homologous protein</p></def></def-item><def-item><term id="cns70378-li-0039">CL</term><def id="cns70378-li-0040"><p>cardiolipin</p></def></def-item><def-item><term id="cns70378-li-0041">CMT</term><def id="cns70378-li-0042"><p>Charcot&#x02013;Marie&#x02010;Tooth</p></def></def-item><def-item><term id="cns70378-li-0043">DRP1</term><def id="cns70378-li-0044"><p>dynamin&#x02010;related protein1</p></def></def-item><def-item><term id="cns70378-li-0045">ER</term><def id="cns70378-li-0046"><p>endoplasmic reticulum</p></def></def-item><def-item><term id="cns70378-li-0047">FAD</term><def id="cns70378-li-0048"><p>familial AD</p></def></def-item><def-item><term id="cns70378-li-0049">Fis1</term><def id="cns70378-li-0050"><p>fission protein 1</p></def></def-item><def-item><term id="cns70378-li-0051">FUNDC1</term><def id="cns70378-li-0052"><p>FUN14 domain&#x02010;containing protein 1</p></def></def-item><def-item><term id="cns70378-li-0053">FUS</term><def id="cns70378-li-0054"><p>fused in sarcoma</p></def></def-item><def-item><term id="cns70378-li-0055">GRAMD1C</term><def id="cns70378-li-0056"><p>GRAM domain containing 1C</p></def></def-item><def-item><term id="cns70378-li-0057">GRP75</term><def id="cns70378-li-0058"><p>glucose&#x02010;regulated protein 75</p></def></def-item><def-item><term id="cns70378-li-0059">GSK3&#x003b2;</term><def id="cns70378-li-0060"><p>glycogen synthase kinase 3&#x003b2;</p></def></def-item><def-item><term id="cns70378-li-0061">HD</term><def id="cns70378-li-0062"><p>Huntington's disease</p></def></def-item><def-item><term id="cns70378-li-0063">HTT</term><def id="cns70378-li-0064"><p>huntingtin protein</p></def></def-item><def-item><term id="cns70378-li-0065">Insig</term><def id="cns70378-li-0066"><p>insulin&#x02010;induced gene</p></def></def-item><def-item><term id="cns70378-li-0067">InsP3</term><def id="cns70378-li-0068"><p>1,4,5 inositol trisphosphate</p></def></def-item><def-item><term id="cns70378-li-0069">IP3Rs</term><def id="cns70378-li-0070"><p>inositol 1,4,5&#x02010;triphosphate receptors</p></def></def-item><def-item><term id="cns70378-li-0071">IRE1</term><def id="cns70378-li-0072"><p>immunoglobulin&#x02010;regulated enhancer 1</p></def></def-item><def-item><term id="cns70378-li-0073">LRRK2</term><def id="cns70378-li-0074"><p>leucine rich repeat kinase 2</p></def></def-item><def-item><term id="cns70378-li-0075">MAMs</term><def id="cns70378-li-0076"><p>mitochondria&#x02010;associated membranes</p></def></def-item><def-item><term id="cns70378-li-0077">MARCH5</term><def id="cns70378-li-0078"><p>membrane&#x02010;associated RING&#x02010;CH5</p></def></def-item><def-item><term id="cns70378-li-0079">MAVS</term><def id="cns70378-li-0080"><p>mitochondrial antiviral&#x02010;signaling protein</p></def></def-item><def-item><term id="cns70378-li-0081">MCS</term><def id="cns70378-li-0082"><p>membrane contact sites</p></def></def-item><def-item><term id="cns70378-li-0083">MERCS</term><def id="cns70378-li-0084"><p>mitochondria&#x02010;endoplasmic reticulum contact sites</p></def></def-item><def-item><term id="cns70378-li-0085">Mff</term><def id="cns70378-li-0086"><p>mitochondrial fission factor</p></def></def-item><def-item><term id="cns70378-li-0087">MFN1</term><def id="cns70378-li-0088"><p>mitofusin1</p></def></def-item><def-item><term id="cns70378-li-0089">MFN2</term><def id="cns70378-li-0090"><p>mitofusin2</p></def></def-item><def-item><term id="cns70378-li-0091">mHTT</term><def id="cns70378-li-0092"><p>mutant HTT</p></def></def-item><def-item><term id="cns70378-li-0093">MiD49</term><def id="cns70378-li-0094"><p>mitochondrial dynamic proteins of 49</p></def></def-item><def-item><term id="cns70378-li-0095">MiD51</term><def id="cns70378-li-0096"><p>mitochondrial dynamic proteins of 51</p></def></def-item><def-item><term id="cns70378-li-0097">NLRP3</term><def id="cns70378-li-0098"><p>pyrin domain&#x02010;containing protein 3</p></def></def-item><def-item><term id="cns70378-li-0099">Nrf2</term><def id="cns70378-li-0100"><p>nuclear factor&#x02010;erythroid 2&#x02010;related factor 2</p></def></def-item><def-item><term id="cns70378-li-0101">OMM</term><def id="cns70378-li-0102"><p>outer mitochondrial membrane</p></def></def-item><def-item><term id="cns70378-li-0103">OPA1</term><def id="cns70378-li-0104"><p>optic atrophy 1</p></def></def-item><def-item><term id="cns70378-li-0105">ORP5</term><def id="cns70378-li-0106"><p>oxysterol&#x02010;binding protein&#x02010;related proteins 5</p></def></def-item><def-item><term id="cns70378-li-0107">ORP8</term><def id="cns70378-li-0108"><p>oxysterol&#x02010;binding protein&#x02010;related proteins 8</p></def></def-item><def-item><term id="cns70378-li-0109">OSBP</term><def id="cns70378-li-0110"><p>oxysterol binding protein</p></def></def-item><def-item><term id="cns70378-li-0111">PA</term><def id="cns70378-li-0112"><p>phosphatidic acid</p></def></def-item><def-item><term id="cns70378-li-0113">PARP</term><def id="cns70378-li-0114"><p>poly ADP&#x02010;ribose polymerase</p></def></def-item><def-item><term id="cns70378-li-0115">PC</term><def id="cns70378-li-0116"><p>phosphatidylcholine</p></def></def-item><def-item><term id="cns70378-li-0117">PD</term><def id="cns70378-li-0118"><p>Parkinson's disease</p></def></def-item><def-item><term id="cns70378-li-0119">PE</term><def id="cns70378-li-0120"><p>phosphatidylethanolamine</p></def></def-item><def-item><term id="cns70378-li-0121">PEMT2</term><def id="cns70378-li-0122"><p>phosphatidylethanolamine N&#x02010;methyltransferase 2</p></def></def-item><def-item><term id="cns70378-li-0123">PERK</term><def id="cns70378-li-0124"><p>immunoglobulin&#x02010;regulated enhancer 1</p></def></def-item><def-item><term id="cns70378-li-0125">PG</term><def id="cns70378-li-0126"><p>phosphatidylglycerol</p></def></def-item><def-item><term id="cns70378-li-0127">PINK1</term><def id="cns70378-li-0128"><p>PTEN&#x02010;induced putative kinase 1</p></def></def-item><def-item><term id="cns70378-li-0129">polyQ</term><def id="cns70378-li-0130"><p>polyglutamine</p></def></def-item><def-item><term id="cns70378-li-0131">PS</term><def id="cns70378-li-0132"><p>phosphatidylserine</p></def></def-item><def-item><term id="cns70378-li-0133">PS1</term><def id="cns70378-li-0134"><p>presenilin1</p></def></def-item><def-item><term id="cns70378-li-0135">PS2</term><def id="cns70378-li-0136"><p>presenilin2</p></def></def-item><def-item><term id="cns70378-li-0137">PSD</term><def id="cns70378-li-0138"><p>phosphatidylserine decarboxylase</p></def></def-item><def-item><term id="cns70378-li-0139">PSS</term><def id="cns70378-li-0140"><p>phosphatidylserine synthases</p></def></def-item><def-item><term id="cns70378-li-0141">PTPIP51</term><def id="cns70378-li-0142"><p>protein tyrosine phosphatase&#x02010;interacting protein&#x02010;51</p></def></def-item><def-item><term id="cns70378-li-0143">REEP1</term><def id="cns70378-li-0144"><p>receptor expressionenhancing protein 1</p></def></def-item><def-item><term id="cns70378-li-0145">RIG&#x02010;I</term><def id="cns70378-li-0146"><p>RNA helicase retinoic acid inducible gene I</p></def></def-item><def-item><term id="cns70378-li-0147">ROS</term><def id="cns70378-li-0148"><p>reactive oxygen species</p></def></def-item><def-item><term id="cns70378-li-0149">RyRs</term><def id="cns70378-li-0150"><p>ryanodine receptors</p></def></def-item><def-item><term id="cns70378-li-0151">Sig&#x02010;1R</term><def id="cns70378-li-0152"><p>Sigma&#x02010;1 receptor</p></def></def-item><def-item><term id="cns70378-li-0153">SNPs</term><def id="cns70378-li-0154"><p>single&#x02010;nucleotide polymorphisms</p></def></def-item><def-item><term id="cns70378-li-0155">SOD1</term><def id="cns70378-li-0156"><p>superoxide dismutase 1</p></def></def-item><def-item><term id="cns70378-li-0157">STX17</term><def id="cns70378-li-0158"><p>syntaxin 17</p></def></def-item><def-item><term id="cns70378-li-0159">TBI</term><def id="cns70378-li-0160"><p>traumatic brain injury</p></def></def-item><def-item><term id="cns70378-li-0161">TBK1</term><def id="cns70378-li-0162"><p>TANK&#x02010;binding kinase 1</p></def></def-item><def-item><term id="cns70378-li-0163">TDP&#x02010;43</term><def id="cns70378-li-0164"><p>TAR DNA binding&#x02010;protein 43</p></def></def-item><def-item><term id="cns70378-li-0165">TG2</term><def id="cns70378-li-0166"><p>transglutaminase type 2</p></def></def-item><def-item><term id="cns70378-li-0167">TIM23</term><def id="cns70378-li-0168"><p>translocator of the inner mitochondrial membrane</p></def></def-item><def-item><term id="cns70378-li-0169">TOM70</term><def id="cns70378-li-0170"><p>translocase of outer mitochondria&#x02010;70</p></def></def-item><def-item><term id="cns70378-li-0171">UPR</term><def id="cns70378-li-0172"><p>unfolded protein response</p></def></def-item><def-item><term id="cns70378-li-0173">UPRmt</term><def id="cns70378-li-0174"><p>mitochondrial unfolded protein response</p></def></def-item><def-item><term id="cns70378-li-0175">VAPB</term><def id="cns70378-li-0176"><p>vesicle&#x02010;associated membrane proteinassociated protein B</p></def></def-item><def-item><term id="cns70378-li-0177">VCP</term><def id="cns70378-li-0178"><p>valocin&#x02010;containing protein</p></def></def-item><def-item><term id="cns70378-li-0179">VDAC</term><def id="cns70378-li-0180"><p>voltage&#x02010;dependent anion channels</p></def></def-item></def-list><sec id="cns70378-sec-0001"><label>1</label><title>Introduction</title><p>The World Health Organization has announced that neurodegenerative diseases will pose the most significant health challenges in the twenty&#x02010;first century [<xref rid="cns70378-bib-0001" ref-type="bibr">1</xref>]. These diseases have emerged as a widespread and increasingly significant cause of both mortality and morbidity globally, especially among the older population [<xref rid="cns70378-bib-0002" ref-type="bibr">2</xref>]. Unfortunately, for the majority of neurodegenerative diseases, effective treatments remain elusive [<xref rid="cns70378-bib-0003" ref-type="bibr">3</xref>]. Recently, some research has shown that neurons heavily rely on a special area called mitochondria&#x02010;associated membranes (MAMs) for signaling molecules and metabolite exchange between organelles [<xref rid="cns70378-bib-0004" ref-type="bibr">4</xref>].</p><p>MAM refers to vital interfaces between the mitochondrial outer membrane and endoplasmic reticulum (ER) membrane which play a key role in regulating intracellular signaling and cellular metabolism [<xref rid="cns70378-bib-0005" ref-type="bibr">5</xref>]. As an outstanding platform for crosstalk between the ER and mitochondria, MAM plays a crucial role in diverse signaling pathways that facilitate swift exchange of biological molecules, thereby keeping cellular healthy [<xref rid="cns70378-bib-0006" ref-type="bibr">6</xref>]. Studies have shown that MAMs have significant effects on a variety of cellular processes, including Ca<sup>2+</sup> signal transduction, lipid metabolism, inflammation, autophagy, apoptosis, and ER stress [<xref rid="cns70378-bib-0007" ref-type="bibr">7</xref>, <xref rid="cns70378-bib-0008" ref-type="bibr">8</xref>]. Notably, there is a significant preponderance of genes linked to mitochondrial and ER homeostasis in numerous inherited neurodegenerative disorders, emphasizing the crucial role of MAMs in neuronal function [<xref rid="cns70378-bib-0004" ref-type="bibr">4</xref>]. This provides a new idea for the treatment of neurodegenerative diseases. This review will focus on the structural composition and function of MAMs. In addition, it will summarize various neurodegenerative diseases and their relationship with MAMs.</p></sec><sec id="cns70378-sec-0002"><label>2</label><title>Structural Composition of <styled-content style="fixed-case" toggle="no">MAMs</styled-content>
</title><p>The initial measurement revealed a distance of approximately 100&#x02009;nm between the ER and mitochondria [<xref rid="cns70378-bib-0009" ref-type="bibr">9</xref>]. With the development of microscope technology, the first electron microscopy analysis revealed a distance ranging from approximately 10&#x02013;30&#x02009;nm [<xref rid="cns70378-bib-0010" ref-type="bibr">10</xref>]. Research indicates that a distance of &#x0003c;&#x02009;30&#x02009;nm between the two organelles suggests their connection [<xref rid="cns70378-bib-0011" ref-type="bibr">11</xref>]. MAMs are not formed by membrane fusion [<xref rid="cns70378-bib-0012" ref-type="bibr">12</xref>]. Instead, they use protein tethers to bring the membranes close together, allowing signaling molecules to move quickly and directly between the two compartments [<xref rid="cns70378-bib-0012" ref-type="bibr">12</xref>]. The distance between the ER and mitochondria within MAMs varies based on their specific function [<xref rid="cns70378-bib-0013" ref-type="bibr">13</xref>]. For example, in MAMs involved in Ca<sup>2+</sup> exchange, the distance ranges from 10 to 25&#x02009;nm, conducive to accommodating Ca<sup>2+</sup> channels [<xref rid="cns70378-bib-0014" ref-type="bibr">14</xref>]. When ER tubules participate in mitochondrial fission, they enclose mitochondria at approximately 30&#x02009;nm, exhibiting a distinct spatial arrangement [<xref rid="cns70378-bib-0015" ref-type="bibr">15</xref>]. In the 1990s, Vance et&#x000a0;al. were the first to isolate MAMs from mouse liver by a special method and investigate its biochemical functions [<xref rid="cns70378-bib-0016" ref-type="bibr">16</xref>]. MAMs are composed of the outer membrane of mitochondria and adjacent subdomains of the ER [<xref rid="cns70378-bib-0017" ref-type="bibr">17</xref>]. These structures are made up of phospholipids and display dynamic fluctuations due to their high fluidity [<xref rid="cns70378-bib-0017" ref-type="bibr">17</xref>, <xref rid="cns70378-bib-0018" ref-type="bibr">18</xref>]. Numerous research studies show that the narrow gap between the ER and mitochondria hosts numerous proteins [<xref rid="cns70378-bib-0019" ref-type="bibr">19</xref>]. The MAM executes its duties through these proteins as its primary means [<xref rid="cns70378-bib-0008" ref-type="bibr">8</xref>]. The initial comprehensive proteome analysis of MAMs was conducted by Zhang et&#x000a0;al., revealing approximately 991 proteins within the MAM fraction [<xref rid="cns70378-bib-0020" ref-type="bibr">20</xref>]. Subsequently, Poston et&#x000a0;al. expanded the pool of candidates to 1212, encompassing even weakly soluble proteins present at the MAM [<xref rid="cns70378-bib-0021" ref-type="bibr">21</xref>]. In addition to modulating MAM physical interaction, these proteins located on MAMs also play a significant role in regulating the tethering complexes in MAM [<xref rid="cns70378-bib-0022" ref-type="bibr">22</xref>]. There are four major tethering complexes in MAMs of mammalian cells [<xref rid="cns70378-bib-0023" ref-type="bibr">23</xref>].</p><sec id="cns70378-sec-0003"><label>2.1</label><title>VAPB&#x02010;PTPIP51</title><p>Vesicle&#x02010;associated membrane protein&#x02010;associated protein B (VAPB), a membrane protein associated with vesicles in the ER, interacts with protein tyrosine phosphatase&#x02010;interacting protein&#x02010;51 (PTPIP51), a protein found on the outer mitochondrial membrane (OMM; Figure&#x000a0;<xref rid="cns70378-fig-0001" ref-type="fig">1a</xref>) [<xref rid="cns70378-bib-0024" ref-type="bibr">24</xref>]. Together, they form the VAPB&#x02010;PTPIP51 tethering complex, which plays a crucial role in regulating the transmission of Ca<sup>2+</sup> between the ER and mitochondria, mitochondrial adenosine triphosphate (ATP) production, bioenergetics, lipid synthesis, autophagy, and synaptic activity&#x000a0;[<xref rid="cns70378-bib-0025" ref-type="bibr">25</xref>, <xref rid="cns70378-bib-0026" ref-type="bibr">26</xref>, <xref rid="cns70378-bib-0027" ref-type="bibr">27</xref>].</p><fig position="float" fig-type="FIGURE" id="cns70378-fig-0001"><label>FIGURE 1</label><caption><p>Four major tethering complexes in MAMs of mammalian cells. There are many complex proteins in MAMs. Four of the most important complexes are VAPB&#x02010;PTPIP51, BAP31&#x02010;Fis1, IP3R&#x02010;GRP75&#x02010;VDAC, and MFN2&#x02010;MFN1. These four tethering complexes have different functions, but they all play a role in neurodegenerative diseases.</p></caption><graphic xlink:href="CNS-31-e70378-g001" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="cns70378-sec-0004"><label>2.2</label><title>BAP31&#x02010; Fis1</title><p>During apoptosis, B&#x02010;cell receptor&#x02010;associated protein 31 (BAP31), a protein located in the ER, interacts with the mitochondrial fission protein 1 (Fis1) on the OMM, serving as a tether for MAMs and triggering the apoptotic process (Figure&#x000a0;<xref rid="cns70378-fig-0001" ref-type="fig">1b</xref>) [<xref rid="cns70378-bib-0028" ref-type="bibr">28</xref>]. The BAP31&#x02010;Fis1 complex plays a pivotal role in recruiting and activating procaspase 8, thereby facilitating the transmission of proapoptotic signals from mitochondria to the ER [<xref rid="cns70378-bib-0023" ref-type="bibr">23</xref>].</p></sec><sec id="cns70378-sec-0005"><label>2.3</label><title>IP3R&#x02010; GRP75&#x02014;VDAC</title><p>The tripartite complex formed by the ER Ca<sup>2+</sup> channel inositol 1,4,5&#x02010;triphosphate receptors (IP3Rs), the OMM voltage&#x02010;dependent anion channels (VDACs), and the cytoplasmic chaperone glucose&#x02010;regulated protein 75 (GRP75) regulates the juxtaposition of ER and mitochondria (Figure&#x000a0;<xref rid="cns70378-fig-0001" ref-type="fig">1c</xref>) [<xref rid="cns70378-bib-0029" ref-type="bibr">29</xref>]. GRP75 oversees the interaction between IP3Rs and VDAC1, ensuring the conformational stability of IP3Rs involved in facilitating Ca<sup>2+</sup> transport from the ER to mitochondria [<xref rid="cns70378-bib-0030" ref-type="bibr">30</xref>]. The Sigma&#x02010;1 receptor (Sig&#x02010;1R) interacts with other ER chaperones, such as the binding immunoglobulin protein (BiP), via the IP3R&#x02010;VDAC complex [<xref rid="cns70378-bib-0031" ref-type="bibr">31</xref>]. Through this interaction, Sig&#x02010;1R helps regulate various functions by supporting the formation of Ca<sup>2+</sup>&#x02010;sensitive complexes, which strengthen ionic signaling between the ER and mitochondria [<xref rid="cns70378-bib-0031" ref-type="bibr">31</xref>].</p></sec><sec id="cns70378-sec-0006"><label>2.4</label><title>MFN2&#x02010;MFN1</title><p>Mitofusin2, also known as MFN2, was initially characterized as a dynamin&#x02010;like protein that plays a crucial role in the fusion of the OMM [<xref rid="cns70378-bib-0032" ref-type="bibr">32</xref>]. This protein is integral to mitochondrial fusion processes and contributes significantly to the preservation of the mitochondrial network [<xref rid="cns70378-bib-0033" ref-type="bibr">33</xref>]. ER&#x02010;resident MFN2 creates either homodimer or heterodimer connections with mitofusin1 (MFN1) or itself on the OMM (Figure&#x000a0;<xref rid="cns70378-fig-0001" ref-type="fig">1d</xref>) [<xref rid="cns70378-bib-0034" ref-type="bibr">34</xref>]. MFN1 and MFN2 possess overlapping yet distinct functionalities, operating within three distinct molecular complexes to facilitate mitochondrial fusion [<xref rid="cns70378-bib-0035" ref-type="bibr">35</xref>].</p></sec></sec><sec id="cns70378-sec-0007"><label>3</label><title>Functions of <styled-content style="fixed-case" toggle="no">MAMs</styled-content>
</title><sec id="cns70378-sec-0008"><label>3.1</label><title>Lipid Metabolism and Transportation</title><p>The MAM plays a pivotal role in numerous lipid metabolic pathways [<xref rid="cns70378-bib-0013" ref-type="bibr">13</xref>]. Phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL) are produced within the mitochondria, yet their precursors and a majority of mitochondrial phospholipids undergo synthesis in the ER prior to being transferred to the mitochondria [<xref rid="cns70378-bib-0036" ref-type="bibr">36</xref>]. Phosphatidylserine (PS) is generated through the action of phosphatidylserine synthases (PSS) in the MAM, and it is then transformed into PE by PS decarboxylase (PSD) within the mitochondria [<xref rid="cns70378-bib-0037" ref-type="bibr">37</xref>]. PE is then transformed into phosphatidylcholine (PC) by some enzymes including phosphatidylethanolamine N&#x02010;methyltransferase 2 (PEMT2), which was discovered to be exclusively located within the MAMs [<xref rid="cns70378-bib-0038" ref-type="bibr">38</xref>, <xref rid="cns70378-bib-0039" ref-type="bibr">39</xref>, <xref rid="cns70378-bib-0040" ref-type="bibr">40</xref>]. In addition, MAMs are rich in other proteins that participate in lipid metabolism, such as fatty acid CoA ligase 4, acyl coenzyme A: cholesterol acyltransferase (ACAT), and diacylglycerol acyltransferase 2 [<xref rid="cns70378-bib-0041" ref-type="bibr">41</xref>, <xref rid="cns70378-bib-0042" ref-type="bibr">42</xref>].</p><p>Vance et&#x000a0;al. demonstrated that apart from vesicle transportation, lipid transport between organelles may also occur through protein&#x02010;facilitated reactions or tight junctions between membranes [<xref rid="cns70378-bib-0043" ref-type="bibr">43</xref>]. MAMs create a hydrophilic interface between the ER and mitochondria, fostering the bidirectional and nonvesicular exchange of lipids [<xref rid="cns70378-bib-0042" ref-type="bibr">42</xref>]. Studies have pinpointed relative proteins situated in the MAM, namely oxysterol&#x02010;binding protein&#x02010;related proteins 5 and 8 (ORP5/8), MFN2, and CDP&#x02010;diacylglycerol synthase&#x02010;2 (CDS2), which facilitate the nonvascular transfer of PS from the ER to mitochondria [<xref rid="cns70378-bib-0044" ref-type="bibr">44</xref>, <xref rid="cns70378-bib-0045" ref-type="bibr">45</xref>, <xref rid="cns70378-bib-0046" ref-type="bibr">46</xref>]. CL undergoes a series of modifications derived from phosphatidic acid (PA), and research indicates that the VAPB&#x02010;PTPIP51 complex plays a crucial role in regulating the transfer of PA within the MAMs [<xref rid="cns70378-bib-0047" ref-type="bibr">47</xref>]. GRAM domain containing 1C (GRAMD1C) and caveolin&#x02010;1 (CAV1), both located in the MAM, have also been shown to be involved in the transport of lipids between membranes [<xref rid="cns70378-bib-0048" ref-type="bibr">48</xref>, <xref rid="cns70378-bib-0049" ref-type="bibr">49</xref>]. All these processes are summarized in Figure&#x000a0;<xref rid="cns70378-fig-0002" ref-type="fig">2</xref>.</p><fig position="float" fig-type="FIGURE" id="cns70378-fig-0002"><label>FIGURE 2</label><caption><p>MAM in lipid metabolism and transportation. PA is transformed to PS by PSS in the ER. PS is transferred from the ER to mitochondria with the action of ORP5/8, MFN2, and CDS2. Then, it can be transformed to PE by PSD in mitochondria. PE moves to the ER and is transferred to PC by PEMT2. Finally, PC can be transformed to mitochondria again. VAPB&#x02010;PTPIP51 also plays a role in the movement of PA. GRAMD1C and CAV1 are proved to take part in the movement of cholesterol from the ER to mitochondria.</p></caption><graphic xlink:href="CNS-31-e70378-g004" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="cns70378-sec-0009"><label>3.2</label><title>Ca<sup>2+</sup> Transportation</title><p>MAMs act as central hubs for Ca<sup>2+</sup> signaling [<xref rid="cns70378-bib-0050" ref-type="bibr">50</xref>]. They enable the transfer of Ca<sup>2+</sup> from the ER, which is a key storage site for this ion, to mitochondria through the physical contact points mediated by MAMs [<xref rid="cns70378-bib-0050" ref-type="bibr">50</xref>]. MAM harbors two distinct calcium&#x02010;releasing channels: ryanodine receptors (RyRs) and IP3Rs [<xref rid="cns70378-bib-0051" ref-type="bibr">51</xref>]. Although RyRs have been shown to play a role in neurodegenerative diseases, studies on its association with MAMs have been lacking [<xref rid="cns70378-bib-0052" ref-type="bibr">52</xref>]. The IP3R, which is abundantly present at ER&#x02010;mitochondrial contact sites, is considered the key Ca<sup>2+</sup> channel facilitating the release of Ca<sup>2+</sup> from the ER to mitochondria [<xref rid="cns70378-bib-0037" ref-type="bibr">37</xref>]. Upon activation, IP3R on the ER membrane releases Ca<sup>2+</sup> from the lumen [<xref rid="cns70378-bib-0008" ref-type="bibr">8</xref>]. With GRP75's aid, Ca<sup>2+</sup> is then sequestered by VDAC1 on the OMM, traverses the MCU of the IMM, and forms a Ca<sup>2+</sup> signaling cascade within MAMs [<xref rid="cns70378-bib-0008" ref-type="bibr">8</xref>]. Besides the previously mentioned proteins, MAMs contain numerous other proteins vital to Ca<sup>2+</sup> transport. Glycogen synthase kinase 3&#x003b2; (GSK3&#x003b2;) modulates mitochondrial Ca<sup>2+</sup> homeostasis in cardiomyocytes through its interaction with IP3Rs [<xref rid="cns70378-bib-0053" ref-type="bibr">53</xref>]. Cyclophilin D plays a crucial role in maintaining cardiac function by regulating calcium dynamics in these cells [<xref rid="cns70378-bib-0054" ref-type="bibr">54</xref>]. Sig&#x02010;1R, a non&#x02010;G&#x02010;protein coupled chaperone of the ER, preserves the stability of IP3R, also ensuring effective Ca<sup>2+</sup> signaling between the ER and mitochondria [<xref rid="cns70378-bib-0055" ref-type="bibr">55</xref>]. Moreover, calnexin participates in protein folding while also engaging with ER Ca<sup>2+</sup> pumps [<xref rid="cns70378-bib-0056" ref-type="bibr">56</xref>]. Besides, studies have shown that the distance between the ER and mitochondria can influence Ca<sup>2+</sup> transport and organelle function [<xref rid="cns70378-bib-0057" ref-type="bibr">57</xref>]. A 15&#x02009;nm increase in this distance enhances Ca<sup>2+</sup> transport efficiency, whereas a reduction to 5&#x02009;nm results in decreased efficiency [<xref rid="cns70378-bib-0058" ref-type="bibr">58</xref>].</p></sec><sec id="cns70378-sec-0010"><label>3.3</label><title>Mitochondrial Dynamics</title><p>Mitochondrial dynamics, encompassing both fission and fusion, are essential for upholding cellular homeostasis [<xref rid="cns70378-bib-0018" ref-type="bibr">18</xref>]. MAM regulates mitochondrial morphology, including shape, size, and length, by balancing mitochondrial fusion and fission processes [<xref rid="cns70378-bib-0059" ref-type="bibr">59</xref>]. Mitochondrial fission is regulated by motility&#x02010;related GTPase proteins, including dynamin&#x02010;related protein1 (DRP1) and its receptors Fis1, mitochondrial fission factor (Mff), as well as mitochondrial dynamic proteins of 49 and 51 (MiD49 and MiD51), which together control the process [<xref rid="cns70378-bib-0060" ref-type="bibr">60</xref>]. Drp1 resides primarily in the cytoplasm and is summoned to ER&#x02010;mitochondrial contact sites via receptors like Mff, Fis1, and MiD49/51 [<xref rid="cns70378-bib-0061" ref-type="bibr">61</xref>, <xref rid="cns70378-bib-0062" ref-type="bibr">62</xref>]. There, it assembles into a helical oligomer, triggering membrane constriction and scission [<xref rid="cns70378-bib-0061" ref-type="bibr">61</xref>, <xref rid="cns70378-bib-0062" ref-type="bibr">62</xref>]. Mitochondrial fusion necessitates synchronized outer and inner membrane fusion processes, primarily controlled by three GTPases: MFN1, MFN2, and optic atrophy 1 (OPA1) [<xref rid="cns70378-bib-0063" ref-type="bibr">63</xref>]. MFN2 can form dimers with either MFN1 or MFN2 present on the mitochondria, thereby facilitating the fusion of the OMM of mitochondria [<xref rid="cns70378-bib-0035" ref-type="bibr">35</xref>]. The pro&#x02010;apoptotic Bcl2 protein Bax also interacts with MFN2 to enhance mitochondrial fusion in healthy cells [<xref rid="cns70378-bib-0064" ref-type="bibr">64</xref>]. In this process, the soluble, monomeric form of Bax regulates the assembly of MFN2 complexes at the sites of mitochondrial fusion [<xref rid="cns70378-bib-0064" ref-type="bibr">64</xref>]. Some other MAM&#x02010;associated molecules also play a significant role in regulating mitochondrial dynamics, such as syntaxin 17 (STX17), the ER&#x02010;anchored isoform of the formin protein inverted formin 2, phosphofurin acidic cluster sorting protein 2, FUN14 domain&#x02010;containing protein 1 (FUNDC1), and so on [<xref rid="cns70378-bib-0065" ref-type="bibr">65</xref>, <xref rid="cns70378-bib-0066" ref-type="bibr">66</xref>, <xref rid="cns70378-bib-0067" ref-type="bibr">67</xref>].</p></sec><sec id="cns70378-sec-0011"><label>3.4</label><title>Autophagy and Apoptosis</title><p>A significant number of autophagic proteins reside in MAMs, and it is possible that autophagosomal membranes are derived from these structures&#x000a0;[<xref rid="cns70378-bib-0018" ref-type="bibr">18</xref>]. After autophagy induction, the preautophagosome marker autophagy&#x02010;related gene 14&#x02010;like (ATG14L) and omegaome marker double FYVE domain&#x02010;containing protein 1 localize to the MAMs again to stimulate the formation of autophagosome [<xref rid="cns70378-bib-0068" ref-type="bibr">68</xref>]. Additionally, ATG5, another marker of autophagosome formation, also relocates to the MAMs following starvation [<xref rid="cns70378-bib-0069" ref-type="bibr">69</xref>]. It has been reported that the recruitment of ATG5 and ATG14 is regulated by soluble N&#x02010;ethylmaleimide&#x02010;sensitive factor attachment protein receptor protein STX17 [<xref rid="cns70378-bib-0069" ref-type="bibr">69</xref>]. The tethering complex VAPB&#x02010;PTPIP51 also plays a role in regulating autophagy. Increasing the expression of VAPB or PTPIP51 can decrease autophagosome formation by strengthening the connections between the ER and mitochondria [<xref rid="cns70378-bib-0024" ref-type="bibr">24</xref>]. Conversely, decreasing these contacts by suppressing VAPB or PTPIP51 expression can promote autophagosome formation [<xref rid="cns70378-bib-0024" ref-type="bibr">24</xref>]. Moreover, during hypoxic conditions, key enzymes involved in mitophagy, including PTEN&#x02010;induced putative kinase 1 (PINK1), recombinant beclin 1 (BECN1), PARK2, and FUNDC1, accumulate at the MAM to initiate autophagosome formation, thereby facilitating the removal of damaged mitochondria [<xref rid="cns70378-bib-0070" ref-type="bibr">70</xref>, <xref rid="cns70378-bib-0071" ref-type="bibr">71</xref>].</p><p>Tethering complex BAP31&#x02010; Fis1 and IP3R&#x02010; GRP75&#x02014;VDAC in MAMs both contribute to apoptosis [<xref rid="cns70378-bib-0072" ref-type="bibr">72</xref>]. The protein Fis1 on the OMM plays a crucial role in recruiting DRP1 to sites of mitochondrial division [<xref rid="cns70378-bib-0073" ref-type="bibr">73</xref>]. Meanwhile, the ER chaperone BAP31 modulates the degradation of misfolded proteins and the apoptotic pathway [<xref rid="cns70378-bib-0074" ref-type="bibr">74</xref>]. The apoptotic signal originating from mitochondria is transmitted to the ER via Fis1's physical interaction with BAP31, triggering caspase&#x02010;dependent cleavage of BAP31 [<xref rid="cns70378-bib-0075" ref-type="bibr">75</xref>]. This cascade leads to the activation of procaspase&#x02010;8, which moves to the MAM by the Fis1&#x02010;BAP31 tethering complex [<xref rid="cns70378-bib-0075" ref-type="bibr">75</xref>]. Effectively suppressing IP3R expression attenuated apoptosis triggered by both extrinsic and intrinsic apoptotic pathways [<xref rid="cns70378-bib-0076" ref-type="bibr">76</xref>]. Analogously, downregulation of VDAC1 expression specifically rescued the apoptotic process initiated by low&#x02010;amplitude apoptotic Ca<sup>2+</sup> signal transduction [<xref rid="cns70378-bib-0077" ref-type="bibr">77</xref>].</p></sec><sec id="cns70378-sec-0012"><label>3.5</label><title>
<styled-content style="fixed-case" toggle="no">ER</styled-content> Stress</title><p>An imbalance between the protein folding demands and the ER's folding capacity, resulting from physiological needs or disease conditions, can trigger ER stress [<xref rid="cns70378-bib-0078" ref-type="bibr">78</xref>]. This results in the accumulation of unfolded or misfolded proteins within the ER lumen, triggering the activation of the unfolded protein response (UPR) [<xref rid="cns70378-bib-0011" ref-type="bibr">11</xref>]. UPR is a conserved adaptive pathway that enables the recovery of normal functions in organelles, even when misfolded proteins accumulate in them [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>]. The pathway is primarily mediated by the ER&#x02010;resident sensor proteins immunoglobulin&#x02010;regulated enhancer 1 (IRE1), protein kinase R&#x02010;like endoplasmic reticulum kinase (PERK), and activating transcription factor 6 (ATF6), which are normally maintained in an inactive state by GRP78 [<xref rid="cns70378-bib-0080" ref-type="bibr">80</xref>]. Studies show that the lack of PERK reduces endogenous apoptosis caused by ER stress [<xref rid="cns70378-bib-0081" ref-type="bibr">81</xref>]. This is because PERK deficiency hinders MAM formation and interferes with the transmission of ROS signals to nearby mitochondria [<xref rid="cns70378-bib-0081" ref-type="bibr">81</xref>]. IRE1's presence in MAMs determines IP3R's effectiveness in facilitating Ca<sup>2+</sup> transfer to mitochondria [<xref rid="cns70378-bib-0082" ref-type="bibr">82</xref>]. These mechanisms bridge the gap between ER stress and mitochondrial function, ultimately influencing cellular fate.</p></sec><sec id="cns70378-sec-0013"><label>3.6</label><title>Mitochondrial Stress</title><p>To uphold cellular stability and prevent stress&#x02010;related damage, mitochondria trigger a series of reactions termed mitochondrial stress responses. These include the dynamic processes of fission and fusion, mitophagy, mitochondrial unfolded protein response (UPRmt), and antioxidant defenses [<xref rid="cns70378-bib-0083" ref-type="bibr">83</xref>]. We have already mentioned fission, fusion, and mitophagy before. Now, we will focus on UPRmt and antioxidant defenses. The synchronization of UPR signaling with energetic requirements occurs at MAMs, which are specialized regions facilitating communication between organelles [<xref rid="cns70378-bib-0084" ref-type="bibr">84</xref>]. Studies have demonstrated that MAMs transmit stress signals from the ER to mitochondrial targets through UPR pathways, particularly when ER protease homeostasis is disrupted [<xref rid="cns70378-bib-0085" ref-type="bibr">85</xref>]. During the UPR's adaptive phase, ER&#x02010;mitochondrial interactions increase ATP production by facilitating Ca<sup>2+</sup> transfer through MAMs [<xref rid="cns70378-bib-0084" ref-type="bibr">84</xref>]. Additionally, numerous other UPR pathway components and calcium&#x02010;regulating factors are situated at the MAMs. For antioxidant defenses, studies have shown that MAMs exerts an indirect antioxidant effect by regulating Ca<sup>2+</sup> flow and lipid metabolism to maintain mitochondrial function [<xref rid="cns70378-bib-0086" ref-type="bibr">86</xref>]. Take for example, Sig&#x02010;1R located in MAMs exhibits antioxidant properties by regulating Ca<sup>2+</sup> and lipid transport, effectively decreasing lipid peroxidation [<xref rid="cns70378-bib-0087" ref-type="bibr">87</xref>]. Proteins in MAMs, such as STARD7, are also involved in the synthesis and transport of coenzyme Q (CoQ), which is an important component of the mitochondrial antioxidant defense system [<xref rid="cns70378-bib-0088" ref-type="bibr">88</xref>]. Moreover, in Alzheimer's disease, the MAM reduces oxidative stress and delays disease progression by regulating the communication between mitochondria and ER [<xref rid="cns70378-bib-0019" ref-type="bibr">19</xref>].</p></sec><sec id="cns70378-sec-0014"><label>3.7</label><title>Inflammation</title><p>Tschopp et&#x000a0;al. observed that ROS promotes the activation of the NLRP3 inflammasome, a member of the NOD&#x02010;like receptor family [<xref rid="cns70378-bib-0089" ref-type="bibr">89</xref>]. This finding connects the ER&#x02010;mitochondria interface to the regulation of inflammatory responses [<xref rid="cns70378-bib-0089" ref-type="bibr">89</xref>]. The MAM was discovered to play a dual role, not only participating in the activation of inflammation but also serving as a hub for NLRP3 inflammasome assembly [<xref rid="cns70378-bib-0090" ref-type="bibr">90</xref>]. In its resting state, NLRP3 resides in the cytoplasm and within the ER [<xref rid="cns70378-bib-0090" ref-type="bibr">90</xref>]. After stimulation, the NLRP3 inflammasome is recruited to MAM sites together with its adaptor apoptosis&#x02010;associated speck&#x02010;like protein containing a CARD (ASC), indicating that NLRP3 accumulates strategically at mitochondria to detect mitochondrial damage [<xref rid="cns70378-bib-0089" ref-type="bibr">89</xref>]. Moreover, the distribution of the VDAC protein across MAM holds significant implications for the inflammatory response [<xref rid="cns70378-bib-0011" ref-type="bibr">11</xref>]. VDAC1 plays a pivotal role not just in facilitating the mitochondrial uptake of Ca<sup>2+</sup> but also in augmenting the generation of ROS [<xref rid="cns70378-bib-0089" ref-type="bibr">89</xref>]. Notably, the downregulation of VDAC1 markedly suppresses the formation of the IL&#x02010;1&#x003b2; inflammasome, further emphasizing its crucial function in the inflammatory cascade [<xref rid="cns70378-bib-0089" ref-type="bibr">89</xref>].</p></sec><sec id="cns70378-sec-0015"><label>3.8</label><title>Regulation of Antiviral Signaling</title><p>Upon infection with an RNA virus, the cytosolic RNA helicase retinoic acid inducible gene I (RIG&#x02010;I) receptor, responsible for recognizing pathogens, is recruited to the junction between the ER and mitochondria [<xref rid="cns70378-bib-0091" ref-type="bibr">91</xref>]. There, it recruits its adaptor protein mitochondrial antiviral&#x02010;signaling protein (MAVS), initiating an intracellular immune hub that triggers the body's natural defenses against the virus [<xref rid="cns70378-bib-0091" ref-type="bibr">91</xref>]. Moreover, Michael Gale Jr.'s group conducted proteomic analysis, revealing the localization of novel proteins to MAMs during RNA virus replication, including members of the RAS oncogene family 1B, vitronectin, and Lon peptidase 1 [<xref rid="cns70378-bib-0092" ref-type="bibr">92</xref>].</p></sec></sec><sec id="cns70378-sec-0016"><label>4</label><title>
<styled-content style="fixed-case" toggle="no">MAMs</styled-content> in Neurodegenerative Diseases</title><sec id="cns70378-sec-0017"><label>4.1</label><title>Alzheimers' Disease</title><p>Alzheimer's disease (AD) remains the most prevalent cause of dementia, making up a significant portion (80%) of dementia diagnoses [<xref rid="cns70378-bib-0093" ref-type="bibr">93</xref>]. It stands as the primary cause of dementia, swiftly emerging as one of the most costly, fatal, and burdensome illnesses of this century [<xref rid="cns70378-bib-0094" ref-type="bibr">94</xref>]. The disease typically begins with mild memory problems&#x000a0;[<xref rid="cns70378-bib-0095" ref-type="bibr">95</xref>]. Over time, it progresses to more noticeable cognitive decline, difficulty performing complex daily tasks, and impairments in other cognitive functions [<xref rid="cns70378-bib-0095" ref-type="bibr">95</xref>]. Alzheimer's currently affects more than 55 million people worldwide [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>].</p><p>The aberrant cleavage of the amyloid precursor protein (APP) serves as a key indicator of AD pathogenesis [<xref rid="cns70378-bib-0004" ref-type="bibr">4</xref>]. Key contributors to familial AD (FAD) are mutations in presenilin1 (PS1) and presenilin2 (PS2), integral components of the &#x003b3;&#x02010;secretase complex that is instrumental in APP processing [<xref rid="cns70378-bib-0097" ref-type="bibr">97</xref>]. Research has demonstrated that MAMs serve as a hub for key proteins implicated in AD pathogenesis [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. One reason is that both PS1 and PS2 are highly concentrated in MAMs [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. Additionally, ACAT, an enzyme thought to play a key role in A&#x003b2; production, is also mainly located in these membrane compartments [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. Eric Schon's team initially established the concentration of presenilins in the MAM, proposing it as the primary subcellular locale for PS1/PS2 and &#x003b3;&#x02010;secretase activity&#x000a0;[<xref rid="cns70378-bib-0072" ref-type="bibr">72</xref>]. Subsequently, they discovered a marked elevation in MAM functionality and ER&#x02010;mitochondrial communication in cells lacking presenilin as well as in fibroblasts derived from patients with both familial and sporadic forms of AD [<xref rid="cns70378-bib-0072" ref-type="bibr">72</xref>]. When PS1 and PS2 mutate, these proteins trigger the opening of IP3R channels, leading to an influx of intracellular Ca<sup>2+</sup> and ultimately stimulating the production of A&#x003b2; [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. Moreover, Area&#x02010;Gomez et&#x000a0;al. demonstrated that APP is also enhanced and active in a MAM&#x02010;enriched subcellular fraction [<xref rid="cns70378-bib-0099" ref-type="bibr">99</xref>].</p><p>Sig&#x02010;1R also plays a significant role in Alzheimer's disease. Although Sig&#x02010;1R levels remain relatively stable during normal aging, it has been observed that there is a decrease in Sig&#x02010;1R levels in the brains and postmortem tissues of AD patients [<xref rid="cns70378-bib-0100" ref-type="bibr">100</xref>]. The interaction between Sig&#x02010;1R and insulin&#x02010;induced gene (Insig) may play a significant role in this disease, given that Insig has been implicated in disease progression through its influence on cholesterol synthesis [<xref rid="cns70378-bib-0101" ref-type="bibr">101</xref>]. Sig&#x02010;1R plays a crucial role in preserving the structural integrity of the MAM, presumably by anchoring it to IP3R and VDAC [<xref rid="cns70378-bib-0102" ref-type="bibr">102</xref>]. An increase in the expression of IP3R and VDAC has been observed in brain samples from AD patients [<xref rid="cns70378-bib-0102" ref-type="bibr">102</xref>]. VDAC is a key protein that interacts with more than 150 other proteins, such as phosphorylated tau, A&#x003b2;, and &#x003b3;&#x02010;secretase [<xref rid="cns70378-bib-0103" ref-type="bibr">103</xref>]. These interactions may enhance their harmful effects, potentially triggering cell death and mitochondrial dysfunction during the development and progression of AD [<xref rid="cns70378-bib-0103" ref-type="bibr">103</xref>]. The functional impairment of Sig&#x02010;1R also plays a crucial role in neuronal loss triggered by &#x003b2;&#x02010;amyloid (A&#x003b2;) [<xref rid="cns70378-bib-0104" ref-type="bibr">104</xref>]. As the central component of AD pathology, A&#x003b2; is composed of self&#x02010;aggregated peptides containing 40&#x02013;42 amino acids derived from the proteolysis of APP, a membrane protein ubiquitously expressed in the central nervous system [<xref rid="cns70378-bib-0105" ref-type="bibr">105</xref>]. In the amyloidogenic process, APP is initially cleaved by &#x003b2;&#x02010;secretase, releasing a soluble APP&#x003b2; fragment and C99 [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>]. Subsequently, &#x003b3;&#x02010;secretase cleaves C99, generating the APP intracellular domain and A&#x003b2; [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>]. In healthy neurons, C99 is cleaved to generate A&#x003b2;40 (40 amino acids long) [<xref rid="cns70378-bib-0106" ref-type="bibr">106</xref>]. However, in neurons affected by AD, C99 is cleaved to produce A&#x003b2;42 (42 amino acids long), leading to an increased ratio of A&#x003b2;42 to A&#x003b2;40 [<xref rid="cns70378-bib-0106" ref-type="bibr">106</xref>]. This accumulation of A&#x003b2;42 in plaques can cause cellular toxicity and result in abnormal hyperphosphorylation of tau [<xref rid="cns70378-bib-0106" ref-type="bibr">106</xref>]. APP and &#x003b2;&#x02010;secretases in this process are present in MAMs, where they engage in APP processing activities [<xref rid="cns70378-bib-0107" ref-type="bibr">107</xref>]. Enhanced expression of mutant APP or exposure to nanomolar levels of A&#x003b2; elevates the number of ER&#x02010;mitochondria contact points and mitochondrial Ca<sup>2+</sup> concentrations [<xref rid="cns70378-bib-0102" ref-type="bibr">102</xref>, <xref rid="cns70378-bib-0107" ref-type="bibr">107</xref>]. The interaction of Ca<sup>2+</sup> with &#x003b2;&#x02010;site amyloid precursor protein cleaving enzyme 1 (BACE1) enhances its proteolytic activity, leading to increased A&#x003b2; peptide production, exacerbation of A&#x003b2; formation, and promotion of tau hyperphosphorylation [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. Certain genetic combinations of Sig&#x02010;1R and apolipoprotein E (Apo&#x02010;E) genotypes can also interact synergistically to elevate the risk of AD [<xref rid="cns70378-bib-0108" ref-type="bibr">108</xref>]. Tambini et&#x000a0;al. proposed that ApoE4 secreted by astrocytes notably enhances ER&#x02010;mitochondrial communication and MAM function, as indicated by the synthesis of phospholipids and cholesteryl esters [<xref rid="cns70378-bib-0109" ref-type="bibr">109</xref>].</p><p>Moreover, some other MAM&#x02010;related proteins have also been implicated in Alzheimer's disease. For example, MFN1, MFN2, and translocase of outer mitochondria&#x02010;70 (TOM70) are essential proteins in mitochondria&#x02010;ER contact sites (MERCS), with their levels being decreased in FAD cases&#x000a0;[<xref rid="cns70378-bib-0110" ref-type="bibr">110</xref>]. Elevated levels of reactive oxygen species (ROS) could also potentially contribute to the onset of AD [<xref rid="cns70378-bib-0110" ref-type="bibr">110</xref>]. All these mechanisms and proteins involved are summarized in Figure&#x000a0;<xref rid="cns70378-fig-0003" ref-type="fig">3</xref>.</p><fig position="float" fig-type="FIGURE" id="cns70378-fig-0003"><label>FIGURE 3</label><caption><p>The influence of MAMs on Alzheimer's disease. The effect of MAM on Alzheimers' disease involves multiple pathways. (1). Mutation of APP will lead to an increase of ER&#x02010;mitochondria contact points, which can cause Ca<sup>2+</sup> homeostasis disorder and increase A&#x003b2; generation. (2). Mutation of PS1/PS2 will open IP3R, which also causes Ca<sup>2+</sup> homeostasis disorder and increases A&#x003b2; generation. (3). As components of the &#x003b3;&#x02010;secretase, PS can influence the production of A&#x003b2;42. The abnormal ratio of A&#x003b2;42 to A&#x003b2;40 will affect cellular toxicity and hyperphosphorylation of tau. (4). Sig&#x02010;1R can influence Insig, which will cause cholesterol metabolism imbalance and lead to A&#x003b2; generation. (5). APOE4, ACAT, TOM70, and some other proteins also play a significant role in Alzheimer's disease.</p></caption><graphic xlink:href="CNS-31-e70378-g003" position="anchor" id="jats-graphic-7"/></fig><p>A major reason for the lack of effective Alzheimer's disease treatments is our limited understanding of the specific molecular and cellular mechanisms that cause the disease [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>]. MAMs occupy a crucial role in AD pathogenesis, making them a promising therapeutic target. Many studies have shown that GSK3&#x003b2;, a key brain homeostasis regulator implicated in numerous disorders including AD, acts as a negative modulator of ER&#x02010;mitochondria membrane contact sites formation, presenting itself as a potential therapeutic target [<xref rid="cns70378-bib-0111" ref-type="bibr">111</xref>, <xref rid="cns70378-bib-0112" ref-type="bibr">112</xref>, <xref rid="cns70378-bib-0113" ref-type="bibr">113</xref>]. Besides, drugs that activate Sig&#x02010;1R are regarded as neuroprotective and anti&#x02010;amnestic agents in neurodegenerative diseases, including AD [<xref rid="cns70378-bib-0104" ref-type="bibr">104</xref>]. For example, a recent study showed that N, N&#x02010;dimethyltryptamine, a natural hallucinogenic drug, may improve AD by restoring ER&#x02010;mitochondrial crosstalk mediated by neurons' Sig&#x02010;1R [<xref rid="cns70378-bib-0114" ref-type="bibr">114</xref>]. Moreover, emerging research proposes a unique mechanism linking transglutaminase type 2 (TG2) brain activation with the regulation of A&#x003b2;&#x02010;induced Ca<sup>2+</sup> signaling and MAM function in AD [<xref rid="cns70378-bib-0115" ref-type="bibr">115</xref>]. Hence, future studies might explore the modulation of TG2 activity as a promising therapeutic approach. In addition, Rer1 has been identified as a candidate protein for treating glucocorticoid&#x02010;triggered A&#x003b2; production in mitochondria [<xref rid="cns70378-bib-0116" ref-type="bibr">116</xref>]. At present, there are many studies on A&#x003b2;, but there are few studies on tau. In the future, we can conduct more in&#x02010;depth research on tau to find newer therapeutic targets for Alzheimer's disease.</p></sec><sec id="cns70378-sec-0018"><label>4.2</label><title>Parkinson's Disease</title><p>James Parkinson, a British physician, initially described Parkinson's disease (PD) in 1817 [<xref rid="cns70378-bib-0117" ref-type="bibr">117</xref>]. With a global prevalence exceeding 6 million individuals, this disease ranks as the second most common neurodegenerative disease [<xref rid="cns70378-bib-0117" ref-type="bibr">117</xref>]. Its occurrence has increased dramatically, with a 2.5&#x02010;fold rise in prevalence over the past generation [<xref rid="cns70378-bib-0118" ref-type="bibr">118</xref>]. As a result, it has become a leading cause of neurological disabilities worldwide [<xref rid="cns70378-bib-0118" ref-type="bibr">118</xref>]. PD is a disease related to age. Global statistics indicate that 1%&#x02013;2% of individuals aged 65 and older, and 4%&#x02013;5% of those over 85, are afflicted with PD [<xref rid="cns70378-bib-0119" ref-type="bibr">119</xref>]. Furthermore, the occurrence of this disease rises by 5&#x02013;10 times among those aged 60&#x02013;90 [<xref rid="cns70378-bib-0119" ref-type="bibr">119</xref>]. While most PD cases occur sporadically, there have been instances of familial cases associated with genetic mutations in specific genes, known as PARK genes [<xref rid="cns70378-bib-0120" ref-type="bibr">120</xref>]. These genes encode proteins such as &#x003b1;&#x02010;synuclein (PARK1/4 or SNCA), parkin (PARK2), PINK1 (PARK6), DJ&#x02010;1 (PARK7), leucine&#x02010;rich&#x02010;repeat kinase 2 (LRRK2, PARK8), and others [<xref rid="cns70378-bib-0120" ref-type="bibr">120</xref>].</p><p>One of the crucial pathophysiology features of PD is the presence of Lewy bodies, which are composed of aggregated &#x003b1;&#x02010;synuclein [<xref rid="cns70378-bib-0121" ref-type="bibr">121</xref>]. In 2013, Poston et&#x000a0;al. analyzed proteins from mouse brains and detected &#x003b1;&#x02010;synuclein in MERCS [<xref rid="cns70378-bib-0021" ref-type="bibr">21</xref>]. Guardia&#x02010;Laguarta et&#x000a0;al. later confirmed this, suggesting that &#x003b1;&#x02010;synuclein is specifically found in MERCS, not mitochondria as previously thought [<xref rid="cns70378-bib-0122" ref-type="bibr">122</xref>]. Since MAM regulates many cellular processes, studying &#x003b1;&#x02010;synuclein's presence and role in MAM will improve our understanding of its functions and its damaging effects in Parkinson's disease. Wild&#x02010;type &#x003b1;&#x02010;synuclein, with its strong affinity for lipid rafts, localizes to MAMs, facilitating physical interactions with mitochondria [<xref rid="cns70378-bib-0123" ref-type="bibr">123</xref>]. Contrary to wild&#x02010;type &#x003b1;&#x02010;synuclein, mutant forms of &#x003b1;&#x02010;synuclein that cause PD lead to a downregulation of ER&#x02010;mitochondrial apposition, resulting in reduced MAM function and increased mitochondrial fragmentation [<xref rid="cns70378-bib-0122" ref-type="bibr">122</xref>]. A30P and A53T are the mutant forms of this protein [<xref rid="cns70378-bib-0037" ref-type="bibr">37</xref>]. The A30P mutation modifies the interaction between SNCA and rafts, while the A53T mutation leads to a reduced amount of SNCA, resulting in a lower association accordingly [<xref rid="cns70378-bib-0037" ref-type="bibr">37</xref>]. Overexpression and mutation of &#x003b1;&#x02010;synuclein will further cause disruptions in Ca<sup>2+</sup> homeostasis between organelles, leading to elevated mitochondrial ATP production [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. Moreover, synaptic dysfunction is also a prominent aspect of PD [<xref rid="cns70378-bib-0125" ref-type="bibr">125</xref>]. A study revealed that &#x003b1;&#x02010;synuclein can interact with VAPB, disrupting the VAPB&#x02010;PTPIP51 interaction and ultimately leading to reduced mitochondrial ATP production [<xref rid="cns70378-bib-0125" ref-type="bibr">125</xref>]. Research also shows that &#x003b1;&#x02010;synuclein can interfere with the expression of the IP3R&#x02010;GRP75&#x02010;VDAC complex, blocking Ca<sup>2+</sup> transfer between the ER and mitochondria [<xref rid="cns70378-bib-0126" ref-type="bibr">126</xref>]. Remarkably, neurons from familial PD patients with pathogenic triplication of &#x003b1;&#x02010;synuclein show this disruption [<xref rid="cns70378-bib-0125" ref-type="bibr">125</xref>]. Furthermore, the presence of SNCA and its function in MAMs may affect cholesterol regulation in PD, due to MAM dysfunction resulting from SNCA mutations [<xref rid="cns70378-bib-0122" ref-type="bibr">122</xref>].</p><p>Mutations that disable PINK1 and Parkin (an E3 ubiquitin ligase), both proteins essential for mitophagy, underlie familial PD [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. Both of them localize to the MAM compartment [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. Research has found increased contacts between mitochondria and the ER in flies and human fibroblasts from PD patients with PINK1 or Parkin mutations [<xref rid="cns70378-bib-0127" ref-type="bibr">127</xref>]. Previous studies have shown that overexpressing Parkin enhances the physical and functional coupling between the ER and mitochondria, boosting ATP production and Ca<sup>2+</sup> exchange&#x000a0;[<xref rid="cns70378-bib-0128" ref-type="bibr">128</xref>]. Conversely, knocking down Parkin has the opposite effect, disrupting mitochondrial morphology [<xref rid="cns70378-bib-0128" ref-type="bibr">128</xref>]. This may be caused by MFN2 in MAMs and agonist generated by 1,4,5 inositol trisphosphate (InsP3) [<xref rid="cns70378-bib-0128" ref-type="bibr">128</xref>, <xref rid="cns70378-bib-0129" ref-type="bibr">129</xref>]. During mitochondrial and ER stress, Parkin levels increase in an ATF4&#x02010;dependent way [<xref rid="cns70378-bib-0130" ref-type="bibr">130</xref>]. This helps regulate the interaction between the ER and mitochondria, promoting cell survival under stress [<xref rid="cns70378-bib-0130" ref-type="bibr">130</xref>]. Moreover, Parkin plays an important role in the ubiquitin&#x02013;proteasome system [<xref rid="cns70378-bib-0131" ref-type="bibr">131</xref>]. An elevated level of Parkin within the MAM fraction results in ubiquitination of numerous MAM proteins, including VDAC and MFN2 [<xref rid="cns70378-bib-0132" ref-type="bibr">132</xref>]. Therefore, it is noteworthy that in cells lacking Parkin and human fibroblasts with Parkin mutations, the connection between the ER and mitochondria is reduced [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. PINK1, a protein linked to familial PD and mitochondria quality control, as well as the autophagy&#x02010;promoting protein BECN1/Beclin1, were both detected at the MAM [<xref rid="cns70378-bib-0071" ref-type="bibr">71</xref>]. The interaction between PINK1 and Beclin1 strengthened the contact between the ER and mitochondria, facilitating the formation of autophagosomes during mitophagy induction [<xref rid="cns70378-bib-0071" ref-type="bibr">71</xref>]. During mitophagy, PINK1 and Parkin jointly catalyze a swift surge in MFN2 ubiquitination, leading to the detachment of mitochondria from the ER by dismantling MFN2 tethers [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. As a result, MAMs disintegrate, and the decrease in ER&#x02010;mitochondria appositions accelerates the rate of mitochondrial degradation [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. In addition, the silencing of the PINK1 gene in M17 dopaminergic cells led to a decrease in the number of ER&#x02010;to&#x02010;mitochondria contacts, resulting in an impaired Ca<sup>2+</sup> homeostasis [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. Overexpression of Parkin or PINK1 mutated in familial PD has been demonstrated to trigger the PERK pathway of the UPR of ER and enhance the connectivity between the ER and mitochondria in a mitofusin&#x02010;dependent fashion [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>, <xref rid="cns70378-bib-0127" ref-type="bibr">127</xref>]. Furthermore, PINK1/Parkin&#x02010;mediated mitophagy is one of the underlying mechanisms leading to dopaminergic neuron death [<xref rid="cns70378-bib-0071" ref-type="bibr">71</xref>]. A study on neurons exposed to glutamate&#x02010;induced excitotoxicity revealed that the expression of Parkin increases in the MAM fraction following mitophagy [<xref rid="cns70378-bib-0133" ref-type="bibr">133</xref>]. PINK1 facilitates the proteasomal degradation of Miro1/2 and MFN1/2 in a Parkin&#x02010;dependent manner [<xref rid="cns70378-bib-0004" ref-type="bibr">4</xref>]. Miro, a target of PINK1/Parkin, plays a pivotal role in mitochondrial transfer along microtubules [<xref rid="cns70378-bib-0131" ref-type="bibr">131</xref>]. Its dysfunction can contribute to the malfunctioning of mitochondria or ER in Parkinson's disease [<xref rid="cns70378-bib-0131" ref-type="bibr">131</xref>]. Interestingly, the lack of Miro has been shown to counteract the effects of PINK1 mutations linked to Parkinson's disease in Drosophila and helps remove damaged mitochondria in HeLa cells [<xref rid="cns70378-bib-0134" ref-type="bibr">134</xref>]. This highlights its important role in the disease process.</p><p>DJ&#x02010;1, encoded by the PARK7 gene, is a multifunctional protein encompassing 189 amino acids [<xref rid="cns70378-bib-0030" ref-type="bibr">30</xref>, <xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. Multiple gene mutations in DJ&#x02010;1, including deletions and point mutations, have been firmly linked to early autosomal recessive Parkinson's disease [<xref rid="cns70378-bib-0135" ref-type="bibr">135</xref>]. The DJ&#x02010;1 protein can also be found at the MAM, affecting its interactions and the flow of Ca<sup>2+</sup> between the ER and mitochondria [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. Liu et&#x000a0;al. demonstrated that DJ&#x02010;1 can interact with MAM and is a key part of the IP3R&#x02010;Grp75&#x02010;VDAC complexes [<xref rid="cns70378-bib-0136" ref-type="bibr">136</xref>]. Lower DJ&#x02010;1 levels in the substantia nigra of PD patients might damage the IP3R&#x02010;GRP75&#x02010;VDAC tethering protein complex, disrupting Ca<sup>2+</sup> crosstalk and ATP production, ultimately resulting in mitochondrial structural abnormalities and dysfunction [<xref rid="cns70378-bib-0105" ref-type="bibr">105</xref>]. In addition, the interaction between DJ&#x02010;1 and the anti&#x02010;oncogene p53 is thought to play a role in PD [<xref rid="cns70378-bib-0137" ref-type="bibr">137</xref>]. Excessive p53 has the opposite effect on ER&#x02010;mitochondria Ca<sup>2+</sup> transfer and ER&#x02010;mitochondrial interaction compared to DJ&#x02010;1, reducing Ca<sup>2+</sup> transients and this interaction [<xref rid="cns70378-bib-0138" ref-type="bibr">138</xref>]. However, when DJ&#x02010;1 and p53 are expressed together, the impact of p53 overexpression is counteracted [<xref rid="cns70378-bib-0138" ref-type="bibr">138</xref>]. This restores histamine&#x02010;induced Ca<sup>2+</sup> transients to DJ&#x02010;1 levels and brings ER&#x02010;mitochondrial interactions back to normal, matching control cell levels [<xref rid="cns70378-bib-0138" ref-type="bibr">138</xref>]. Moreover, S&#x02010;palmitoylation (a reversible protein post&#x02010;translational modification) of DJ&#x02010;1 prompts its localization to lipid rafts in astrocytes, potentially contributing to PD pathogenesis [<xref rid="cns70378-bib-0137" ref-type="bibr">137</xref>]. It has also been demonstrated that suppressing DJ&#x02010;1 results in elevated levels of aggregated &#x003b1;&#x02010;synuclein in PD cells and animal models [<xref rid="cns70378-bib-0105" ref-type="bibr">105</xref>].</p><p>Mutations in the leucine&#x02010;rich repeat kinase 2 (LRRK2) gene are associated with late&#x02010;onset autosomal PD [<xref rid="cns70378-bib-0139" ref-type="bibr">139</xref>]. Six significant mutations in the LRRK2 gene have been identified as pathogenic, accounting for 5%&#x02013;6% of familial PD cases and 1%&#x02013;2% of sporadic PD cases&#x000a0;[<xref rid="cns70378-bib-0139" ref-type="bibr">139</xref>]. In 2020, Toyofuku et&#x000a0;al. found that LRRK2 plays a crucial role in the formation and function of MERCS [<xref rid="cns70378-bib-0140" ref-type="bibr">140</xref>]. Specifically, the deletion of LRRK2 led to a decrease in contact sites and a disruption in Ca<sup>2+</sup> flux to mitochondria [<xref rid="cns70378-bib-0140" ref-type="bibr">140</xref>]. LRRK2 has been shown to control PERK activity, which affects the structure of MERCS [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>]. It also regulates the IP3R&#x02010;VDAC1&#x02010;dependent Ca<sup>2+</sup> transfer between the ER and mitochondria by phosphorylating and activating Parkin [<xref rid="cns70378-bib-0079" ref-type="bibr">79</xref>]. Studies have shown that the mutated LRRK2 gene binds to E3 ubiquitin ligases like Parkin and membrane&#x02010;associated RING&#x02010;CH5 (MARCH5), inhibiting their activation in MAM [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. This prevents the ubiquitination and degradation of MAM components, leading to a reduction in IP3R&#x02010;GRP75&#x02010;VDAC&#x02010;mediated Ca<sup>2+</sup> export and mitochondrial ATP production [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. Additionally, overexpression of mutant LRRK2 genes, specifically G2019S and R1441C, leads to enhanced interaction with Drp1, resulting in hyperphosphorylation of fission proteins [<xref rid="cns70378-bib-0141" ref-type="bibr">141</xref>]. This, in turn, increases ROS production and mitochondrial fragmentation [<xref rid="cns70378-bib-0141" ref-type="bibr">141</xref>]. LRRK2 also modulates the activity of proteins involved in mitochondrial fusion, such as MFN1, MFN2, and OPA1 [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. All these mechanisms and proteins involved are summarized in Figure&#x000a0;<xref rid="cns70378-fig-0004" ref-type="fig">4</xref>.</p><fig position="float" fig-type="FIGURE" id="cns70378-fig-0004"><label>FIGURE 4</label><caption><p>The influence of MAM on Parkinson's Disease. There are five main types of mutations that affect Parkinson's disease in MAMs. They are &#x003b1;&#x02010;synuclein, Parkin, PINK1, DJ&#x02010;1, and LRRK2. For &#x003b1;&#x02010;synuclein, (1) it will bind to or interfere with VAPB, which disrupts contact between the ER and mitochondria. (2) It can cause ER&#x02010;mitochondria contact decrease directly. (3) It will block Ca<sup>2+</sup> transduction through its influence on IP3R&#x02010;GRP75&#x02010;VDAC. For Parkin: (1) Knocking down Parkin may disrupt mitochondrial morphology. (2) It will influence ubiquitination of protein, including VDAC and MFN2. Then, it will affect ER&#x02010;mitochondria contact and blocking Ca<sup>2+</sup> transduction. (3) It will work together with PINK to increase degradation of Miro1/2 and MFN1/2. For PINK1, (1) it will influence ubiquitination of protein like Parkin. (2) It will interact with Beclin1 to decrease ER&#x02010;mitochondrial contact. Then lead to blockage of Ca<sup>2+</sup> transduction. For DJ&#x02010;1, (1) it can impair IP3R&#x02010;GRP75&#x02010;VDAC which may affect transduction of Ca<sup>2+</sup>. (2) The number of DJ&#x02010;1 has effects on the number of P53. An excess of P53 will cause a decrease of Ca<sup>2+</sup> in MAMs. (3) Disruption of DJ&#x02010;1 will elevate levels of aggregated &#x003b1;&#x02010;synuclein. For LRRK2, (1) loss of LRRK2 will lead to ER&#x02010;mitochondria contact decrease directly. (2) It can affect IP3R&#x02010;GRP75&#x02010;VDAC and influence Ca<sup>2+</sup> through phosphorylation and activation of Parkin. (3) It plays a role in ubiquitination of protein through binding to E3 ubiquitin ligases like Parkin.</p></caption><graphic xlink:href="CNS-31-e70378-g005" position="anchor" id="jats-graphic-9"/></fig><p>There are some other substances related to MAM that play a role in PD. The dopamine receptors and Sig&#x02010;1R interactions are also a potential point of interference of MAMs in PD [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. There is compelling evidence that suggests ER stress could be a supplementary mechanism underlying the pathogenesis of PD [<xref rid="cns70378-bib-0142" ref-type="bibr">142</xref>]. Bioinformatics analysis has revealed the presence of two single&#x02010;nucleotide polymorphisms (SNPs) within the genes encoding CAST, an endogenous inhibitor of the calpastatin gene [<xref rid="cns70378-bib-0143" ref-type="bibr">143</xref>]. These SNPs are associated with a predisposition to idiopathic PD, indicating a potential genetic link between these variations and the disease's development [<xref rid="cns70378-bib-0143" ref-type="bibr">143</xref>]. The initial report linking MAMs and neuroinflammation was published by Zhou et&#x000a0;al., highlighting the crucial role of mitochondria in NLRP3 inflammasome activation [<xref rid="cns70378-bib-0089" ref-type="bibr">89</xref>]. The presence of angiotensin receptors and the RAS components in the MAM fractions is also supposed to be a potential target for various neurodegenerative diseases, including Parkinson's disease [<xref rid="cns70378-bib-0124" ref-type="bibr">124</xref>]. Moreover, genes involved in lipid and lipoprotein signaling play a role in PD pathogenesis, such as oxidative stress, lysosomal dysfunction, ER stress response, and immune response [<xref rid="cns70378-bib-0137" ref-type="bibr">137</xref>].</p><p>Developing treatments to slow or stop Parkinson's disease progression remains a critical focus for both patients and researchers alike, yet no definitive disease&#x02010;modifying therapies have been identified to date [<xref rid="cns70378-bib-0144" ref-type="bibr">144</xref>]. Some research suggests that targeting Sig&#x02010;1R might be one of the most promising strategies for treating Parkinson's disease [<xref rid="cns70378-bib-0145" ref-type="bibr">145</xref>]. Recent studies reveal that phillyrin boosts MAM formation by increasing receptor expression&#x02010;enhancing protein 1 (REEP1) levels [<xref rid="cns70378-bib-0146" ref-type="bibr">146</xref>]. This reduces cardiolipin externalization through the REEP1&#x02010;NDPK&#x02010;D interaction and strengthens autophagosome production [<xref rid="cns70378-bib-0146" ref-type="bibr">146</xref>]. This mechanism highlights phillyrin's potential as a treatment for Parkinson's disease. Moreover, Jihoon Lee et&#x000a0;al. developed a platform called autophagy&#x02010;targeting chimera (ATUOTAC), which can facilitate the creation of degraders targeting &#x003b1;&#x02010;syn aggregates, presenting a novel therapeutic approach to modify the course of PD [<xref rid="cns70378-bib-0147" ref-type="bibr">147</xref>]. New study also shows that S&#x02010;palmitoylation could be a potential therapeutic target in the future [<xref rid="cns70378-bib-0137" ref-type="bibr">137</xref>].</p></sec><sec id="cns70378-sec-0019"><label>4.3</label><title>Amyotrophic Lateral Sclerosis</title><p>Amyotrophic lateral sclerosis (ALS) is a progressively fatal neuromuscular disease, distinguished by the degradation of both upper and lower motor neurons, ultimately leading to the malfunction of the body's somatic muscles [<xref rid="cns70378-bib-0148" ref-type="bibr">148</xref>]. ALS is a relatively uncommon disorder, with a standardized global incidence rate of only 1.68 cases per 100,000 person&#x02010;years of follow&#x02010;up, but this figure may vary depending on the region [<xref rid="cns70378-bib-0149" ref-type="bibr">149</xref>]. The majority of ALS patients succumb to respiratory failure within 3&#x02009;years of diagnosis [<xref rid="cns70378-bib-0150" ref-type="bibr">150</xref>]. ALS manifests both sporadically and as a familial condition, accounting for 10%&#x02013;15% of cases being familial and 85%&#x02013;90% being sporadic [<xref rid="cns70378-bib-0151" ref-type="bibr">151</xref>]. Due to the absence of effective treatments beyond Riluzole, which at best extends lifespan by a few months, there is an urgent demand for novel therapeutic strategies for ALS patients [<xref rid="cns70378-bib-0152" ref-type="bibr">152</xref>]. Mutations in genes encoding the MAM proteins VAPB and Sig&#x02010;1R are implicated in ALS pathogenesis [<xref rid="cns70378-bib-0153" ref-type="bibr">153</xref>]. Additionally, mutations in key ALS&#x02010;related genes, including TAR DNA binding&#x02010;protein 43 (TDP&#x02010;43), fused in sarcoma (FUS), superoxide dismutase 1 (SOD1), and the C9orf72 repeat expansion, have been associated with impaired mitochondrial function and Ca<sup>2+</sup> regulation [<xref rid="cns70378-bib-0154" ref-type="bibr">154</xref>]. Interestingly, these genes do not code for mitochondrial or ER proteins [<xref rid="cns70378-bib-0154" ref-type="bibr">154</xref>].</p><p>Mutations in VAPB can lead to ALS, exhibiting a wide range of clinical manifestations [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. These include severe ALS with rapid disease progression, autosomal&#x02010;dominant ALS8, and late&#x02010;onset spinal muscular atrophy in affected individuals [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. When VAPB undergoes mutation, it forms inclusions within the ER, leading to structural alterations in the ER [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. The VAPB P56S mutation, a well&#x02010;known cause of familial ALS type&#x02010;8, has been shown to accumulate and exacerbate MERCS [<xref rid="cns70378-bib-0131" ref-type="bibr">131</xref>]. This mutation affects the interaction between the MAM protein VAPB and PTPIP51, leading to the formation of the MAM tether complex, which ultimately disrupts Ca<sup>2+</sup> homeostasis [<xref rid="cns70378-bib-0131" ref-type="bibr">131</xref>, <xref rid="cns70378-bib-0155" ref-type="bibr">155</xref>]. In neurons carrying mutant VAPB, dysregulation of Ca<sup>2+</sup> within the ER leads to decreased mitochondrial transport [<xref rid="cns70378-bib-0156" ref-type="bibr">156</xref>]. This could be due to the influence of Ca<sup>2+</sup> on Miro1, a cargo adaptor that bridges mitochondria to kinesins and microtubules [<xref rid="cns70378-bib-0156" ref-type="bibr">156</xref>]. Since mutant VAPB can trap the wild&#x02010;type VAPB protein, this interaction may reduce VAPB levels [<xref rid="cns70378-bib-0157" ref-type="bibr">157</xref>]. This could change the lipid composition of membranes and disrupt vesicle formation in ALS [<xref rid="cns70378-bib-0157" ref-type="bibr">157</xref>]. Additionally, phosphoinositide phosphatase Sac1, another VAP binding partner, plays a role in ALS8 pathogenesis [<xref rid="cns70378-bib-0158" ref-type="bibr">158</xref>]. In drosophila, the ortholog of VAPB, known as VAP33, has been found to interact with the oxysterol binding protein (OSBP) [<xref rid="cns70378-bib-0152" ref-type="bibr">152</xref>]. This interaction is crucial for the proper localization of OSBP in the ER [<xref rid="cns70378-bib-0152" ref-type="bibr">152</xref>]. However, ALS&#x02010;associated mutations in VAPB have been shown to disrupt this interaction with OSBP, preventing its correct localization in the ER [<xref rid="cns70378-bib-0155" ref-type="bibr">155</xref>]. Furthermore, the disruption of VAPB&#x02010;PTPIP51 tethers emerges as an initial characteristic in mutant C9orf72 transgenic mice, preceding the manifestation of disease symptoms [<xref rid="cns70378-bib-0159" ref-type="bibr">159</xref>]. Given the significance attributed to early pathogenic changes, this discovery underscores the critical role of VAPB&#x02010;PTPIP51 tether disruption in the pathogenesis of ALS [<xref rid="cns70378-bib-0159" ref-type="bibr">159</xref>].</p><p>Genetic mutations in the coding sequence of Sig&#x02010;1R have also been implicated in the development of ALS [<xref rid="cns70378-bib-0153" ref-type="bibr">153</xref>]. The Sig&#x02010;1R, an ER protein, serves as a chaperone for IP3R, thereby facilitating the delivery of Ca<sup>2+</sup> to mitochondria [<xref rid="cns70378-bib-0160" ref-type="bibr">160</xref>]. Mutations in Sig&#x02010;1R lead to ALS because the mutant protein is unable to bind to IP3R3, resulting in a detachment of the ER from mitochondria [<xref rid="cns70378-bib-0161" ref-type="bibr">161</xref>]. This dissociation disrupts calcium homeostasis and impairs ATP synthesis, subsequently stalling axon extension, ultimately leading to the development of ALS in animals [<xref rid="cns70378-bib-0161" ref-type="bibr">161</xref>]. A homozygous E102Q mutation within a conserved transmembrane segment of Sig&#x02010;1R has been identified as the underlying cause of a juvenile autosomal recessive form of ALS16 [<xref rid="cns70378-bib-0153" ref-type="bibr">153</xref>]. In SOD1 mutant mice, the destruction of Sig&#x02010;1R expedited the onset of disease, concurrent with the dismantling of the MAM structure&#x000a0;[<xref rid="cns70378-bib-0105" ref-type="bibr">105</xref>]. A reduction in Sig&#x02010;1R function may contribute to ALS pathology by inducing aberrant ER morphology, destabilizing lipid rafts, disrupting calcium signaling, and compromising ER&#x02010;Golgi trafficking [<xref rid="cns70378-bib-0152" ref-type="bibr">152</xref>]. The proximity of Sig&#x02010;1R to the muscarinic acetylcholine receptor at the plasma membrane hints at a potential role in ALS pathogenesis [<xref rid="cns70378-bib-0162" ref-type="bibr">162</xref>]. Furthermore, the interaction between Sig&#x02010;1R and Insig may contribute to the disease etiology, given that Insig has been implicated in reducing glutamate&#x02010;induced excitotoxicity, a key mechanism in ALS [<xref rid="cns70378-bib-0163" ref-type="bibr">163</xref>]. Therapy using Sig&#x02010;1R agonists has proven effective in various ALS models [<xref rid="cns70378-bib-0131" ref-type="bibr">131</xref>]. By targeting Sig&#x02010;1R with agonists, it may be possible to mitigate protein aggregation and slow disease progression because of the agonists' ability to enhance the chaperone activity of Sig&#x02010;1R [<xref rid="cns70378-bib-0164" ref-type="bibr">164</xref>].</p><p>TDP&#x02010;43 accumulation is a notable feature in ALS pathology, and mutations in the TDP&#x02010;43 gene are found in about 3% of familial ALS cases and 1.5% of sporadic cases&#x000a0;[<xref rid="cns70378-bib-0165" ref-type="bibr">165</xref>]. TDP&#x02010;43 is a versatile protein that binds to both RNA and DNA, playing a role in transcription, transportation, and translation processes of RNA [<xref rid="cns70378-bib-0105" ref-type="bibr">105</xref>]. The misfolding, mislocalization, and hyperphosphorylation of TDP&#x02010;43 represent characteristic pathological aspects of ALS [<xref rid="cns70378-bib-0166" ref-type="bibr">166</xref>]. TDP&#x02010;43 modifies MAM tethering and Ca<sup>2+</sup> homeostasis through disrupting the interaction between VAPB and PTPIP51 [<xref rid="cns70378-bib-0121" ref-type="bibr">121</xref>]. Notably, this disruption is mediated via the activation of GSK&#x02010;3&#x003b2; [<xref rid="cns70378-bib-0113" ref-type="bibr">113</xref>]. Hence, GSK3&#x003b2; inhibitors could potentially offer therapeutic benefits for ALS [<xref rid="cns70378-bib-0160" ref-type="bibr">160</xref>]. Following IP3R&#x02010;mediated Ca<sup>2+</sup> release from the ER, TDP&#x02010;43 elevation increases cytosolic Ca<sup>2+</sup> levels while reducing mitochondrial Ca<sup>2+</sup> levels [<xref rid="cns70378-bib-0113" ref-type="bibr">113</xref>]. This aligns with weaker ER&#x02013;mitochondria connections [<xref rid="cns70378-bib-0113" ref-type="bibr">113</xref>]. These disruptions in cellular Ca<sup>2+</sup> balance have extensive implications, affecting mitochondrial ATP synthesis, mitochondria transport, autophagy, and ER stress, all of which are variably impacted in ALS [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. Moreover, the overexpression of wild&#x02010;type or ALS&#x02010;associated mutant forms of TDP&#x02010;43 leads to the misplacement of Miro1 into the cytosol [<xref rid="cns70378-bib-0113" ref-type="bibr">113</xref>].</p><p>FUS, another significant pathological aspect of ALS, has also been demonstrated to disrupt the association between VAPB and PTPIP51, as well as the tethering of MAMs, via the activation of GSK&#x02010;3&#x003b2; [<xref rid="cns70378-bib-0167" ref-type="bibr">167</xref>]. The mutated FUS gene in ALS interacts with the valocin&#x02010;containing protein (VCP), potentially elucidating certain mitochondrial abnormalities observed in the disease [<xref rid="cns70378-bib-0168" ref-type="bibr">168</xref>].</p><p>Over 150 mutations identified in the SOD1 gene account for approximately 20% of familial ALS occurrences [<xref rid="cns70378-bib-0110" ref-type="bibr">110</xref>]. These mutants interact with Bcl&#x02010;2, impacting calcium balance [<xref rid="cns70378-bib-0110" ref-type="bibr">110</xref>]. VDAC is recognized as a molecular target affected by damage from ALS mutant SOD1 [<xref rid="cns70378-bib-0169" ref-type="bibr">169</xref>]. Studies have shown that physical association with mutant SOD1 aggregates partially inactivates VDAC [<xref rid="cns70378-bib-0169" ref-type="bibr">169</xref>]. In addition, mutant SOD1 disrupts ER&#x02010;mitochondria signaling by impairing Sig&#x02010;1R function [<xref rid="cns70378-bib-0161" ref-type="bibr">161</xref>].</p><p>There is something else that causes ALS. Most familial ALS cases are caused by C9orf72 gene mutations [<xref rid="cns70378-bib-0170" ref-type="bibr">170</xref>]. Research indicates that in the spinal cord of ALS patients, there is an elevation in levels of sphingomyelin, ceramides, and cholesterol esters, likely due to oxidative stress [<xref rid="cns70378-bib-0171" ref-type="bibr">171</xref>]. Consequently, it is plausible to suggest that in the ALS spinal cord, heightened synthesis of cholesteryl ester from cholesterol by lecithin cholesterol esterase leads to reduced cholesterol levels at MAMs and augmented ER&#x02010;mitochondrial interactions [<xref rid="cns70378-bib-0152" ref-type="bibr">152</xref>]. Mutations in genes governing lipid droplet biogenesis and dynamics have been found to influence the ALS phenotype in various model organisms, including mice, drosophila, and worms [<xref rid="cns70378-bib-0172" ref-type="bibr">172</xref>]. The dysfunction of lipid droplet biogenesis may have a significant impact on the pathological aspects of human VAPB&#x02010;mediated ALS [<xref rid="cns70378-bib-0173" ref-type="bibr">173</xref>]. In a comprehensive genome&#x02010;wide study, polymorphism in the IP3R has been linked to a heightened susceptibility to ALS [<xref rid="cns70378-bib-0174" ref-type="bibr">174</xref>]. The specific accumulation of IP3R3 in motor neurons implies that the preservation of MAM integrity is pivotal for understanding the selective susceptibility observed in ALS [<xref rid="cns70378-bib-0161" ref-type="bibr">161</xref>].</p><p>Like Alzheimer's disease and Parkinson's disease, ALS urgently needs treatment strategies. The latest study reveals MAM defects in oligodendroglia from induced pluripotent stem cells, linked to abnormal lipid metabolism, ER stress, mitochondrial issues, and reduced Ca<sup>2+</sup> signaling [<xref rid="cns70378-bib-0175" ref-type="bibr">175</xref>]. This discovery offers new insights into the role of mutant FUS in oligodendroglial function and motor neuron degeneration. Recent studies also suggested that the Sig&#x02010;1R&#x02013;AAA ATPase domain&#x02010;containing protein 3A (ATAD3A) axis and MAM&#x02010;TANK&#x02010;binding kinase 1 (TBK1) axis could be a promising new therapeutic point for mitochondrial dysfunction in neurological disorders including ALS [<xref rid="cns70378-bib-0176" ref-type="bibr">176</xref>, <xref rid="cns70378-bib-0177" ref-type="bibr">177</xref>].</p></sec><sec id="cns70378-sec-0020"><label>4.4</label><title>Huntington's Disease</title><p>In 1872, Huntington's disease (HD) was first described by a 22&#x02010;year&#x02010;old American physician named George Huntington [<xref rid="cns70378-bib-0178" ref-type="bibr">178</xref>]. It is a rare and hereditary neurodegenerative disease characterized by the gradual emergence of motor dysfunction, psychiatric manifestations, and cognitive decline [<xref rid="cns70378-bib-0179" ref-type="bibr">179</xref>]. Globally, it is approximated that the occurrence of HD stands at 2.7 individuals per 100,000 [<xref rid="cns70378-bib-0180" ref-type="bibr">180</xref>].</p><p>Given the intricate and dynamic connections between the ER and mitochondria, proteins located at the MAMs play a pivotal role in the development of Huntington's disease [<xref rid="cns70378-bib-0181" ref-type="bibr">181</xref>]. HD is caused by an abnormal expansion of CAG repeats in the HTT gene [<xref rid="cns70378-bib-0182" ref-type="bibr">182</xref>]. This gene encodes a polyglutamine (polyQ) stretch located at the N&#x02010;terminal of the huntingtin protein (HTT), which is subsequently referred to as mutant HTT (mHTT) [<xref rid="cns70378-bib-0182" ref-type="bibr">182</xref>]. Evidence has accumulated indicating that the soluble N&#x02010;terminal of mHTT interacts with both the outer and inner mitochondrial membranes [<xref rid="cns70378-bib-0182" ref-type="bibr">182</xref>]. Notably, it directly interacts with the translocator of the inner mitochondrial membrane (TIM23), disrupting mitochondrial protein import [<xref rid="cns70378-bib-0182" ref-type="bibr">182</xref>]. Research has demonstrated that mHTT binds to IP3R, leading to increased sensitivity of IP3R to activation by IP3 in both planar lipid bilayers and primary medium spiny neurons [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. These neurons are the most significantly affected in Huntington's disease [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. Research indicates that poly Q&#x02010;induced toxicity in Huntington's disease is linked to Sig&#x02010;1R expression, which regulates NF&#x02010;&#x003ba;B&#x02010;mediated upregulation of antioxidants and reduction of ROS levels [<xref rid="cns70378-bib-0181" ref-type="bibr">181</xref>]. Furthermore, Hyrskyluoto et&#x000a0;al. noticed that the administration of the Sig&#x02010;1R agonist, PRE084, not only enhanced cell survival but also assisted in mitigating the harmful consequences induced by PolyQ repeats [<xref rid="cns70378-bib-0181" ref-type="bibr">181</xref>]. Sig&#x02010;1R accumulates in neuronal inclusions containing mHTT, potentially boosting proteasome activity and facilitating mHTT degradation [<xref rid="cns70378-bib-0183" ref-type="bibr">183</xref>]. Additionally, the activation of NMDARs or increased activity of ER Ca<sup>2+</sup> release channels (InsP3R, RyR) quickly triggers Ca<sup>2+</sup> uptake into mitochondria [<xref rid="cns70378-bib-0182" ref-type="bibr">182</xref>]. Given the numerous intersections between HD pathology and PGC&#x02010;1&#x003b1; dysfunction, it is intriguing to hypothesize that PGC&#x02010;1&#x003b1; at the ER&#x02010;mitochondria interface holds a crucial significance [<xref rid="cns70378-bib-0098" ref-type="bibr">98</xref>]. The HTT, which carries a polyglutamine repeat mutation linked to HD, has been identified as a protein associated with ER [<xref rid="cns70378-bib-0184" ref-type="bibr">184</xref>]. Multiple models of HD have shown that VCP specifically relocates to mitochondria, where it interacts with mHTT, leading to excessive mitophagy and subsequent neuronal death [<xref rid="cns70378-bib-0073" ref-type="bibr">73</xref>]. The accumulation of polyglutamine&#x02010;expanded HTT within protein aggregates triggers ER stress, leading to the upregulation of BiP/GRP78, C/EBP homologous protein (CHOP), PDI, and Sig&#x02010;1R protein levels [<xref rid="cns70378-bib-0185" ref-type="bibr">185</xref>]. Additionally, mutant HTT's direct interaction with GTPase Drp1 boosts its enzymatic activity, causing mitochondrial movement defects and synaptic insufficiencies [<xref rid="cns70378-bib-0181" ref-type="bibr">181</xref>, <xref rid="cns70378-bib-0186" ref-type="bibr">186</xref>]. In the postmortem striatum of HD patients, late&#x02010;stage HD exhibited smaller mitochondria with increased DRP1 protein levels and decreased expression of the fusion protein MFN1 [<xref rid="cns70378-bib-0187" ref-type="bibr">187</xref>]. In cardiac models of Huntington's disease expressing PolyQ77, Drp1 interacts with Fis1, resulting in excessive mitochondrial fragmentation, ROS production, and lysosomal dysfunction [<xref rid="cns70378-bib-0188" ref-type="bibr">188</xref>].</p><p>For treatment, a recent study has shown that morin hydrate can mitigate HD&#x02010;related ER stress, MERC, mitophagy, and apoptosis by inhibiting the mTOR/IRE1&#x02010;&#x003b1; signaling, IP3R/VDAC interaction, PINK1/ubiquitin/Mfn2 pathway, and cytochrome c/caspase 3 axis [<xref rid="cns70378-bib-0189" ref-type="bibr">189</xref>]. More treatments for HD should be further studied.</p></sec><sec id="cns70378-sec-0021"><label>4.5</label><title>Traumatic Brain Injury</title><p>A traumatic brain injury (TBI) refers to a non&#x02010;congenital injury sustained by the brain, caused by an external physical force, potentially leading to temporary or irreversible impairment in functionality [<xref rid="cns70378-bib-0190" ref-type="bibr">190</xref>]. Worldwide, an estimated 70 million individuals suffer from traumatic brain injuries annually [<xref rid="cns70378-bib-0191" ref-type="bibr">191</xref>]. TBI stands out as a prominent cause of fatalities among younger adults, significantly contributing to mortality rates and disability globally [<xref rid="cns70378-bib-0192" ref-type="bibr">192</xref>].</p><p>TBI is primarily classified into two categories: primary and secondary brain injury [<xref rid="cns70378-bib-0009" ref-type="bibr">9</xref>]. The latter is intricately linked to various biochemical pathways, primarily cerebral inflammation and apoptosis, driven by factors such as mitochondrial dysfunction, autophagy, Ca<sup>2+</sup> imbalance, oxidative stress, excitotoxicity, and free radical generation [<xref rid="cns70378-bib-0009" ref-type="bibr">9</xref>]. Notably, these processes have a close association with MAMs [<xref rid="cns70378-bib-0009" ref-type="bibr">9</xref>]. The experiment also demonstrated the increase of MAM functions in a mouse model of TBI [<xref rid="cns70378-bib-0193" ref-type="bibr">193</xref>]. Sig&#x02010;1R plays an important role in TBI. Research indicates that in brain tissues of both TBI patients and TBI mice, neural expression of Sig&#x02010;1R was elevated [<xref rid="cns70378-bib-0194" ref-type="bibr">194</xref>]. Upon activation following TBI, Sig&#x02010;1R receptors demonstrate the capacity to decrease lesion size, alleviate brain edema, and mitigate neurological impairments [<xref rid="cns70378-bib-0195" ref-type="bibr">195</xref>]. Moreover, neuroinflammation, primarily driven by activated microglia and astrocytes, is a well&#x02010;recognized marker of secondary brain injury following TBI and is a significant contributor to chronic brain damage post&#x02010;TBI [<xref rid="cns70378-bib-0192" ref-type="bibr">192</xref>]. Prior research has shown that Sig&#x02010;1R is widely expressed in microglia and astrocytes, regulating the neuroinflammatory processes mediated by these glial cells in various central nervous system disorders [<xref rid="cns70378-bib-0192" ref-type="bibr">192</xref>].</p><p>Many other organizations in the MAM also play a role in the TBI. Studies revealed that autophagy functions as a suppressor of NLRP3 inflammasome activation [<xref rid="cns70378-bib-0196" ref-type="bibr">196</xref>]. Activation of the NLRP3 inflammasome can trigger the processing and release of IL&#x02010;1&#x003b2; and IL&#x02010;18, thereby intensifying the inflammatory response following TBI [<xref rid="cns70378-bib-0197" ref-type="bibr">197</xref>]. The expression of GRP&#x02010;78 was notably elevated in brain samples from both TBI patients and TBI mice, suggesting the presence of ER stress in the brain following TBI [<xref rid="cns70378-bib-0194" ref-type="bibr">194</xref>]. High levels of cytosolic Ca<sup>2+</sup> can break down cytoskeletal and extracellular matrix proteins [<xref rid="cns70378-bib-0198" ref-type="bibr">198</xref>]. This increases ROS production, which plays a major role in the development of TBI [<xref rid="cns70378-bib-0198" ref-type="bibr">198</xref>, <xref rid="cns70378-bib-0199" ref-type="bibr">199</xref>]. Research indicates that PERK, a MAM component crucial in regulating ER&#x02010;mitochondria interactions and mitochondrial apoptosis after TBI, modulates ROS signaling between the ER and mitochondria [<xref rid="cns70378-bib-0081" ref-type="bibr">81</xref>]. Moreover, nuclear factor&#x02010;erythroid 2&#x02010;related factor 2 (Nrf2), an anti&#x02010;oxidative stress factor and direct substrate of PERK, can be influenced by MAMs, thus protecting against TBI through its regulation of microglial function [<xref rid="cns70378-bib-0009" ref-type="bibr">9</xref>].</p><p>Recent studies have shown that activating Sig&#x02010;1R may offer a promising clinical strategy for pharmacological treatment in TBI patients [<xref rid="cns70378-bib-0192" ref-type="bibr">192</xref>, <xref rid="cns70378-bib-0194" ref-type="bibr">194</xref>]. More treatments for TBI should be further studied.</p></sec><sec id="cns70378-sec-0022"><label>4.6</label><title>Glaucoma</title><p>Glaucoma constitutes a set of conditions that cause irreversible vision loss, notably marked by the progressive deterioration of retinal ganglion cells [<xref rid="cns70378-bib-0200" ref-type="bibr">200</xref>]. Globally, it is a significant factor contributing to irreversible blindness [<xref rid="cns70378-bib-0201" ref-type="bibr">201</xref>]. An increase in intraocular pressure and relative hypoxia in the retina trigger the generation of ROS, subsequently placing the retina and optic nerve under chronic stress [<xref rid="cns70378-bib-0202" ref-type="bibr">202</xref>].</p><p>In response to hypoxic conditions stemming from inadequate oxygen transport, glaucoma&#x02010;related axonal transport deficiencies arise [<xref rid="cns70378-bib-0203" ref-type="bibr">203</xref>]. Under these conditions, FUNDC1 undergoes a significant increase in MAMs, recruiting DRP1 to enhance mitochondrial fission, ultimately initiating mitophagy [<xref rid="cns70378-bib-0203" ref-type="bibr">203</xref>]. This mitophagy triggers the involvement of another key player, the NLRP3 inflammasome (the only inflammasome associated with MAM dysregulation) [<xref rid="cns70378-bib-0203" ref-type="bibr">203</xref>, <xref rid="cns70378-bib-0204" ref-type="bibr">204</xref>]. While NLRP3 is typically found in the ER, when activated by mitophagy/autophagy or ROS, it migrates from the ER to MAMs and connects with the adaptor protein ASC, initiating the assembly of the NLRP3 inflammasome [<xref rid="cns70378-bib-0203" ref-type="bibr">203</xref>]. In a glaucoma rat model involving ocular hypertension, a notable upregulation of Grp78 and CHOP, two proteins within the PERK signaling pathway, was observed [<xref rid="cns70378-bib-0205" ref-type="bibr">205</xref>]. Furthermore, blocking the PERK&#x02010;eIF2&#x02010;CHOP pathway exhibited protective effects on retinal ganglion cell soma and axons across various mouse glaucoma models [<xref rid="cns70378-bib-0205" ref-type="bibr">205</xref>, <xref rid="cns70378-bib-0206" ref-type="bibr">206</xref>]. Chronic ocular hypertension elevates the levels of cleaved&#x02010;poly ADP&#x02010;ribose polymerase (PARP) and NLRP3, leading to disturbances in MAM regulation and mitochondrial malfunction [<xref rid="cns70378-bib-0204" ref-type="bibr">204</xref>]. Moreover, it has been shown that when retinal ganglion cells undergo apoptosis due to hydrostatic pressure, there is an increase in calcium levels within these cells [<xref rid="cns70378-bib-0205" ref-type="bibr">205</xref>].</p><p>At present, there is a lack of research on the treatment of glaucoma through MAMs, and we can further study this in the future to find new targets for the treatment of glaucoma.</p></sec><sec id="cns70378-sec-0023"><label>4.7</label><title>Charcot&#x02013;Marie&#x02013;Tooth Disease</title><p>Charcot&#x02013;Marie&#x02010;Tooth (CMT) disease is a genetically diverse group of inherited neuropathies [<xref rid="cns70378-bib-0207" ref-type="bibr">207</xref>]. It is typically marked by both sensory and motor problems and is often called hereditary sensory and motor neuropathy [<xref rid="cns70378-bib-0207" ref-type="bibr">207</xref>]. Typically, patients display distal muscle weakness and atrophy, accompanied by reduced ankle dorsiflexion, diminished tendon reflexes, and prominent foot arches (known as Pes cavus deformities) [<xref rid="cns70378-bib-0208" ref-type="bibr">208</xref>]. Additionally, they often experience a slight to moderate loss of distal sensation, predominantly occurring in a symmetric stocking&#x02013;glove distribution, which often parallels the presentation of muscle weakness [<xref rid="cns70378-bib-0209" ref-type="bibr">209</xref>].</p><p>The etiology of CMT disease lies in abnormalities within axons, myelin sheaths, or both [<xref rid="cns70378-bib-0210" ref-type="bibr">210</xref>]. Among the axonal variants of CMT, a specific subtype known as CMT2A is attributed to mutations in the MFN2 gene [<xref rid="cns70378-bib-0211" ref-type="bibr">211</xref>]. Research indicates that a disrupted interplay between the ER and mitochondria plays a contributory role in the development of axonopathy observed in CMT2A transgenic mice [<xref rid="cns70378-bib-0210" ref-type="bibr">210</xref>]. In contrast, multiple studies have documented that mutations in the MFN2 gene associated with CMT2A disrupt the contact points between the ER and mitochondria, resulting in impairments in mitochondrial dynamics and their distribution within axons [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. Additionally, reducing the activity of GDAP1, a protein linked to CMT when mutated, weakens the interaction between the ER and mitochondria [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. This also disrupts Ca<sup>2+</sup> balance in both vitro and vivo models [<xref rid="cns70378-bib-0096" ref-type="bibr">96</xref>]. GDAP1 is an outer mitochondrial membrane protein [<xref rid="cns70378-bib-0100" ref-type="bibr">100</xref>]. The absence of GDAP1 triggers alterations in mitochondrial networks and their interactions with ER, causing reduced ER&#x02010;Ca<sup>2+</sup> levels and impairments in store&#x02010;operated calcium entry [<xref rid="cns70378-bib-0100" ref-type="bibr">100</xref>]. This dysfunction is attributed to a mislocalization of mitochondria to subplasmalemmal sites [<xref rid="cns70378-bib-0100" ref-type="bibr">100</xref>]. Motor neurons derived from GDAP1<sup>&#x02212;/&#x02212;</sup> mice exhibited a decrease in the quantity of ER&#x02010;mitochondria interfaces, leading to diminished ATP production and disturbances in the axonal transport of mitochondria [<xref rid="cns70378-bib-0212" ref-type="bibr">212</xref>]. Moreover, the gene responsible for encoding IP3R3 has been proved to be a contributor to CMT, and fibroblasts from affected patients exhibited imbalances in Ca<sup>2+</sup> homeostasis [<xref rid="cns70378-bib-0213" ref-type="bibr">213</xref>].</p><p>The latest study has corrected the root genetic defect of CMT2A in a mouse model, and future research should continue into the possibility of application in humans [<xref rid="cns70378-bib-0214" ref-type="bibr">214</xref>].</p></sec><sec id="cns70378-sec-0024"><label>4.8</label><title>Wolfram Syndrome</title><p>Wolfram syndrome is distinctively marked by the early onset of diabetes mellitus, accompanied by diabetes insipidus, optic nerve deterioration, auditory impairment, and progressive neurodegeneration [<xref rid="cns70378-bib-0215" ref-type="bibr">215</xref>]. It is a rare autosomal recessive condition, occurring in approximately one out of 700,000 individuals [<xref rid="cns70378-bib-0216" ref-type="bibr">216</xref>]. Many patients have harmful mutations in the WFS1 gene [<xref rid="cns70378-bib-0217" ref-type="bibr">217</xref>]. Besides, a recessive mutation in the CISD2 gene encoding CDGSH iron&#x02013;sulfur domain&#x02010;containing protein 2 has been reported in rare cases of type 2 Wolfram syndrome [<xref rid="cns70378-bib-0217" ref-type="bibr">217</xref>].</p><p>A portion of this disease stems from mutations in the WSF1 gene, which encodes the wolframin protein, a transmembrane protein of the ER that plays a role in MAMs [<xref rid="cns70378-bib-0218" ref-type="bibr">218</xref>]. An initial electrophysiological investigation of Xenopus oocytes showed an interaction between WFS1 and IP3Rs [<xref rid="cns70378-bib-0219" ref-type="bibr">219</xref>]. By examining channel activity in lipid bilayers, it was observed that the incorporation of WFS1 into these bilayers resulted in an augmented IP3&#x02010;triggered current [<xref rid="cns70378-bib-0219" ref-type="bibr">219</xref>]. Conversely, neurons lacking WFS1 exhibited reduced IP3R&#x02010;mediated Ca<sup>2+</sup> release and disrupted mitochondrial dynamics, thereby contributing to delayed development [<xref rid="cns70378-bib-0220" ref-type="bibr">220</xref>]. At the MAMs, WFS1 interacts with Sig&#x02010;1R, facilitating the positive regulation of calcium transfer between the ER and mitochondria [<xref rid="cns70378-bib-0219" ref-type="bibr">219</xref>]. Research has shown that the activation of Sig&#x02010;1R has the potential to mitigate the functional impairments in MAMs resulting from wolframin deficiency [<xref rid="cns70378-bib-0218" ref-type="bibr">218</xref>]. Utilizing PRE&#x02010;084, an agonist of the Sig&#x02010;1R, to stimulate the receptor can effectively counteract the WFS1 deficiency&#x02010;induced decrement in IP3R&#x02010;mediated Ca<sup>2+</sup> release and subsequent ER&#x02010;mitochondrial Ca<sup>2+</sup> transfer [<xref rid="cns70378-bib-0218" ref-type="bibr">218</xref>]. Moreover, VDAC1 has been determined to interact with WFS1, and the loss of this interaction in WS cells may negatively impact mitochondrial function [<xref rid="cns70378-bib-0221" ref-type="bibr">221</xref>]. However, replenishing WFS1 levels in WS cells reinstates the WFS1&#x02010;VDAC1 interaction, which is associated with an expansion in MAMs and mitochondrial networks, potentially enhancing mitochondrial function [<xref rid="cns70378-bib-0221" ref-type="bibr">221</xref>].</p><p>WS type 2 is a condition that arises from mutations in the CISD2 gene, encoding a protein primarily expressed in the MAMs [<xref rid="cns70378-bib-0105" ref-type="bibr">105</xref>]. According to transmission electron microscopy findings, fibroblasts from WS type 2 patients exhibit a notable increase in ER&#x02010;mitochondrial contacts compared to healthy controls [<xref rid="cns70378-bib-0222" ref-type="bibr">222</xref>]. CISD2 holds a pivotal position in regulating cytosolic Ca<sup>2+</sup> homeostasis as well as maintaining ER integrity and mitochondrial functionality [<xref rid="cns70378-bib-0223" ref-type="bibr">223</xref>]. Rouzier et&#x000a0;al. provided experimental evidence suggesting that imbalances in Ca<sup>2+</sup> homeostasis and disrupted ER&#x02010;mitochondrial interactions are significant pathophysiological factors that ultimately contribute to the development and progression of CISD2&#x02010;related diseases [<xref rid="cns70378-bib-0217" ref-type="bibr">217</xref>]. Cisd2, IP3R, and Bcl&#x02010;2 constitute a macrocomplex, essential for regulating Ca<sup>2+</sup> signaling and the physiology of MAMs [<xref rid="cns70378-bib-0224" ref-type="bibr">224</xref>]. Biophysical investigations have confirmed that the Cisd2&#x02010;Bcl&#x02010;2 complex functions through the interaction between Cisd2's catalytic domain and Bcl&#x02010;2's BH4 domain, which is also responsible for inhibiting IP3R [<xref rid="cns70378-bib-0219" ref-type="bibr">219</xref>].</p><p>Recent studies demonstrated that ER calcium depletion plays a crucial role in disrupting ER&#x02010;to&#x02010;mitochondria calcium transfer and causing mitochondrial dysfunction in Wolfram syndrome [<xref rid="cns70378-bib-0225" ref-type="bibr">225</xref>]. This presents a significant opportunity for treating neuronal diseases linked to defective ER&#x02010;mitochondria contact sites, including Wolfram syndrome. Another recent study suggests that future research should focus on neuron&#x02013;glia communication to gain a deeper understanding of WS pathogenesis [<xref rid="cns70378-bib-0226" ref-type="bibr">226</xref>].</p></sec></sec><sec sec-type="conclusions" id="cns70378-sec-0025"><label>5</label><title>Conclusions</title><p>In summary, MAMs serve as a key node for the interaction between mitochondria and ER, and their dysfunction is a common feature in multiple neurodegenerative diseases. Through this review, we delve into the significance of MAMs as a crucial platform for the communication between mitochondria and the ER in regulating intracellular signaling and metabolism. For numerous neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, we provided a detailed analysis of how MAM dysfunction contributes to the onset and progression of these diseases. Specifically, MAMs exhibit significant impacts on regulating APP processing, &#x003b1;&#x02010;synuclein aggregation, mitochondrial ATP production, and mitochondrial dynamics, among other changes that subsequently trigger neuronal dysfunction and death. Furthermore, this review highlights the critical roles of the Sig&#x02010;1R and other MAM&#x02010;associated proteins in maintaining ER&#x02010;mitochondrial communication, closely linking their dysfunction to various neurodegenerative diseases.</p><p>Through the analysis of the effects of MAM on neurodegenerative diseases, we found that the relationship between MAM and neurodegenerative diseases is not well understood. We found something that was contradictory in previous studies and worthy of further investigation, such as in Parkinson's disease, &#x003b1;&#x02010;synuclein overexpression or mutation disrupts Ca<sup>2+</sup> homeostasis, leading to increased ATP levels. At the same time, &#x003b1;&#x02010;synuclein interacts with VAPB, destroying VAPB&#x02010;PTPIP51 and resulting in decreased ATP levels. Also in Parkinson's disease, the interaction between PINK1 and Beclin1 leads to increased mitochondrial contact in the ER, which in turn promotes the formation of autophagosomes. In the process of autophagy, MFN2 ubiquitination increases, leading to the dismantling of MFN2 chains, which in turn leads to reduced mitochondrial contact in the ER. Similarly, &#x003b1;&#x02010;synuclein mutations cause Parkinson's disease and lead to decreased ER mitochondrial contact. PINK and Parkin mutations cause Parkinson's disease but lead to increased ER mitochondrial contact. Recent research suggests that communication between ER and mitochondria may play a double&#x02010;edged role. This partly explains these contradictions. However, the current research is not comprehensive. Among these conditions, it is crucial to investigate the tissue&#x02010;specific function of MAMs and delve into methods to precisely regulate their formation and function. The latest research findings have shown that ERMCSs possess unique subdomains and exhibit highly dynamic characteristics, where tethers diffuse in and out of the site within milliseconds, and the size and configuration of contact sites vary in response to various stimuli. We should do more in&#x02010;depth research based on this in the future. In addition, for Alzheimer's disease and other neurodegenerative diseases, the molecular mechanism of MAMs has not been fully understood, but we can analyze the existing literature to show that key proteins such as Sig&#x02010;1R, IP3R, and VAPB play an important role in most neurodegenerative diseases. Ca<sup>2+</sup> also plays an unparalleled role. Lipids such as cholesterol also participate in many neurodegenerative diseases. These may offer new ideas and approaches for the treatment of neurodegenerative diseases. In the future, we can develop more effective targeted therapeutic drugs for these proven key substances.</p></sec><sec id="cns70378-sec-0029"><title>Author Contributions</title><p>The review was designed by Y.L., X.G., and Y.Z. Related articles were screened and analyzed by Y.Z. The manuscript of this review was prepared by Y.Z. Y.L., X.G., X.W., F.H., and X.R. critically revised the draft before submission. J.W., H.L., and Q.W. helped perform the analysis with constructive discussions. All authors contributed to the article. All authors read and approved the final version.</p></sec><sec sec-type="COI-statement" id="cns70378-sec-0028"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><sec sec-type="data-availability" id="cns70378-sec-0027"><title>Data Availability Statement</title><p>The authors have nothing to report.</p></sec><ref-list content-type="cited-references" id="cns70378-bibl-0001"><title>References</title><ref id="cns70378-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cns70378-cit-0001">
<string-name>
<given-names>Z.</given-names>
<surname>Asefy</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Hoseinnejhad</surname>
</string-name>, and <string-name>
<given-names>Z.</given-names>
<surname>Ceferov</surname>
</string-name>, &#x0201c;<article-title>Nanoparticles Approaches in Neurodegenerative Diseases Diagnosis and Treatment</article-title>,&#x0201d; <source>Neurological Sciences</source>
<volume>42</volume>, no. <issue>7</issue> (<year>2021</year>): <fpage>2653</fpage>&#x02013;<lpage>2660</lpage>.<pub-id pub-id-type="pmid">33846881</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cns70378-cit-0002">
<string-name>
<given-names>M. G.</given-names>
<surname>Erkkinen</surname>
</string-name>, <string-name>
<given-names>M. O.</given-names>
<surname>Kim</surname>
</string-name>, and <string-name>
<given-names>M. D.</given-names>
<surname>Geschwind</surname>
</string-name>, &#x0201c;<article-title>Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases</article-title>,&#x0201d; <source>Cold Spring Harbor Perspectives in Biology</source>
<volume>10</volume>, no. <issue>4</issue> (<year>2018</year>): <elocation-id>a033118</elocation-id>.<pub-id pub-id-type="pmid">28716886</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cns70378-cit-0003">
<string-name>
<given-names>S. B.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Luo</surname>
</string-name>, <string-name>
<given-names>X. L.</given-names>
<surname>Deng</surname>
</string-name>, <string-name>
<given-names>Y. F.</given-names>
<surname>Zhou</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Hu</surname>
</string-name>, &#x0201c;<article-title>Long Non&#x02010;Coding RNAs in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Neurochemistry International</source>
<volume>148</volume> (<year>2021</year>): <elocation-id>105096</elocation-id>.<pub-id pub-id-type="pmid">34118305</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cns70378-cit-0004">
<string-name>
<given-names>M.</given-names>
<surname>Krols</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>van Isterdael</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Asselbergh</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes as Hubs for Neurodegeneration</article-title>,&#x0201d; <source>Acta Neuropathologica</source>
<volume>131</volume>, no. <issue>4</issue> (<year>2016</year>): <fpage>505</fpage>&#x02013;<lpage>523</lpage>.<pub-id pub-id-type="pmid">26744348</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0005"><label>5</label><mixed-citation publication-type="book" id="cns70378-cit-0005">
<string-name>
<given-names>M.</given-names>
<surname>Pera</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Montesinos</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Larrea</surname>
</string-name>, et&#x000a0;al., &#x0201c;<part-title>MAM and C99, Key Players in the Pathogenesis of Alzheimer's Disease</part-title>,&#x0201d; in <source>Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities With Metabolic Diseases</source>, vol. <volume>154</volume>, ed. <person-group person-group-type="editor">
<string-name>
<given-names>G.</given-names>
<surname>Soderbom</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>R.</given-names>
<surname>Esterline</surname>
</string-name>
</person-group>, <person-group person-group-type="editor">
<string-name>
<given-names>J.</given-names>
<surname>Oscarsson</surname>
</string-name>
</person-group>, and <person-group person-group-type="editor">
<string-name>
<given-names>M. P.</given-names>
<surname>Mattson</surname>
</string-name>
</person-group> (<publisher-name>Elsevier</publisher-name>, <year>2020</year>), <fpage>235</fpage>&#x02013;<lpage>278</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cns70378-cit-0006">
<string-name>
<given-names>S.</given-names>
<surname>Missiroli</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Patergnani</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Caroccia</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes (MAMs) and Inflammation</article-title>,&#x0201d; <source>Cell Death and Disease</source>
<volume>9</volume> (<year>2018</year>): <elocation-id>329</elocation-id>.<pub-id pub-id-type="pmid">29491386</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cns70378-cit-0007">
<string-name>
<given-names>R. R.</given-names>
<surname>Agrawal</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Montesinos</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Larrea</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Area&#x02010;Gomez</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Pera</surname>
</string-name>, &#x0201c;<article-title>The Silence of the Fats: A MAM's Story About Alzheimer</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>145</volume> (<year>2020</year>): <elocation-id>105062</elocation-id>.<pub-id pub-id-type="pmid">32866617</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cns70378-cit-0008">
<string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Y. J.</given-names>
<surname>Qiao</surname>
</string-name>, <string-name>
<given-names>S. K.</given-names>
<surname>Pan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Broadening Horizons: The Contribution of Mitochondria&#x02010; Associated Endoplasmic Reticulum Membrane (MAM) Dysfunction in Diabetic Kidney Disease</article-title>,&#x0201d; <source>International Journal of Biological Sciences</source>
<volume>19</volume>, no. <issue>14</issue> (<year>2023</year>): <fpage>4427</fpage>&#x02013;<lpage>4441</lpage>.<pub-id pub-id-type="pmid">37781026</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cns70378-cit-0009">
<string-name>
<given-names>D. D.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Gu</surname>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>J. N.</given-names>
<surname>Zhang</surname>
</string-name>, &#x0201c;<article-title>Potential Roles of Mitochondria&#x02010;Associated ER Membranes (MAMs) in Traumatic Brain Injury</article-title>,&#x0201d; <source>Cellular and Molecular Neurobiology</source>
<volume>37</volume>, no. <issue>8</issue> (<year>2017</year>): <fpage>1349</fpage>&#x02013;<lpage>1357</lpage>.<pub-id pub-id-type="pmid">28324201</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cns70378-cit-0010">
<string-name>
<given-names>L.</given-names>
<surname>Barazzuol</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Giamogante</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Cal&#x000ec;</surname>
</string-name>, &#x0201c;<article-title>Mitochondria Associated Membranes (MAMs): Architecture and Physiopathological Role</article-title>,&#x0201d; <source>Cell Calcium</source>
<volume>94</volume> (<year>2021</year>): <elocation-id>102343</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.ceca.2020.102343</pub-id>.<pub-id pub-id-type="pmid">33418313</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cns70378-cit-0011">
<string-name>
<given-names>R. Q.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>Q. Q.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Sheng</surname>
</string-name>, &#x0201c;<article-title>Mitochondria Associated ER Membranes and Cerebral Ischemia: Molecular Mechanisms and Therapeutic Strategies</article-title>,&#x0201d; <source>Pharmacological Research</source>
<volume>191</volume> (<year>2023</year>): <elocation-id>106761</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.phrs.2023.106761</pub-id>.<pub-id pub-id-type="pmid">37028777</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cns70378-cit-0012">
<string-name>
<given-names>A. A.</given-names>
<surname>Rowland</surname>
</string-name> and <string-name>
<given-names>G. K.</given-names>
<surname>Voeltz</surname>
</string-name>, &#x0201c;<article-title>Endoplasmic Reticulum&#x02010;Mitochondria Contacts: Function of the Junction</article-title>,&#x0201d; <source>Nature Reviews Molecular Cell Biology</source>
<volume>13</volume>, no. <issue>10</issue> (<year>2012</year>): <fpage>607</fpage>&#x02013;<lpage>615</lpage>.<pub-id pub-id-type="pmid">22992592</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cns70378-cit-0013">
<string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Huo</surname>
</string-name>, <string-name>
<given-names>K. D.</given-names>
<surname>Ren</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membrane (MAM): A Dark Horse for Diabetic Cardiomyopathy Treatment</article-title>,&#x0201d; <source>Cell Death Discovery</source>
<volume>10</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>148</fpage>, <pub-id pub-id-type="doi">10.1038/s41420-024-01918-3</pub-id>.<pub-id pub-id-type="pmid">38509100</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cns70378-cit-0014">
<string-name>
<given-names>T.</given-names>
<surname>Simmen</surname>
</string-name> and <string-name>
<given-names>M. S.</given-names>
<surname>Herrera&#x02010;Cruz</surname>
</string-name>, &#x0201c;<article-title>Plastic Mitochondria&#x02010;Endoplasmic Reticulum (ER) Contacts Use Chaperones and Tethers to Mould Their Structure and Signaling</article-title>,&#x0201d; <source>Current Opinion in Cell Biology</source>
<volume>53</volume> (<year>2018</year>): <fpage>61</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">29870872</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cns70378-cit-0015">
<string-name>
<given-names>J. R.</given-names>
<surname>Friedman</surname>
</string-name>, <string-name>
<given-names>L. L.</given-names>
<surname>Lackner</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>West</surname>
</string-name>, <string-name>
<given-names>J. R.</given-names>
<surname>DiBenedetto</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Nunnari</surname>
</string-name>, and <string-name>
<given-names>G. K.</given-names>
<surname>Voeltz</surname>
</string-name>, &#x0201c;<article-title>ER Tubules Mark Sites of Mitochondrial Division</article-title>,&#x0201d; <source>Science</source>
<volume>334</volume>, no. <issue>6054</issue> (<year>2011</year>): <fpage>358</fpage>&#x02013;<lpage>362</lpage>.<pub-id pub-id-type="pmid">21885730</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cns70378-cit-0016">
<string-name>
<given-names>J. E.</given-names>
<surname>Vance</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Stone</surname>
</string-name>, and <string-name>
<given-names>J. R.</given-names>
<surname>Faust</surname>
</string-name>, &#x0201c;<article-title>Abnormalities in Mitochondria&#x02010;Associated Membranes and Phospholipid Biosynthetic Enzymes in the Mnd/Mnd Mouse Model of Neuronal Ceroid Lipofuscinosis</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta&#x02010;Lipids and Lipid Metabolism</source>
<volume>1344</volume>, no. <issue>3</issue> (<year>1997</year>): <fpage>286</fpage>&#x02013;<lpage>299</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cns70378-cit-0017">
<string-name>
<given-names>M.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>C. R.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Sun</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes (MAMs): A Novel Therapeutic Target for Treating Metabolic Syndrome</article-title>,&#x0201d; <source>Current Medicinal Chemistry</source>
<volume>28</volume>, no. <issue>7</issue> (<year>2021</year>): <fpage>1347</fpage>&#x02013;<lpage>1362</lpage>.<pub-id pub-id-type="pmid">32048952</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cns70378-cit-0018">
<string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>J. Y.</given-names>
<surname>Yao</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y. S.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>X. J.</given-names>
<surname>Shi</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes (MAMs): Possible Therapeutic Targets in Heart Failure</article-title>,&#x0201d; <source>Frontiers in Cardiovascular Medicine</source>
<volume>10</volume> (<year>2023</year>): <elocation-id>1083935</elocation-id>.<pub-id pub-id-type="pmid">36776252</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cns70378-cit-0019">
<string-name>
<given-names>W. W.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>H. Q.</given-names>
<surname>Jin</surname>
</string-name>, and <string-name>
<given-names>Y. N.</given-names>
<surname>Huang</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes (MAMs): A Potential Therapeutic Target for Treating Alzheimer's Disease</article-title>,&#x0201d; <source>Clinical Science</source>
<volume>135</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>109</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">33404051</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cns70378-cit-0020">
<string-name>
<given-names>P.</given-names>
<surname>Gao</surname>
</string-name>, <string-name>
<given-names>W. X.</given-names>
<surname>Yang</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Sun</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease</article-title>,&#x0201d; <source>Oxidative Medicine and Cellular Longevity</source>
<volume>2020</volume> (<year>2020</year>): <elocation-id>3120539</elocation-id>.<pub-id pub-id-type="pmid">32952849</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cns70378-cit-0021">
<string-name>
<given-names>C. N.</given-names>
<surname>Poston</surname>
</string-name>, <string-name>
<given-names>S. C.</given-names>
<surname>Krishnan</surname>
</string-name>, and <string-name>
<given-names>C. R.</given-names>
<surname>Bazemore&#x02010;Walker</surname>
</string-name>, &#x0201c;<article-title>In&#x02010;Depth Proteomic Analysis of Mammalian Mitochondria&#x02010;Associated Membranes (MAM)</article-title>,&#x0201d; <source>Journal of Proteomics</source>
<volume>79</volume> (<year>2013</year>): <fpage>219</fpage>&#x02013;<lpage>230</lpage>.<pub-id pub-id-type="pmid">23313214</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cns70378-cit-0022">
<string-name>
<given-names>B.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>X. Z.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Y. L.</given-names>
<surname>Ma</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>So Close, Yet So Far Away: The Relationship Between MAM and Cardiac Disease</article-title>,&#x0201d; <source>Frontiers in Cardiovascular Medicine</source>
<volume>11</volume> (<year>2024</year>): <elocation-id>1353533</elocation-id>.<pub-id pub-id-type="pmid">38374992</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cns70378-cit-0023">
<string-name>
<given-names>Y.</given-names>
<surname>Luan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Luan</surname>
</string-name>, <string-name>
<given-names>R. X.</given-names>
<surname>Yuan</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Yang</surname>
</string-name>, &#x0201c;<article-title>Structure and Function of Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Cardiovascular Diseases</article-title>,&#x0201d; <source>Oxidative Medicine and Cellular Longevity</source>
<volume>2021</volume> (<year>2021</year>): <elocation-id>4578809</elocation-id>.<pub-id pub-id-type="pmid">34336092</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cns70378-cit-0024">
<string-name>
<given-names>P.</given-names>
<surname>Gomez&#x02010;Suaga</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Paillusson</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Stoica</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Noble</surname>
</string-name>, <string-name>
<given-names>D. P.</given-names>
<surname>Hanger</surname>
</string-name>, and <string-name>
<given-names>C. C. J.</given-names>
<surname>Miller</surname>
</string-name>, &#x0201c;<article-title>The ER&#x02010;Mitochondria Tethering Complex VAPB&#x02010;PTPIP51 Regulates Autophagy</article-title>,&#x0201d; <source>Current Biology</source>
<volume>27</volume>, no. <issue>3</issue> (<year>2017</year>): <fpage>371</fpage>&#x02013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">28132811</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cns70378-cit-0025">
<string-name>
<given-names>P.</given-names>
<surname>G&#x000f3;mez&#x02010;Suaga</surname>
</string-name>, <string-name>
<given-names>B. G.</given-names>
<surname>P&#x000e9;rez&#x02010;Nievas</surname>
</string-name>, <string-name>
<given-names>E. B.</given-names>
<surname>Glennon</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The VAPB&#x02010;PTPIP51 Endoplasmic Reticulum&#x02010;Mitochondria Tethering Proteins are Present in Neuronal Synapses and Regulate Synaptic Activity</article-title>,&#x0201d; <source>Acta Neuropathologica Communications</source>
<volume>7</volume> (<year>2019</year>): <fpage>35</fpage>.<pub-id pub-id-type="pmid">30841933</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cns70378-cit-0026">
<string-name>
<given-names>N.</given-names>
<surname>Hartopp</surname>
</string-name>, <string-name>
<given-names>D. H. W.</given-names>
<surname>Lau</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Martin&#x02010;Guerrero</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Disruption of the VAPB&#x02010;PTPIP51 ER&#x02010;Mitochondria Tethering Proteins in Post&#x02010;Mortem Human Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>10</volume> (<year>2022</year>): <elocation-id>950767</elocation-id>.<pub-id pub-id-type="pmid">36051435</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cns70378-cit-0027">
<string-name>
<given-names>G. M.</given-names>
<surname>M&#x000f3;rotz</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Mart&#x000ed;n&#x02010;Guerrero</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Markovinovic</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The PTPIP51 Coiled&#x02010;Coil Domain is Important in VAPB Binding, Formation of ER&#x02010;Mitochondria Contacts and IP3 Receptor Delivery of Ca<sup>2+</sup> to Mitochondria</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>10</volume> (<year>2022</year>): <elocation-id>920947</elocation-id>.<pub-id pub-id-type="pmid">36120587</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cns70378-cit-0028">
<string-name>
<given-names>N.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>H. Y.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The MAMs Structure and Its Role in Cell Death</article-title>,&#x0201d; <source>Cells</source>
<volume>10</volume>, no. <issue>3</issue> (<year>2021</year>): <elocation-id>657</elocation-id>.<pub-id pub-id-type="pmid">33809551</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cns70378-cit-0029">
<string-name>
<given-names>Y. J.</given-names>
<surname>Chi</surname>
</string-name>, <string-name>
<given-names>Z. Y.</given-names>
<surname>Bai</surname>
</string-name>, <string-name>
<given-names>G. L.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>X. H.</given-names>
<surname>Lai</surname>
</string-name>, and <string-name>
<given-names>Y. F.</given-names>
<surname>Song</surname>
</string-name>, &#x0201c;<article-title>ER&#x02010;Mitochondria Contact Sites Regulate Hepatic Lipogenesis via Ip3r&#x02010;Grp75&#x02010;Vdac Complex Recruiting Seipin</article-title>,&#x0201d; <source>Cell Communication and Signaling</source>
<volume>22</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>464</fpage>, <pub-id pub-id-type="doi">10.1186/s12964-024-01829-x</pub-id>.<pub-id pub-id-type="pmid">39350150</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cns70378-cit-0030">
<string-name>
<given-names>V.</given-names>
<surname>Basso</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Marchesan</surname>
</string-name>, and <string-name>
<given-names>E.</given-names>
<surname>Ziviani</surname>
</string-name>, &#x0201c;<article-title>A Trio Has Turned Into a Quartet: DJ&#x02010;1 Interacts With the IP3R&#x02010;Grp75&#x02010;VDAC Complex to Control ER&#x02010;Mitochondria Interaction</article-title>,&#x0201d; <source>Cell Calcium</source>
<volume>87</volume> (<year>2020</year>): <elocation-id>102186</elocation-id>.<pub-id pub-id-type="pmid">32120195</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cns70378-cit-0031">
<string-name>
<given-names>M.</given-names>
<surname>Ort&#x000ed;z&#x02010;Renter&#x000ed;a</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Ju&#x000e1;rez&#x02010;Contreras</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Gonz&#x000e1;lez&#x02010;Ram&#x000ed;rez</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>TRPV1 Channels and the Progesterone Receptor Sig&#x02010;1R Interact to Regulate Pain</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>115</volume>, no. <issue>7</issue> (<year>2018</year>): <fpage>E1657</fpage>&#x02013;<lpage>E1666</lpage>.<pub-id pub-id-type="pmid">29378958</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cns70378-cit-0032">
<string-name>
<given-names>X. L.</given-names>
<surname>Tang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Yuan</surname>
</string-name>, <string-name>
<given-names>X. L.</given-names>
<surname>Liang</surname>
</string-name>, and <string-name>
<given-names>X.</given-names>
<surname>Jiang</surname>
</string-name>, &#x0201c;<article-title>Mitofusin2 Expression is Associated With Podocyte Injury in IgA Nephropathy</article-title>,&#x0201d; <source>European Journal of Medical Research</source>
<volume>28</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>142</elocation-id>.<pub-id pub-id-type="pmid">36998021</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cns70378-cit-0033">
<string-name>
<given-names>Y. L.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>S. X.</given-names>
<surname>Meng</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Chen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>MFN1 Structures Reveal Nucleotide&#x02010;Triggered Dimerization Critical for Mitochondrial Fusion</article-title>,&#x0201d; <source>Nature</source>
<volume>542</volume>, no. <issue>7641</issue> (<year>2017</year>): <fpage>372</fpage>&#x02013;<lpage>376</lpage>.<pub-id pub-id-type="pmid">28114303</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cns70378-cit-0034">
<string-name>
<given-names>G.</given-names>
<surname>Yepuri</surname>
</string-name>, <string-name>
<given-names>L. M.</given-names>
<surname>Ramirez</surname>
</string-name>, <string-name>
<given-names>G. G.</given-names>
<surname>Theophall</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>DIAPH1&#x02010;MFN2 Interaction Regulates Mitochondria&#x02010;SR/ER Contact and Modulates Ischemic/Hypoxic Stress</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>14</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>6900</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cns70378-cit-0035">
<string-name>
<given-names>A.</given-names>
<surname>Alghamdi</surname>
</string-name>, &#x0201c;<article-title>A Detailed Review of Pharmacology of MFN1 (Mitofusion&#x02010;1)&#x02010;Mediated Mitochondrial Dynamics: Implications for Cellular Health and Diseases</article-title>,&#x0201d; <source>Saudi Pharmaceutical Journal</source>
<volume>32</volume>, no. <issue>4</issue> (<year>2024</year>): <elocation-id>102012</elocation-id>.<pub-id pub-id-type="pmid">38463181</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cns70378-cit-0036">
<string-name>
<given-names>S. E.</given-names>
<surname>Horvath</surname>
</string-name> and <string-name>
<given-names>G.</given-names>
<surname>Daum</surname>
</string-name>, &#x0201c;<article-title>Lipids of Mitochondria</article-title>,&#x0201d; <source>Progress in Lipid Research</source>
<volume>52</volume>, no. <issue>4</issue> (<year>2013</year>): <fpage>590</fpage>&#x02013;<lpage>614</lpage>.<pub-id pub-id-type="pmid">24007978</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cns70378-cit-0037">
<string-name>
<given-names>M.</given-names>
<surname>Rodr&#x000ed;guez&#x02010;Arribas</surname>
</string-name>, <string-name>
<given-names>S. M. S.</given-names>
<surname>Yakhine&#x02010;Diop</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Pedro</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease</article-title>,&#x0201d; <source>Molecular Neurobiology</source>
<volume>54</volume>, no. <issue>8</issue> (<year>2017</year>): <fpage>6287</fpage>&#x02013;<lpage>6303</lpage>.<pub-id pub-id-type="pmid">27714635</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cns70378-cit-0038">
<string-name>
<given-names>Z.</given-names>
<surname>Cui</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Vance</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>D. R.</given-names>
<surname>Voelker</surname>
</string-name>, and <string-name>
<given-names>D. E.</given-names>
<surname>Vance</surname>
</string-name>, &#x0201c;<article-title>Cloning and Expression of A Novel Phosphatidylethanolamine N&#x02010;METHYLTRANSFERASE &#x02010; A Specific Biochemical and Cytological Marker for A Unique Membrane&#x02010;Fraction in Rat&#x02010;Liver</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>268</volume>, no. <issue>22</issue> (<year>1993</year>): <fpage>16655</fpage>&#x02013;<lpage>16663</lpage>.<pub-id pub-id-type="pmid">8344945</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cns70378-cit-0039">
<string-name>
<given-names>J.</given-names>
<surname>Szymanski</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Janikiewicz</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Michalska</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Interaction of Mitochondria With the Endoplasmic Reticulum and Plasma Membrane in Calcium Homeostasis, Lipid Trafficking and Mitochondrial Structure</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>18</volume>, no. <issue>7</issue> (<year>2017</year>): <elocation-id>1576</elocation-id>.<pub-id pub-id-type="pmid">28726733</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cns70378-cit-0040">
<string-name>
<given-names>D. E.</given-names>
<surname>Vance</surname>
</string-name>, <string-name>
<given-names>C. J.</given-names>
<surname>Walkey</surname>
</string-name>, and <string-name>
<given-names>Z.</given-names>
<surname>Cui</surname>
</string-name>, &#x0201c;<article-title>Phosphatidylethanolamine N&#x02010;Methyltransferase From Liver</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta&#x02010;Lipids and Lipid Metabolism</source>
<volume>1348</volume> (<year>1997</year>): <fpage>142</fpage>&#x02013;<lpage>150</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cns70378-cit-0041">
<string-name>
<given-names>I.</given-names>
<surname>Anastasia</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Ilacqua</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Raimondi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Rough&#x02010;ER Contacts in the Liver Regulate Systemic Lipid Homeostasis</article-title>,&#x0201d; <source>Cell Reports</source>
<volume>34</volume>, no. <issue>11</issue> (<year>2021</year>): <elocation-id>108873</elocation-id>.<pub-id pub-id-type="pmid">33730569</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cns70378-cit-0042">
<string-name>
<given-names>A. E.</given-names>
<surname>Rusinol</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Cui</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>J. E.</given-names>
<surname>Vance</surname>
</string-name>, &#x0201c;<article-title>A Unique Mitochondria&#x02010;Associated Membrane&#x02010;Fraction From Rat&#x02010;Liver Has A High&#x02010;Capacity for Lipid&#x02010;Synthesis and Contains Pre&#x02010;Golgi Secretory Proteins Including Nascent Lipoproteins</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>269</volume>, no. <issue>44</issue> (<year>1994</year>): <fpage>27494</fpage>&#x02013;<lpage>27502</lpage>.<pub-id pub-id-type="pmid">7961664</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cns70378-cit-0043">
<string-name>
<given-names>J. E.</given-names>
<surname>Vance</surname>
</string-name>, &#x0201c;<article-title>Inter&#x02010;Organelle Membrane Contact Sites: Implications for Lipid Metabolism</article-title>,&#x0201d; <source>Biology Direct</source>
<volume>15</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>24</fpage>.<pub-id pub-id-type="pmid">33176847</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cns70378-cit-0044">
<string-name>
<given-names>M. I.</given-names>
<surname>Hern&#x000e1;ndez&#x02010;Alvarez</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sebasti&#x000e1;n</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Vives</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Deficient Endoplasmic Reticulum&#x02010;Mitochondrial Phosphatidylserine Transfer Causes Liver Disease</article-title>,&#x0201d; <source>Cell</source>
<volume>177</volume>, no. <issue>4</issue> (<year>2019</year>): <fpage>881</fpage>&#x02013;<lpage>895</lpage>.e17.<pub-id pub-id-type="pmid">31051106</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cns70378-cit-0045">
<string-name>
<given-names>V. F.</given-names>
<surname>Monteiro&#x02010;Cardoso</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Rochin</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Arora</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>ORP5/8 and MIB/MICOS Link ER&#x02010;Mitochondria and Intra&#x02010;Mitochondrial Contacts for Non&#x02010;Vesicular Transport of Phosphatidylserine</article-title>,&#x0201d; <source>Cell Reports</source>
<volume>40</volume>, no. <issue>12</issue> (<year>2022</year>): <elocation-id>111364</elocation-id>.<pub-id pub-id-type="pmid">36130504</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cns70378-cit-0046">
<string-name>
<given-names>J. S.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>S. Y.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Hepatic CDP&#x02010;Diacylglycerol Synthase 2 Deficiency Causes Mitochondrial Dysfunction and Promotes Rapid Progression of NASH and Fibrosis</article-title>,&#x0201d; <source>Science Bulletin</source>
<volume>67</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>299</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">36546079</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cns70378-cit-0047">
<string-name>
<given-names>H. K.</given-names>
<surname>Yeo</surname>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>H. Y.</given-names>
<surname>Kim</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Phospholipid Transfer Function of PTPIP51 at Mitochondria&#x02010;Associated ER Membranes</article-title>,&#x0201d; <source>EMBO Reports</source>
<volume>22</volume>, no. <issue>6</issue> (<year>2021</year>): <elocation-id>e51323</elocation-id>.<pub-id pub-id-type="pmid">33938112</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cns70378-cit-0048">
<string-name>
<given-names>M. Y. W.</given-names>
<surname>Ng</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Charsou</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Lapao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Cholesterol Transport Protein GRAMD1C Regulates Autophagy Initiation and Mitochondrial Bioenergetics</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>13</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>6283</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cns70378-cit-0049">
<string-name>
<given-names>A.</given-names>
<surname>Sala&#x02010;Vila</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Navarro&#x02010;L&#x000e9;rida</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>S&#x000e1;nchez&#x02010;Alvarez</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Interplay Between Hepatic Mitochondria&#x02010;Associated Membranes, Lipid Metabolism and Caveolin&#x02010;1 in Mice</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>6</volume> (<year>2016</year>): <elocation-id>27351</elocation-id>, <pub-id pub-id-type="doi">10.1038/srep27351</pub-id>.<pub-id pub-id-type="pmid">27272971</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cns70378-cit-0050">
<string-name>
<given-names>J.</given-names>
<surname>More</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Galusso</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Veloso</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>N&#x02010;Acetylcysteine Prevents the Spatial Memory Deficits and the Redox&#x02010;Dependent RyR2 Decrease Displayed by an Alzheimer's Disease Rat Model</article-title>,&#x0201d; <source>Frontiers in Aging Neuroscience</source>
<volume>10</volume> (<year>2018</year>): <elocation-id>399</elocation-id>.<pub-id pub-id-type="pmid">30574085</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cns70378-cit-0051">
<string-name>
<given-names>C. W.</given-names>
<surname>Taylor</surname>
</string-name> and <string-name>
<given-names>V.</given-names>
<surname>Konieczny</surname>
</string-name>, &#x0201c;<article-title>IP3 Receptors: Take Four IP3 to Open</article-title>,&#x0201d; <source>Science Signaling</source>
<volume>9</volume>, no. <issue>422</issue> (<year>2016</year>): <fpage>pe1</fpage>.<pub-id pub-id-type="pmid">27048564</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cns70378-cit-0052">
<string-name>
<given-names>F. K.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>G. H.</given-names>
<surname>Du</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Xie</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>RyRs Mediate Lead&#x02010;Induced Neurodegenerative Disorders Through Calcium Signaling Pathways</article-title>,&#x0201d; <source>Science of the Total Environment</source>
<volume>701</volume> (<year>2020</year>): <elocation-id>134901</elocation-id>.<pub-id pub-id-type="pmid">31710906</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cns70378-cit-0053">
<string-name>
<given-names>Y. H.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Depletion of Peroxiredoxin II Promotes Keratinocyte Apoptosis and Alleviates Psoriatic Skin Lesions via the PI3K/AKT/GSK3&#x003b2; Signaling Axis</article-title>,&#x0201d; <source>Cell Death Discovery</source>
<volume>9</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>263</fpage>.<pub-id pub-id-type="pmid">37500620</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="cns70378-cit-0054">
<string-name>
<given-names>G.</given-names>
<surname>Beutner</surname>
</string-name>, <string-name>
<given-names>J. R.</given-names>
<surname>Burris</surname>
</string-name>, and <string-name>
<given-names>G. A.</given-names>
<surname>Porter</surname>
</string-name>, &#x0201c;<article-title>Aceylated Cyclophilin D Regulates Mitochondrial Function in the Developing Mouse Heart</article-title>,&#x0201d; <source>Biophysical Journal</source>
<volume>120</volume>, no. <issue>3</issue> (<year>2021</year>): <fpage>350A</fpage>.</mixed-citation></ref><ref id="cns70378-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="cns70378-cit-0055">
<string-name>
<given-names>S.</given-names>
<surname>Dong</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>IP3R&#x02010;1 Aggravates Endotoxin&#x02010;Induced Acute Lung Injury in Mice by Regulating MAM Formation and Mitochondrial Function</article-title>,&#x0201d; <source>Experimental Biology and Medicine</source>
<volume>248</volume>, no. <issue>23</issue> (<year>2023</year>): <fpage>2262</fpage>&#x02013;<lpage>2272</lpage>, <pub-id pub-id-type="doi">10.1177/15353702231220667</pub-id>.<pub-id pub-id-type="pmid">38159072</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="cns70378-cit-0056">
<string-name>
<given-names>W. D.</given-names>
<surname>Ge</surname>
</string-name>, <string-name>
<given-names>T. T.</given-names>
<surname>Du</surname>
</string-name>, <string-name>
<given-names>C. Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>L. N.</given-names>
<surname>Sun</surname>
</string-name>, and <string-name>
<given-names>Y. Q.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>Calcium Signaling Crosstalk Between the Endoplasmic Reticulum and Mitochondria, a New Drug Development Strategies of Kidney Diseases</article-title>,&#x0201d; <source>Biochemical Pharmacology</source>
<volume>225</volume> (<year>2024</year>): <elocation-id>116278</elocation-id>.<pub-id pub-id-type="pmid">38740223</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="cns70378-cit-0057">
<string-name>
<given-names>M. A.</given-names>
<surname>Carpio</surname>
</string-name>, <string-name>
<given-names>R. E.</given-names>
<surname>Means</surname>
</string-name>, <string-name>
<given-names>A. L.</given-names>
<surname>Brill</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sainz</surname>
</string-name>, <string-name>
<given-names>B. E.</given-names>
<surname>Ehrlich</surname>
</string-name>, and <string-name>
<given-names>S. G.</given-names>
<surname>Katz</surname>
</string-name>, &#x0201c;<article-title>BOK Controls Apoptosis by Ca<sup>2+</sup> Transfer Through ER&#x02010;Mitochondrial Contact Sites</article-title>,&#x0201d; <source>Cell Reports</source>
<volume>34</volume>, no. <issue>10</issue> (<year>2021</year>): <elocation-id>108827</elocation-id>.<pub-id pub-id-type="pmid">33691099</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="cns70378-cit-0058">
<string-name>
<given-names>P.</given-names>
<surname>Veeresh</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Kaur</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sarmah</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endoplasmic Reticulum&#x02010;Mitochondria Crosstalk: From Junction to Function Across Neurological Disorders</article-title>,&#x0201d; <source>Annals of the New York Academy of Sciences</source>
<volume>1457</volume>, no. <issue>1</issue> (<year>2019</year>): <fpage>41</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">31460675</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="cns70378-cit-0059">
<string-name>
<given-names>L.</given-names>
<surname>Scorrano</surname>
</string-name>, &#x0201c;<article-title>Keeping Mitochondria in Shape: A Matter of Life and Death</article-title>,&#x0201d; <source>European Journal of Clinical Investigation</source>
<volume>43</volume>, no. <issue>8</issue> (<year>2013</year>): <fpage>886</fpage>&#x02013;<lpage>893</lpage>.<pub-id pub-id-type="pmid">23869410</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="cns70378-cit-0060">
<string-name>
<given-names>D.</given-names>
<surname>Patten</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Harper</surname>
</string-name>, and <string-name>
<given-names>N.</given-names>
<surname>Boardman</surname>
</string-name>, &#x0201c;<article-title>Harnessing the Protective Role of OPA1 in Diabetic Cardiomyopathy</article-title>,&#x0201d; <source>Acta Physiologica</source>
<volume>229</volume>, no. <issue>1</issue> (<year>2020</year>): <elocation-id>e13466</elocation-id>.<pub-id pub-id-type="pmid">32175678</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="cns70378-cit-0061">
<string-name>
<given-names>T.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Ruan</surname>
</string-name>, <string-name>
<given-names>P. C.</given-names>
<surname>Luo</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Modulation of ER&#x02010;Mitochondria Tethering Complex VAPB&#x02010;PTPIP51: Novel Therapeutic Targets for Aging&#x02010;Associated Diseases</article-title>,&#x0201d; <source>Ageing Research Reviews</source>
<volume>98</volume> (<year>2024</year>): <elocation-id>102320</elocation-id>.<pub-id pub-id-type="pmid">38719161</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="cns70378-cit-0062">
<string-name>
<given-names>F.</given-names>
<surname>Kraus</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Roy</surname>
</string-name>, <string-name>
<given-names>T. J.</given-names>
<surname>Pucadyil</surname>
</string-name>, and <string-name>
<given-names>M. T.</given-names>
<surname>Ryan</surname>
</string-name>, &#x0201c;<article-title>Function and Regulation of the Divisome for Mitochondrial Fission</article-title>,&#x0201d; <source>Nature</source>
<volume>590</volume>, no. <issue>7844</issue> (<year>2021</year>): <fpage>57</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">33536648</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="cns70378-cit-0063">
<string-name>
<given-names>T.</given-names>
<surname>Vezza</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>D&#x000ed;az&#x02010;Pozo</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Canet</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Role of Mitochondrial Dynamic Dysfunction in Age&#x02010;Associated Type 2 Diabetes</article-title>,&#x0201d; <source>World Journal of Men's Health</source>
<volume>40</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>399</fpage>&#x02013;<lpage>411</lpage>, <pub-id pub-id-type="doi">10.5534/wjmh.210146</pub-id>.</mixed-citation></ref><ref id="cns70378-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="cns70378-cit-0064">
<string-name>
<given-names>Q. H.</given-names>
<surname>Gu</surname>
</string-name>, <string-name>
<given-names>K. Z.</given-names>
<surname>Duan</surname>
</string-name>, <string-name>
<given-names>R. S.</given-names>
<surname>Petralia</surname>
</string-name>, <string-name>
<given-names>Y. X.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>Z.</given-names>
<surname>Li</surname>
</string-name>, &#x0201c;<article-title>BAX Regulates Dendritic Spine Development via Mitochondrial Fusion</article-title>,&#x0201d; <source>Neuroscience Research</source>
<volume>182</volume> (<year>2022</year>): <fpage>25</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">35688289</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="cns70378-cit-0065">
<string-name>
<given-names>X. F.</given-names>
<surname>Jin</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Gao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Dysregulation of INF2&#x02010;Mediated Mitochondrial Fission in SPOP&#x02010;Mutated Prostate Cancer</article-title>,&#x0201d; <source>PLoS Genetics</source>
<volume>13</volume>, no. <issue>4</issue> (<year>2017</year>): <elocation-id>e1006748</elocation-id>, <pub-id pub-id-type="doi">10.1371/journal.pgen.1006748</pub-id>.<pub-id pub-id-type="pmid">28448495</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="cns70378-cit-0066">
<string-name>
<given-names>C. R.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>PACS&#x02010;2 Ameliorates Tubular Injury by Facilitating Endoplasmic Reticulum&#x02010;Mitochondria Contact and Mitophagy in Diabetic Nephropathy</article-title>,&#x0201d; <source>Diabetes</source>
<volume>71</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>1034</fpage>&#x02013;<lpage>1050</lpage>.<pub-id pub-id-type="pmid">35133431</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="cns70378-cit-0067">
<string-name>
<given-names>W. X.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>R. Z.</given-names>
<surname>Zhu</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Feng</surname>
</string-name>, &#x0201c;<article-title>FUNDC1 Is a Novel Mitochondrial&#x02010;Associated&#x02010;Membrane (MAM) Protein Required for Hypoxia&#x02010;Induced Mitochondrial Fission and Mitophagy</article-title>,&#x0201d; <source>Autophagy</source>
<volume>12</volume>, no. <issue>9</issue> (<year>2016</year>): <fpage>1675</fpage>&#x02013;<lpage>1676</lpage>.<pub-id pub-id-type="pmid">27314574</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="cns70378-cit-0068">
<string-name>
<given-names>M.</given-names>
<surname>Hamasaki</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Furuta</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Matsuda</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Autophagosomes Form at ER&#x02010;Mitochondria Contact Sites</article-title>,&#x0201d; <source>Nature</source>
<volume>495</volume>, no. <issue>7441</issue> (<year>2013</year>): <fpage>389</fpage>&#x02013;<lpage>393</lpage>.<pub-id pub-id-type="pmid">23455425</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="cns70378-cit-0069">
<string-name>
<given-names>M. L.</given-names>
<surname>Sassano</surname>
</string-name>, <string-name>
<given-names>A. R.</given-names>
<surname>van Vliet</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Agostinis</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes as Networking Platforms and Regulators of Cancer Cell Fate</article-title>,&#x0201d; <source>Frontiers in Oncology</source>
<volume>7</volume> (<year>2017</year>): <fpage>174</fpage>.<pub-id pub-id-type="pmid">28868254</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="cns70378-cit-0070">
<string-name>
<given-names>M.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Z. H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Y. Y.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitophagy Receptor FUNDC1 Regulates Mitochondrial Dynamics and Mitophagy</article-title>,&#x0201d; <source>Autophagy</source>
<volume>12</volume>, no. <issue>4</issue> (<year>2016</year>): <fpage>689</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">27050458</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="cns70378-cit-0071">
<string-name>
<given-names>V.</given-names>
<surname>Gelmetti</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>De Rosa</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Torosantucci</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>PINK1 and BECN1 Relocalize at Mitochondria&#x02010;Associated Membranes During Mitophagy and Promote ER&#x02010;Mitochondria Tethering and Autophagosome Formation</article-title>,&#x0201d; <source>Autophagy</source>
<volume>13</volume>, no. <issue>4</issue> (<year>2017</year>): <fpage>654</fpage>&#x02013;<lpage>669</lpage>.<pub-id pub-id-type="pmid">28368777</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="cns70378-cit-0072">
<string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name> and <string-name>
<given-names>X. W.</given-names>
<surname>Zhu</surname>
</string-name>, &#x0201c;<article-title>Endoplasmic Reticulum&#x02010;Mitochondria Tethering in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Translational Neurodegeneration</source>
<volume>6</volume> (<year>2017</year>): <fpage>21</fpage>, <pub-id pub-id-type="doi">10.1186/s40035-017-0092-6</pub-id>.<pub-id pub-id-type="pmid">28852477</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="cns70378-cit-0073">
<string-name>
<given-names>X. J.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Y. Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y. H.</given-names>
<surname>Fu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Gossypol, a Novel Modulator of VCP, Induces Autophagic Degradation of Mutant Huntingtin by Promoting the Formation of VCP/p97&#x02010;LC3&#x02010;mHTT Complex</article-title>,&#x0201d; <source>Acta Pharmacologica Sinica</source>
<volume>42</volume>, no. <issue>10</issue> (<year>2021</year>): <fpage>1556</fpage>&#x02013;<lpage>1566</lpage>.<pub-id pub-id-type="pmid">33495516</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="cns70378-cit-0074">
<string-name>
<given-names>X. Y.</given-names>
<surname>Wei</surname>
</string-name>, <string-name>
<given-names>L. Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>BAP31 Depletion Inhibited Adipogenesis, Repressed Lipolysis and Promoted Lipid Droplets Abnormal Growth via Attenuating Perilipin1 Proteasomal Degradation</article-title>,&#x0201d; <source>International Journal of Biological Sciences</source>
<volume>19</volume>, no. <issue>6</issue> (<year>2023</year>): <fpage>1713</fpage>&#x02013;<lpage>1730</lpage>.<pub-id pub-id-type="pmid">37063427</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="cns70378-cit-0075">
<string-name>
<given-names>S. S.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>R. X.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>C. X.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>S. Y.</given-names>
<surname>He</surname>
</string-name>, and <string-name>
<given-names>Z. G.</given-names>
<surname>Su</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes in the Pathogenesis of Type 2 Diabetes Mellitus</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>8</volume> (<year>2020</year>): <elocation-id>571554</elocation-id>.<pub-id pub-id-type="pmid">33195204</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="cns70378-cit-0076">
<string-name>
<given-names>J.</given-names>
<surname>Campos</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Gleitze</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Hidalgo</surname>
</string-name>, and <string-name>
<given-names>M. T.</given-names>
<surname>N&#x000fa;&#x000f1;ez</surname>
</string-name>, &#x0201c;<article-title>IP3<italic toggle="yes">R</italic>&#x02010;Mediated Calcium Release Promotes Ferroptotic Death in SH&#x02010;SY5Y Neuroblastoma Cells</article-title>,&#x0201d; <source>Antioxidants</source>
<volume>13</volume>, no. <issue>2</issue> (<year>2024</year>): <elocation-id>196</elocation-id>.<pub-id pub-id-type="pmid">38397794</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="cns70378-cit-0077">
<string-name>
<given-names>J. L.</given-names>
<surname>Morris</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Gillet</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Prudent</surname>
</string-name>, and <string-name>
<given-names>N.</given-names>
<surname>Popgeorgiev</surname>
</string-name>, &#x0201c;<article-title>Bcl&#x02010;2 Family of Proteins in the Control of Mitochondrial Calcium Signalling: An Old Chap With New Roles</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>22</volume>, no. <issue>7</issue> (<year>2021</year>): <elocation-id>3730</elocation-id>.<pub-id pub-id-type="pmid">33918511</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="cns70378-cit-0078">
<string-name>
<given-names>H.</given-names>
<surname>Cheng</surname>
</string-name>, <string-name>
<given-names>X. K.</given-names>
<surname>Gang</surname>
</string-name>, <string-name>
<given-names>G. Y.</given-names>
<surname>He</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Molecular Mechanisms Underlying Mitochondria&#x02010;Associated Endoplasmic Reticulum Membrane&#x02010;Induced Insulin Resistance</article-title>,&#x0201d; <source>Frontiers in Endocrinology</source>
<volume>11</volume> (<year>2020</year>): <elocation-id>592129</elocation-id>.<pub-id pub-id-type="pmid">33329397</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="cns70378-cit-0079">
<string-name>
<given-names>N. S.</given-names>
<surname>Leal</surname>
</string-name> and <string-name>
<given-names>L. M.</given-names>
<surname>Martins</surname>
</string-name>, &#x0201c;<article-title>Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Biomedicine</source>
<volume>9</volume>, no. <issue>2</issue> (<year>2021</year>): <elocation-id>227</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="cns70378-cit-0080">
<string-name>
<given-names>C.</given-names>
<surname>Hetz</surname>
</string-name> and <string-name>
<given-names>F. R.</given-names>
<surname>Papa</surname>
</string-name>, &#x0201c;<article-title>The Unfolded Protein Response and Cell Fate Control</article-title>,&#x0201d; <source>Molecular Cell</source>
<volume>69</volume>, no. <issue>2</issue> (<year>2018</year>): <fpage>169</fpage>&#x02013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">29107536</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="cns70378-cit-0081">
<string-name>
<given-names>T.</given-names>
<surname>Verfaillie</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Rubio</surname>
</string-name>, <string-name>
<given-names>A. D.</given-names>
<surname>Garg</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>PERK Is Required at the ER&#x02010;Mitochondrial Contact Sites to Convey Apoptosis After ROS&#x02010;Based ER Stress</article-title>,&#x0201d; <source>Cell Death and Differentiation</source>
<volume>19</volume>, no. <issue>11</issue> (<year>2012</year>): <fpage>1880</fpage>&#x02013;<lpage>1891</lpage>.<pub-id pub-id-type="pmid">22705852</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="cns70378-cit-0082">
<string-name>
<given-names>A.</given-names>
<surname>Carreras&#x02010;Sureda</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Ja&#x000f1;a</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Urra</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Non&#x02010;Canonical Function of IRE1&#x003b1; Determines Mitochondria&#x02010;Associated Endoplasmic Reticulum Composition to Control Calcium Transfer and Bioenergetics</article-title>,&#x0201d; <source>Nature Cell Biology</source>
<volume>21</volume>, no. <issue>6</issue> (<year>2019</year>): <fpage>755</fpage>&#x02013;<lpage>767</lpage>.<pub-id pub-id-type="pmid">31110288</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="cns70378-cit-0083">
<string-name>
<given-names>S. Z.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>H. P.</given-names>
<surname>Xing</surname>
</string-name>, <string-name>
<given-names>T. T.</given-names>
<surname>Zang</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Ruan</surname>
</string-name>, <string-name>
<given-names>L. L.</given-names>
<surname>Wo</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>He</surname>
</string-name>, &#x0201c;<article-title>Sirtuins in Mitochondrial Stress: Indispensable Helpers Behind the Scenes</article-title>,&#x0201d; <source>Ageing Research Reviews</source>
<volume>44</volume> (<year>2018</year>): <fpage>22</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">29580919</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="cns70378-cit-0084">
<string-name>
<given-names>A.</given-names>
<surname>Carreras&#x02010;Sureda</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Pih&#x000e1;n</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Hetz</surname>
</string-name>, &#x0201c;<article-title>Calcium Signaling at the Endoplasmic Reticulum: Fine&#x02010;Tuning Stress Responses</article-title>,&#x0201d; <source>Cell Calcium</source>
<volume>70</volume> (<year>2018</year>): <fpage>24</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">29054537</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="cns70378-cit-0085">
<string-name>
<given-names>X.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zhuang</surname>
</string-name>, <string-name>
<given-names>W. L.</given-names>
<surname>Song</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membrane: Overview and Inextricable Link With Cancer</article-title>,&#x0201d; <source>Journal of Cellular and Molecular Medicine</source>
<volume>27</volume>, no. <issue>7</issue> (<year>2023</year>): <fpage>906</fpage>&#x02013;<lpage>919</lpage>.<pub-id pub-id-type="pmid">36852470</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="cns70378-cit-0086">
<string-name>
<given-names>L. R.</given-names>
<surname>Rodr&#x000ed;guez</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Calap&#x02010;Quintana</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Lape&#x000f1;a&#x02010;Luz&#x000f3;n</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Oxidative Stress Modulates Rearrangement of Endoplasmic Reticulum&#x02010;Mitochondria Contacts and Calcium Dysregulation in a Friedreich's Ataxia Model</article-title>,&#x0201d; <source>Redox Biology</source>
<volume>37</volume> (<year>2020</year>): <elocation-id>101762</elocation-id>.<pub-id pub-id-type="pmid">33128998</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="cns70378-cit-0087">
<string-name>
<given-names>Z. L.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>W. J.</given-names>
<surname>Gu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>CGI1746 Targets &#x003c3; 1 R to Modulate Ferroptosis Through Mitochondria&#x02010;Associated Membranes</article-title>,&#x0201d; <source>Nature Chemical Biology</source>
<volume>20</volume>, no. <issue>6</issue> (<year>2024</year>): <fpage>699</fpage>&#x02013;<lpage>709</lpage>, <pub-id pub-id-type="doi">10.1038/s41589-023-01512-1</pub-id>.<pub-id pub-id-type="pmid">38212578</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="cns70378-cit-0088">
<string-name>
<given-names>S.</given-names>
<surname>Deshwal</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Onishi</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Tatsuta</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria Regulate Intracellular Coenzyme Q Transport and Ferroptotic Resistance via STARD7</article-title>,&#x0201d; <source>Nature Cell Biology</source>
<volume>25</volume>, no. <issue>2</issue> (<year>2023</year>): <fpage>246</fpage>&#x02013;<lpage>257</lpage>.<pub-id pub-id-type="pmid">36658222</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="cns70378-cit-0089">
<string-name>
<given-names>R. B.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Yazdi</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Menu</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Tschopp</surname>
</string-name>, &#x0201c;<article-title>A Role for Mitochondria in NLRP3 Inflammasome Activation</article-title>,&#x0201d; <source>Nature</source>
<volume>469</volume>, no. <issue>7329</issue> (<year>2011</year>): <fpage>221</fpage>&#x02013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">21124315</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="cns70378-cit-0090">
<string-name>
<given-names>P.</given-names>
<surname>Gao</surname>
</string-name>, <string-name>
<given-names>Z. C.</given-names>
<surname>Yan</surname>
</string-name>, and <string-name>
<given-names>Z. M.</given-names>
<surname>Zhu</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes in Cardiovascular Diseases</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>8</volume> (<year>2020</year>): <elocation-id>604240</elocation-id>.<pub-id pub-id-type="pmid">33240899</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="cns70378-cit-0091">
<string-name>
<given-names>S. M.</given-names>
<surname>Horner</surname>
</string-name>, <string-name>
<given-names>H. M.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>H. S.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Briley</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Gale</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial&#x02010;Associated Endoplasmic Reticulum Membranes (MAM) Form Innate Immune Synapses and Are Targeted by Hepatitis C Virus</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>108</volume>, no. <issue>35</issue> (<year>2011</year>): <fpage>14590</fpage>&#x02013;<lpage>14595</lpage>.<pub-id pub-id-type="pmid">21844353</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="cns70378-cit-0092">
<string-name>
<given-names>S. M.</given-names>
<surname>Horner</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Wilkins</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Badil</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Iskarpatyoti</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Gale</surname>
</string-name>, &#x0201c;<article-title>Proteomic Analysis of Mitochondrial&#x02010;Associated ER Membranes (MAM) During RNA Virus Infection Reveals Dynamic Changes in Protein and Organelle Trafficking</article-title>,&#x0201d; <source>PLoS One</source>
<volume>10</volume>, no. <issue>3</issue> (<year>2015</year>): <elocation-id>e0117963</elocation-id>.<pub-id pub-id-type="pmid">25734423</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="cns70378-cit-0093">
<string-name>
<given-names>J.</given-names>
<surname>Weller</surname>
</string-name> and <string-name>
<given-names>A.</given-names>
<surname>Budson</surname>
</string-name>, &#x0201c;<article-title>Current Understanding of Alzheimer's Disease Diagnosis and Treatment</article-title>,&#x0201d; <source>F1000Research</source>
<volume>7</volume> (<year>2018</year>): <fpage>1161</fpage>&#x02013;<lpage>1169</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="cns70378-cit-0094">
<string-name>
<given-names>P.</given-names>
<surname>Scheltens</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>De Strooper</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kivipelto</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Alzheimer's Disease</article-title>,&#x0201d; <source>Lancet</source>
<volume>397</volume>, no. <issue>10284</issue> (<year>2021</year>): <fpage>1577</fpage>&#x02013;<lpage>1590</lpage>.<pub-id pub-id-type="pmid">33667416</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="cns70378-cit-0095">
<string-name>
<given-names>N.</given-names>
<surname>Mattsson&#x02010;Carlgren</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Salvad&#x000f3;</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Ashton</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers</article-title>,&#x0201d; <source>JAMA Neurology</source>
<volume>80</volume>, no. <issue>4</issue> (<year>2023</year>): <fpage>360</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">36745413</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="cns70378-cit-0096">
<string-name>
<given-names>A.</given-names>
<surname>Markovinovic</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Greig</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Mart&#x000ed;n&#x02010;Guerrero</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Salam</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Paillusson</surname>
</string-name>, &#x0201c;<article-title>Endoplasmic Reticulum&#x02010;Mitochondria Signaling in Neurons and Neurodegenerative Diseases</article-title>,&#x0201d; <source>Journal of Cell Science</source>
<volume>135</volume>, no. <issue>3</issue> (<year>2022</year>): <elocation-id>jcs248534</elocation-id>.<pub-id pub-id-type="pmid">35129196</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="cns70378-cit-0097">
<string-name>
<given-names>J. Y.</given-names>
<surname>Hur</surname>
</string-name>, &#x0201c;<article-title>Gamma&#x02010;Secretase in Alzheimer's Disease</article-title>,&#x0201d; <source>Experimental and Molecular Medicine</source>
<volume>54</volume>, no. <issue>4</issue> (<year>2022</year>): <fpage>433</fpage>&#x02013;<lpage>446</lpage>.<pub-id pub-id-type="pmid">35396575</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="cns70378-cit-0098">
<string-name>
<given-names>A.</given-names>
<surname>Johri</surname>
</string-name> and <string-name>
<given-names>A.</given-names>
<surname>Chandra</surname>
</string-name>, &#x0201c;<article-title>Connection Lost, MAM: Errors in ER&#x02010;Mitochondria Connections in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Brain Sciences</source>
<volume>11</volume>, no. <issue>11</issue> (<year>2021</year>): <elocation-id>1437</elocation-id>.<pub-id pub-id-type="pmid">34827436</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="cns70378-cit-0099">
<string-name>
<given-names>E.</given-names>
<surname>Area&#x02010;Gomez</surname>
</string-name>, <string-name>
<given-names>M. D. L.</given-names>
<surname>Castillo</surname>
</string-name>, <string-name>
<given-names>M. D.</given-names>
<surname>Tambini</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Upregulated Function of Mitochondria&#x02010;Associated ER Membranes in Alzheimer Disease</article-title>,&#x0201d; <source>EMBO Journal</source>
<volume>31</volume>, no. <issue>21</issue> (<year>2012</year>): <fpage>4106</fpage>&#x02013;<lpage>4123</lpage>, <pub-id pub-id-type="doi">10.1038/emboj.2012.202</pub-id>.<pub-id pub-id-type="pmid">22892566</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="cns70378-cit-0100">
<string-name>
<given-names>P.</given-names>
<surname>Gonz&#x000e1;lez&#x02010;S&#x000e1;nchez</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Pla&#x02010;Mart&#x000ed;n</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mart&#x000ed;nez&#x02010;Valero</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>CMT&#x02010;Linked Loss&#x02010;Of&#x02010;Function Mutations in GDAP1 Impair Store&#x02010;Operated Ca<sup>2+</sup> Entry&#x02010;Stimulated Respiration</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>7</volume> (<year>2017</year>): <elocation-id>42993</elocation-id>.<pub-id pub-id-type="pmid">28220846</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="cns70378-cit-0101">
<string-name>
<given-names>N.</given-names>
<surname>Pierrot</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Tyteca</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>D'Auria</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Amyloid Precursor Protein Controls Cholesterol Turnover Needed for Neuronal Activity</article-title>,&#x0201d; <source>EMBO Molecular Medicine</source>
<volume>5</volume>, no. <issue>4</issue> (<year>2013</year>): <fpage>608</fpage>&#x02013;<lpage>625</lpage>.<pub-id pub-id-type="pmid">23554170</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="cns70378-cit-0102">
<string-name>
<given-names>R.</given-names>
<surname>Resende</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Fernandes</surname>
</string-name>, <string-name>
<given-names>A. C.</given-names>
<surname>Pereira</surname>
</string-name>, <string-name>
<given-names>A. P.</given-names>
<surname>Marques</surname>
</string-name>, and <string-name>
<given-names>C. F.</given-names>
<surname>Pereira</surname>
</string-name>, &#x0201c;<article-title>Endoplasmic Reticulum&#x02010;Mitochondria Contacts Modulate Reactive Oxygen Species&#x02010;Mediated Signaling and Oxidative Stress in Brain Disorders: The Key Role of Sigma&#x02010;1 Receptor</article-title>,&#x0201d; <source>Antioxidants and Redox Signaling</source>
<volume>37</volume>, no. <issue>10&#x02013;12</issue> (<year>2022</year>): <fpage>758</fpage>&#x02013;<lpage>780</lpage>.<pub-id pub-id-type="pmid">35369731</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="cns70378-cit-0103">
<string-name>
<given-names>V.</given-names>
<surname>Shoshan&#x02010;Barmatz</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Nahon&#x02010;Crystal</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Shteinfer&#x02010;Kuzmine</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Gupta</surname>
</string-name>, &#x0201c;<article-title>VDAC1, Mitochondrial Dysfunction, and Alzheimer's Disease</article-title>,&#x0201d; <source>Pharmacological Research</source>
<volume>131</volume> (<year>2018</year>): <fpage>87</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">29551631</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="cns70378-cit-0104">
<string-name>
<given-names>B.</given-names>
<surname>Penke</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>F&#x000fc;l&#x000f6;p</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Szucs</surname>
</string-name>, and <string-name>
<given-names>E.</given-names>
<surname>Frecska</surname>
</string-name>, &#x0201c;<article-title>The Role of Sigma&#x02010;1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Current Neuropharmacology</source>
<volume>16</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>97</fpage>&#x02013;<lpage>116</lpage>.<pub-id pub-id-type="pmid">28554311</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="cns70378-cit-0105">
<string-name>
<given-names>J. X.</given-names>
<surname>Liu</surname>
</string-name> and <string-name>
<given-names>J. H.</given-names>
<surname>Yang</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Membranes: A Hub for Neurodegenerative Diseases</article-title>,&#x0201d; <source>Biomedicine and Pharmacotherapy</source>
<volume>149</volume> (<year>2022</year>): <elocation-id>112890</elocation-id>.<pub-id pub-id-type="pmid">35367757</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="cns70378-cit-0106">
<string-name>
<given-names>J.</given-names>
<surname>Hardy</surname>
</string-name>, &#x0201c;<article-title>An Anatomical Cascade Hypothesis for Alzheimers&#x02010;Disease</article-title>,&#x0201d; <source>Trends in Neurosciences</source>
<volume>15</volume>, no. <issue>6</issue> (<year>1992</year>): <fpage>200</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">1378661</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="cns70378-cit-0107">
<string-name>
<given-names>D.</given-names>
<surname>Del Prete</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Suski</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Oul&#x000e8;s</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Localization and Processing of the Amyloid&#x02010;&#x003b2; Protein Precursor in Mitochondria&#x02010;Associated Membranes</article-title>,&#x0201d; <source>Journal of Alzheimers Disease</source>
<volume>55</volume>, no. <issue>4</issue> (<year>2017</year>): <fpage>1549</fpage>&#x02013;<lpage>1570</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="cns70378-cit-0108">
<string-name>
<given-names>N. H.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ye</surname>
</string-name>, <string-name>
<given-names>B. B.</given-names>
<surname>Wan</surname>
</string-name>, <string-name>
<given-names>Y. D.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Liu</surname>
</string-name>, and <string-name>
<given-names>Q. J.</given-names>
<surname>Chen</surname>
</string-name>, &#x0201c;<article-title>Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma&#x02010;1 Receptor in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Molecular Neurobiology</source>
<volume>58</volume>, no. <issue>11</issue> (<year>2021</year>): <fpage>5649</fpage>&#x02013;<lpage>5666</lpage>.<pub-id pub-id-type="pmid">34383254</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="cns70378-cit-0109">
<string-name>
<given-names>M. D.</given-names>
<surname>Tambini</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Pera</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Kanter</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>ApoE4 Upregulates the Activity of Mitochondria&#x02010;Associated ER Membranes</article-title>,&#x0201d; <source>EMBO Reports</source>
<volume>17</volume>, no. <issue>1</issue> (<year>2016</year>): <fpage>27</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">26564908</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="cns70378-cit-0110">
<string-name>
<given-names>V. H.</given-names>
<surname>Sathyamurthy</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Nagarajan</surname>
</string-name>, and <string-name>
<given-names>V. D.</given-names>
<surname>Parvathi</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Endoplasmic Reticulum Contact Sites (MERCS): A New Axis in Neuronal Degeneration and Regeneration</article-title>,&#x0201d; <source>Molecular Neurobiology</source>
<volume>61</volume>, no. <issue>9</issue> (<year>2024</year>): <fpage>6528</fpage>&#x02013;<lpage>6538</lpage>.<pub-id pub-id-type="pmid">38321352</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="cns70378-cit-0111">
<string-name>
<given-names>M.</given-names>
<surname>Llorens&#x02010;Mart&#x000ed;n</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Jurado</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Hern&#x000e1;dez</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Avila</surname>
</string-name>, &#x0201c;<article-title>GSK&#x02010;3&#x003b2;, a Pivotal Kinase in Alzheimer Disease</article-title>,&#x0201d; <source>Frontiers in Molecular Neuroscience</source>
<volume>7</volume> (<year>2014</year>): <elocation-id>46</elocation-id>.<pub-id pub-id-type="pmid">24904272</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="cns70378-cit-0112">
<string-name>
<given-names>X. H.</given-names>
<surname>Qian</surname>
</string-name>, <string-name>
<given-names>S. Y.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>H. D.</given-names>
<surname>Tang</surname>
</string-name>, &#x0201c;<article-title>Multi&#x02010;Strain Probiotics Ameliorate Alzheimer's&#x02010;Like Cognitive Impairment and Pathological Changes Through the AKT/GSK&#x02010;3 &#x003b2; Pathway in Senescence&#x02010;Accelerated Mouse Prone 8 Mice</article-title>,&#x0201d; <source>Brain, Behavior, and Immunity</source>
<volume>119</volume> (<year>2024</year>): <fpage>14</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">38548184</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="cns70378-cit-0113">
<string-name>
<given-names>R.</given-names>
<surname>Stoica</surname>
</string-name>, <string-name>
<given-names>K. J.</given-names>
<surname>De Vos</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Paillusson</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>ER&#x02010;Mitochondria Associations Are Regulated by the VAPB&#x02010;PTPIP51 Interaction and Are Disrupted by ALS/FTD&#x02010;Associated TDP&#x02010;43</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>5</volume> (<year>2014</year>): <elocation-id>3996</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="cns70378-cit-0114">
<string-name>
<given-names>D.</given-names>
<surname>Cheng</surname>
</string-name>, <string-name>
<given-names>Z. G.</given-names>
<surname>Lei</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Chu</surname>
</string-name>, <string-name>
<given-names>O. J. H.</given-names>
<surname>Lam</surname>
</string-name>, <string-name>
<given-names>C. Y.</given-names>
<surname>Chiang</surname>
</string-name>, and <string-name>
<given-names>Z. J.</given-names>
<surname>Zhang</surname>
</string-name>, &#x0201c;<article-title>N, N&#x02010;Dimethyltryptamine, a Natural Hallucinogen, Ameliorates Alzheimer's Disease by Restoring Neuronal Sigma&#x02010;1 Receptor&#x02010;Mediated Endoplasmic Reticulum&#x02010;Mitochondria Crosstalk</article-title>,&#x0201d; <source>Alzheimers Research and Therapy</source>
<volume>16</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>95</fpage>, <pub-id pub-id-type="doi">10.1186/s13195-024-01462-3</pub-id>.</mixed-citation></ref><ref id="cns70378-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="cns70378-cit-0115">
<string-name>
<given-names>J.</given-names>
<surname>Panes&#x02010;Fernandeza</surname>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Godoy</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gavilan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>TG2 Promotes Amyloid Beta Aggregates: Impact on ER&#x02010;Mitochondria Crosstalk, Calcium Homeostasis and Synaptic Function in Alzheimer's Disease</article-title>,&#x0201d; <source>Biomedicine and Pharmacotherapy</source>
<volume>162</volume> (<year>2023</year>): <elocation-id>114596</elocation-id>.<pub-id pub-id-type="pmid">36989728</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="cns70378-cit-0116">
<string-name>
<given-names>G. E.</given-names>
<surname>Choi</surname>
</string-name>, <string-name>
<given-names>J. Y.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>M. R.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Yoon</surname>
</string-name>, and <string-name>
<given-names>H. J.</given-names>
<surname>Han</surname>
</string-name>, &#x0201c;<article-title>Glucocorticoid Enhances presenilin1&#x02010;Dependent A&#x003b2; Production at ER'S Mitochondrial&#x02010;Associated Membrane by Downregulating Rer1 in Neuronal Cells</article-title>,&#x0201d; <source>Redox Biology</source>
<volume>65</volume> (<year>2023</year>): <elocation-id>102821</elocation-id>.<pub-id pub-id-type="pmid">37494768</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="cns70378-cit-0117">
<string-name>
<given-names>J.</given-names>
<surname>Parkinson</surname>
</string-name>, &#x0201c;<article-title>An Essay on the Shaking Palsy (Reprinted)</article-title>,&#x0201d; <source>Journal of Neuropsychiatry and Clinical Neurosciences</source>
<volume>14</volume>, no. <issue>2</issue> (<year>2002</year>): <fpage>223</fpage>&#x02013;<lpage>236</lpage>.<pub-id pub-id-type="pmid">11983801</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="cns70378-cit-0118">
<string-name>
<given-names>E.</given-names>
<surname>Tolosa</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Garrido</surname>
</string-name>, <string-name>
<given-names>S. W.</given-names>
<surname>Scholz</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Poewe</surname>
</string-name>, &#x0201c;<article-title>Challenges in the Diagnosis of Parkinson's Disease</article-title>,&#x0201d; <source>Lancet Neurology</source>
<volume>20</volume>, no. <issue>5</issue> (<year>2021</year>): <fpage>385</fpage>&#x02013;<lpage>397</lpage>.<pub-id pub-id-type="pmid">33894193</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="cns70378-cit-0119">
<string-name>
<given-names>D. K.</given-names>
<surname>Simon</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Tanner</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Brundin</surname>
</string-name>, &#x0201c;<article-title>Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology</article-title>,&#x0201d; <source>Clinics in Geriatric Medicine</source>
<volume>36</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">31733690</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="cns70378-cit-0120">
<string-name>
<given-names>A. G.</given-names>
<surname>Erustes</surname>
</string-name>, <string-name>
<given-names>G. C.</given-names>
<surname>Guarache</surname>
</string-name>, <string-name>
<given-names>E. C.</given-names>
<surname>Guedes</surname>
</string-name>, <string-name>
<given-names>A. H. F. F.</given-names>
<surname>Leao</surname>
</string-name>, <string-name>
<given-names>G. J. S.</given-names>
<surname>Pereira</surname>
</string-name>, and <string-name>
<given-names>S. S.</given-names>
<surname>Smaili</surname>
</string-name>, &#x0201c;<article-title>Alpha&#x02010;Synuclein Interactions in Mitochondria&#x02010;ER Contacts: A Possible Role in Parkinson's Disease</article-title>,&#x0201d; <source>Contact</source>
<volume>5</volume> (<year>2022</year>): <elocation-id>25152564221119347</elocation-id>.<pub-id pub-id-type="pmid">37366506</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="cns70378-cit-0121">
<string-name>
<given-names>J.</given-names>
<surname>Proulx</surname>
</string-name>, <string-name>
<given-names>I. W.</given-names>
<surname>Park</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Borgmann</surname>
</string-name>, &#x0201c;<article-title>CAL&#x02018;MAM&#x02019;ITY at the Endoplasmic Reticulum&#x02010;Mitochondrial Interface: A Potential Therapeutic Target for Neurodegeneration and Human Immunodeficiency Virus&#x02010;Associated Neurocognitive Disorders</article-title>,&#x0201d; <source>Frontiers in Neuroscience</source>
<volume>15</volume> (<year>2021</year>): <elocation-id>715945</elocation-id>.<pub-id pub-id-type="pmid">34744606</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="cns70378-cit-0122">
<string-name>
<given-names>C.</given-names>
<surname>Guardia&#x02010;Laguarta</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Area&#x02010;Gomez</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>R&#x000fc;b</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>&#x003b1;&#x02010;Synuclein is Localized to Mitochondria&#x02010;Associated ER Membranes</article-title>,&#x0201d; <source>Journal of Neuroscience</source>
<volume>34</volume>, no. <issue>1</issue> (<year>2014</year>): <fpage>249</fpage>&#x02013;<lpage>259</lpage>, <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2507-13.2014</pub-id>.<pub-id pub-id-type="pmid">24381286</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="cns70378-cit-0123">
<string-name>
<given-names>T.</given-names>
<surname>Fernandes</surname>
</string-name>, <string-name>
<given-names>M. R.</given-names>
<surname>Domingues</surname>
</string-name>, <string-name>
<given-names>P. I.</given-names>
<surname>Moreira</surname>
</string-name>, and <string-name>
<given-names>C. F.</given-names>
<surname>Pereira</surname>
</string-name>, &#x0201c;<article-title>A Perspective on the Link Between Mitochondria&#x02010;Associated Membranes (MAMs) and Lipid Droplets Metabolism in Neurodegenerative Diseases</article-title>,&#x0201d; <source>Biology</source>
<volume>12</volume>, no. <issue>3</issue> (<year>2023</year>): <elocation-id>414</elocation-id>.<pub-id pub-id-type="pmid">36979106</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="cns70378-cit-0124">
<string-name>
<given-names>T.</given-names>
<surname>Sunanda</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Ray</surname>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Mahalakshmi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Endoplasmic Reticulum Crosstalk in Parkinson's Disease: The Role of Brain Renin Angiotensin System Components</article-title>,&#x0201d; <source>Biomolecules</source>
<volume>11</volume>, no. <issue>11</issue> (<year>2021</year>): <elocation-id>1669</elocation-id>.<pub-id pub-id-type="pmid">34827667</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="cns70378-cit-0125">
<string-name>
<given-names>S.</given-names>
<surname>Paillusson</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Gomez&#x02010;Suaga</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Stoica</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>&#x003b1;&#x02010;Synuclein Binds to the ER&#x02010;Mitochondria Tethering Protein VAPB to Disrupt Ca<sup>2+</sup> Homeostasis and Mitochondrial ATP Production</article-title>,&#x0201d; <source>Acta Neuropathologica</source>
<volume>134</volume>, no. <issue>1</issue> (<year>2017</year>): <fpage>129</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">28337542</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="cns70378-cit-0126">
<string-name>
<given-names>A. G.</given-names>
<surname>Erustes</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>D'Eletto</surname>
</string-name>, <string-name>
<given-names>G. C.</given-names>
<surname>Guarache</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Overexpression of &#x003b1;&#x02010;Synuclein Inhibits Mitochondrial Ca<sup>2+</sup> Trafficking Between the Endoplasmic Reticulum and Mitochondria Through MAMs by Altering the GRP75&#x02010;IP3R Interaction</article-title>,&#x0201d; <source>Journal of Neuroscience Research</source>
<volume>99</volume>, no. <issue>11</issue> (<year>2021</year>): <fpage>2932</fpage>&#x02013;<lpage>2947</lpage>.<pub-id pub-id-type="pmid">34510532</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="cns70378-cit-0127">
<string-name>
<given-names>I.</given-names>
<surname>Celardo</surname>
</string-name>, <string-name>
<given-names>A. C.</given-names>
<surname>Costa</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Lehmann</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitofusin&#x02010;Mediated ER Stress Triggers Neurodegeneration in <italic toggle="yes">pink1/Parkin</italic> Models of Parkinson's Disease</article-title>,&#x0201d; <source>Cell Death and Disease</source>
<volume>7</volume>, no. <issue>6</issue> (<year>2016</year>): <elocation-id>e2271</elocation-id>, <pub-id pub-id-type="doi">10.1038/cddis.2016.173</pub-id>.<pub-id pub-id-type="pmid">27336715</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="cns70378-cit-0128">
<string-name>
<given-names>T.</given-names>
<surname>Cal&#x000ec;</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Ottolini</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Negro</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Brini</surname>
</string-name>, &#x0201c;<article-title>Enhanced Parkin Levels Favor ER&#x02010;Mitochondria Crosstalk and Guarantee Ca<sup>2+</sup> Transfer to Sustain Cell Bioenergetics</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta&#x02010;Molecular Basis of Disease</source>
<volume>1832</volume>, no. <issue>4</issue> (<year>2013</year>): <fpage>495</fpage>&#x02013;<lpage>508</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="cns70378-cit-0129">
<string-name>
<given-names>C. A.</given-names>
<surname>Gautier</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Erpapazoglou</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Mouton&#x02010;Liger</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Endoplasmic Reticulum&#x02010;Mitochondria Interface Is Perturbed in PARK2 Knockout Mice and Patients With PARK2 Mutations</article-title>,&#x0201d; <source>Human Molecular Genetics</source>
<volume>25</volume>, no. <issue>14</issue> (<year>2016</year>): <fpage>2972</fpage>&#x02013;<lpage>2984</lpage>.<pub-id pub-id-type="pmid">27206984</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="cns70378-cit-0130">
<string-name>
<given-names>M. D.</given-names>
<surname>Demmings</surname>
</string-name>, <string-name>
<given-names>E. C.</given-names>
<surname>Tennyson</surname>
</string-name>, <string-name>
<given-names>G. N.</given-names>
<surname>Petroff</surname>
</string-name>, <string-name>
<given-names>H. E.</given-names>
<surname>Tarnowski&#x02010;Garner</surname>
</string-name>, and <string-name>
<given-names>S. P.</given-names>
<surname>Cregan</surname>
</string-name>, &#x0201c;<article-title>Activating Transcription Factor&#x02010;4 Promotes Neuronal Death Induced by Parkinson's Disease Neurotoxins and &#x003b1;&#x02010;Synuclein Aggregates</article-title>,&#x0201d; <source>Cell Death and Differentiation</source>
<volume>28</volume>, no. <issue>5</issue> (<year>2021</year>): <fpage>1627</fpage>&#x02013;<lpage>1643</lpage>.<pub-id pub-id-type="pmid">33277577</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="cns70378-cit-0131">
<string-name>
<given-names>S. S.</given-names>
<surname>Sammeta</surname>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Banarase</surname>
</string-name>, <string-name>
<given-names>S. R.</given-names>
<surname>Rahangdale</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Molecular Understanding of ER&#x02010;MT Communication Dysfunction During Neurodegeneration</article-title>,&#x0201d; <source>Mitochondrion</source>
<volume>72</volume> (<year>2023</year>): <fpage>59</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">37495165</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="cns70378-cit-0132">
<string-name>
<given-names>S. L.</given-names>
<surname>Pereira</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Grossmann</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Delcambre</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hermann</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Gr&#x000fc;newald</surname>
</string-name>, &#x0201c;<article-title>Novel Insights Into Parkin&#x02010;Mediated Mitochondrial Dysfunction and Neuroinflammation in Parkinson's Disease</article-title>,&#x0201d; <source>Current Opinion in Neurobiology</source>
<volume>80</volume> (<year>2023</year>): <elocation-id>102720</elocation-id>.<pub-id pub-id-type="pmid">37023495</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="cns70378-cit-0133">
<string-name>
<given-names>V. S.</given-names>
<surname>Van Laar</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Roy</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Glutamate Excitotoxicity in Neurons Triggers Mitochondrial and Endoplasmic Reticulum Accumulation of Parkin, and, in the Presence of N&#x02010;Acetyl Cysteine, Mitophagy</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>74</volume> (<year>2015</year>): <fpage>180</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">25478815</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="cns70378-cit-0134">
<string-name>
<given-names>S.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Sawada</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Parkinson's Disease&#x02010;Associated Kinase PINK1 Regulates Miro Protein Level and Axonal Transport of Mitochondria</article-title>,&#x0201d; <source>PLoS Genetics</source>
<volume>8</volume>, no. <issue>3</issue> (<year>2012</year>): <elocation-id>e1002537</elocation-id>, <pub-id pub-id-type="doi">10.1371/journal.pgen.1002537</pub-id>.<pub-id pub-id-type="pmid">22396657</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="cns70378-cit-0135">
<string-name>
<given-names>M. M.</given-names>
<surname>Abbas</surname>
</string-name>, <string-name>
<given-names>S. T.</given-names>
<surname>Govindappa</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sudhaman</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Early Onset Parkinson's Disease due to DJ1 Mutations: An Indian Study</article-title>,&#x0201d; <source>Parkinsonism and Related Disorders</source>
<volume>32</volume> (<year>2016</year>): <fpage>20</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">27592010</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="cns70378-cit-0136">
<string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>X. P.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Fujioka</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>S. D.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>X. W.</given-names>
<surname>Zhu</surname>
</string-name>, &#x0201c;<article-title>DJ&#x02010;1 Regulates the Integrity and Function of ER&#x02010;Mitochondria Association Through Interaction With IP3R3&#x02010;Grp75&#x02010;VDAC1</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>116</volume>, no. <issue>50</issue> (<year>2019</year>): <fpage>25322</fpage>&#x02013;<lpage>25328</lpage>.<pub-id pub-id-type="pmid">31767755</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="cns70378-cit-0137">
<string-name>
<given-names>Q. Q.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>M. Y.</given-names>
<surname>Qu</surname>
</string-name>, <string-name>
<given-names>T. Y.</given-names>
<surname>Shen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Control of Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes by Protein S&#x02010;Palmitoylation: Novel Therapeutic Targets for Neurodegenerative Diseases</article-title>,&#x0201d; <source>Ageing Research Reviews</source>
<volume>87</volume> (<year>2023</year>): <elocation-id>101920</elocation-id>.<pub-id pub-id-type="pmid">37004843</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="cns70378-cit-0138">
<string-name>
<given-names>D.</given-names>
<surname>Lim</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Dematteis</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Tapella</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ca<sup>2+</sup> Handling at the Mitochondria&#x02010;ER Contact Sites in Neurodegeneration</article-title>,&#x0201d; <source>Cell Calcium</source>
<volume>98</volume> (<year>2021</year>): <elocation-id>102453</elocation-id>.<pub-id pub-id-type="pmid">34399235</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="cns70378-cit-0139">
<string-name>
<given-names>S.</given-names>
<surname>Bardien</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Lesage</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Brice</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Carr</surname>
</string-name>, &#x0201c;<article-title>Genetic Characteristics of Leucine&#x02010;Rich Repeat Kinase 2 (LRRK2) Associated Parkinson's Disease</article-title>,&#x0201d; <source>Parkinsonism and Related Disorders</source>
<volume>17</volume>, no. <issue>7</issue> (<year>2011</year>): <fpage>501</fpage>&#x02013;<lpage>508</lpage>.<pub-id pub-id-type="pmid">21641266</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="cns70378-cit-0140">
<string-name>
<given-names>T.</given-names>
<surname>Toyofuku</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Okamoto</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Ishikawa</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sasawatari</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Kumanogoh</surname>
</string-name>, &#x0201c;<article-title>LRRK2 Regulates Endoplasmic Reticulum&#x02010;Mitochondrial Tethering Through the PERK&#x02010;Mediated Ubiquitination Pathway</article-title>,&#x0201d; <source>EMBO Journal</source>
<volume>39</volume>, no. <issue>2</issue> (<year>2020</year>): <elocation-id>e100875</elocation-id>, <pub-id pub-id-type="doi">10.15252/embj.2018100875</pub-id>.<pub-id pub-id-type="pmid">31821596</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="cns70378-cit-0141">
<string-name>
<given-names>X. L.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Yan</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Fujioka</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>LRRK2 Regulates Mitochondrial Dynamics and Function Through Direct Interaction With DLP1</article-title>,&#x0201d; <source>Human Molecular Genetics</source>
<volume>21</volume>, no. <issue>9</issue> (<year>2012</year>): <fpage>1931</fpage>&#x02013;<lpage>1944</lpage>.<pub-id pub-id-type="pmid">22228096</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="cns70378-cit-0142">
<string-name>
<given-names>N.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>L. P.</given-names>
<surname>Bai</surname>
</string-name>, <string-name>
<given-names>Z. P.</given-names>
<surname>Lu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>TRPV4 Contributes to ER Stress and Inflammation: Implications for Parkinson's Disease</article-title>,&#x0201d; <source>Journal of Neuroinflammation</source>
<volume>19</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>26</elocation-id>.<pub-id pub-id-type="pmid">35093118</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="cns70378-cit-0143">
<string-name>
<given-names>A. C.</given-names>
<surname>Martins</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Rieck</surname>
</string-name>, <string-name>
<given-names>V. B.</given-names>
<surname>Leotti</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Saraiva&#x02010;Pereira</surname>
</string-name>, and <string-name>
<given-names>L. B.</given-names>
<surname>Jardim</surname>
</string-name>, &#x0201c;<article-title>Variants in Genes of Calpain System as Modifiers of Spinocerebellar Ataxia Type 3 Phenotype</article-title>,&#x0201d; <source>Journal of Molecular Neuroscience</source>
<volume>71</volume>, no. <issue>9</issue> (<year>2021</year>): <fpage>1906</fpage>&#x02013;<lpage>1913</lpage>.<pub-id pub-id-type="pmid">34191270</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="cns70378-cit-0144">
<string-name>
<given-names>N.</given-names>
<surname>Vijiaratnam</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Simuni</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Bandmann</surname>
</string-name>, <string-name>
<given-names>H. R.</given-names>
<surname>Morris</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Foltynie</surname>
</string-name>, &#x0201c;<article-title>Progress Towards Therapies for Disease Modification in Parkinson's Disease</article-title>,&#x0201d; <source>Lancet Neurology</source>
<volume>20</volume>, no. <issue>7</issue> (<year>2021</year>): <fpage>559</fpage>&#x02013;<lpage>572</lpage>.<pub-id pub-id-type="pmid">34146514</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="cns70378-cit-0145">
<string-name>
<given-names>T.</given-names>
<surname>Siddiqui</surname>
</string-name> and <string-name>
<given-names>L. K.</given-names>
<surname>Bhatt</surname>
</string-name>, &#x0201c;<article-title>Targeting Sigma&#x02010;1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease</article-title>,&#x0201d; <source>Neurochemical Research</source>
<volume>48</volume>, no. <issue>10</issue> (<year>2023</year>): <fpage>2925</fpage>&#x02013;<lpage>2935</lpage>.<pub-id pub-id-type="pmid">37259012</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="cns70378-cit-0146">
<string-name>
<given-names>L. F. R.</given-names>
<surname>Qi</surname>
</string-name>, <string-name>
<given-names>Y. C.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Phillyrin Promotes Autophagosome Formation in A53T&#x02010;&#x003b1;Syn&#x02010;Induced Parkinson's Disease Model via Modulation of REEP1</article-title>,&#x0201d; <source>Phytomedicine</source>
<volume>134</volume> (<year>2024</year>): <elocation-id>155952</elocation-id>.<pub-id pub-id-type="pmid">39178680</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="cns70378-cit-0147">
<string-name>
<given-names>J. H.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>K. W.</given-names>
<surname>Sung</surname>
</string-name>, <string-name>
<given-names>E. J.</given-names>
<surname>Bae</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Targeted Degradation of &#x003b1;&#x02010;Synuclein Aggregates in Parkinson's Disease Using the AUTOTAC Technology</article-title>,&#x0201d; <source>Molecular Neurodegeneration</source>
<volume>18</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>41</elocation-id>.<pub-id pub-id-type="pmid">37355598</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="cns70378-cit-0148">
<string-name>
<given-names>M.</given-names>
<surname>Cozzi</surname>
</string-name> and <string-name>
<given-names>V.</given-names>
<surname>Ferrari</surname>
</string-name>, &#x0201c;<article-title>Autophagy Dysfunction in ALS: From Transport to Protein Degradation</article-title>,&#x0201d; <source>Journal of Molecular Neuroscience</source>
<volume>72</volume>, no. <issue>7</issue> (<year>2022</year>): <fpage>1456</fpage>&#x02013;<lpage>1481</lpage>.<pub-id pub-id-type="pmid">35708843</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="cns70378-cit-0149">
<string-name>
<given-names>E. L.</given-names>
<surname>Feldman</surname>
</string-name>, <string-name>
<given-names>S. A.</given-names>
<surname>Goutman</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Petri</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Lancet</source>
<volume>400</volume>, no. <issue>10360</issue> (<year>2022</year>): <fpage>1363</fpage>&#x02013;<lpage>1380</lpage>.<pub-id pub-id-type="pmid">36116464</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="cns70378-cit-0150">
<string-name>
<given-names>J.</given-names>
<surname>Riancho</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Lozano&#x02010;Cuesta</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Santurt&#x000fa;n</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Amyotrophic Lateral Sclerosis in Northern Spain 46&#x02009;Years Later: What Has Changed?</article-title>,&#x0201d; <source>Neurodegenerative Diseases</source>
<volume>16</volume>, no. <issue>5&#x02013;6</issue> (<year>2016</year>): <fpage>337</fpage>&#x02013;<lpage>341</lpage>.<pub-id pub-id-type="pmid">27188850</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="cns70378-cit-0151">
<string-name>
<given-names>H.</given-names>
<surname>Tsuda</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>Y. F.</given-names>
<surname>Yang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors</article-title>,&#x0201d; <source>Cell</source>
<volume>133</volume>, no. <issue>6</issue> (<year>2008</year>): <fpage>963</fpage>&#x02013;<lpage>977</lpage>.<pub-id pub-id-type="pmid">18555774</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="cns70378-cit-0152">
<string-name>
<given-names>G.</given-names>
<surname>Manfredi</surname>
</string-name> and <string-name>
<given-names>H.</given-names>
<surname>Kawamata</surname>
</string-name>, &#x0201c;<article-title>Mitochondria and Endoplasmic Reticulum Crosstalk in Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>90</volume> (<year>2016</year>): <fpage>35</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">26282323</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="cns70378-cit-0153">
<string-name>
<given-names>P. T.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Li&#x000e9;vens</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sigma&#x02010;1 Receptor Chaperones Rescue Nucleocytoplasmic Transport Deficit Seen in Cellular and Drosophila ALS/FTD Models</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>11</volume>, no. <issue>1</issue> (<year>2020</year>): <elocation-id>5580</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="cns70378-cit-0154">
<string-name>
<given-names>E. F.</given-names>
<surname>Smith</surname>
</string-name>, <string-name>
<given-names>P. J.</given-names>
<surname>Shaw</surname>
</string-name>, and <string-name>
<given-names>K. J.</given-names>
<surname>De Vos</surname>
</string-name>, &#x0201c;<article-title>The Role of Mitochondria in Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Neuroscience Letters</source>
<volume>710</volume> (<year>2019</year>): <elocation-id>132933</elocation-id>.<pub-id pub-id-type="pmid">28669745</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="cns70378-cit-0155">
<string-name>
<given-names>S.</given-names>
<surname>Kors</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Costello</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Schrader</surname>
</string-name>, &#x0201c;<article-title>VAP Proteins &#x02010; From Organelle Tethers to Pathogenic Host Interactors and Their Role in Neuronal Disease</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>10</volume> (<year>2022</year>): <elocation-id>895856</elocation-id>.<pub-id pub-id-type="pmid">35756994</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="cns70378-cit-0156">
<string-name>
<given-names>Z.</given-names>
<surname>Nahacka</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Zobalova</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Dubsiova</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Rohlena</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Neuzil</surname>
</string-name>, &#x0201c;<article-title>Miro Proteins Connect Mitochondrial Function and Intercellular Transport</article-title>,&#x0201d; <source>Critical Reviews in Biochemistry and Molecular Biology</source>
<volume>56</volume>, no. <issue>4</issue> (<year>2021</year>): <fpage>401</fpage>&#x02013;<lpage>425</lpage>.<pub-id pub-id-type="pmid">34139898</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="cns70378-cit-0157">
<string-name>
<given-names>E.</given-names>
<surname>Teuling</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ahmed</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Haasdijk</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Motor Neuron Disease&#x02010;Associated Mutant Vesicle&#x02010;Associated Membrane Protein&#x02010;Associated Protein (VAP) B Recruits Wild&#x02010;Type VAPs Into Endoplasmic Reticulum&#x02010;Derived Tubular Aggregates</article-title>,&#x0201d; <source>Journal of Neuroscience</source>
<volume>27</volume>, no. <issue>36</issue> (<year>2007</year>): <fpage>9801</fpage>&#x02013;<lpage>9815</lpage>, <pub-id pub-id-type="doi">10.1523/jneurosci.2661-07.2007</pub-id>.<pub-id pub-id-type="pmid">17804640</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="cns70378-cit-0158">
<string-name>
<given-names>S.</given-names>
<surname>Forrest</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chai</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Sanhueza</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Increased Levels of Phosphoinositides Cause Neurodegeneration in a Drosophila Model of Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Human Molecular Genetics</source>
<volume>22</volume>, no. <issue>13</issue> (<year>2013</year>): <fpage>2689</fpage>&#x02013;<lpage>2704</lpage>.<pub-id pub-id-type="pmid">23492670</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="cns70378-cit-0159">
<string-name>
<given-names>P.</given-names>
<surname>Gomez&#x02010;Suaga</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>M&#x000f3;rotz</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Markovinovic</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Disruption of ER&#x02010;Mitochondria Tethering and Signalling in C9orf72&#x02212;Associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia</article-title>,&#x0201d; <source>Aging Cell</source>
<volume>21</volume>, no. <issue>2</issue> (<year>2022</year>): <elocation-id>e13549</elocation-id>.<pub-id pub-id-type="pmid">35026048</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="cns70378-cit-0160">
<string-name>
<given-names>S. M.</given-names>
<surname>Martin&#x02010;Guerrero</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Markovinovic</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Morotz</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Salam</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Noble</surname>
</string-name>, and <string-name>
<given-names>C. C. J.</given-names>
<surname>Miller</surname>
</string-name>, &#x0201c;<article-title>Targeting ER&#x02010;Mitochondria Signaling as a Therapeutic Target for Frontotemporal Dementia and Related Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>10</volume> (<year>2022</year>): <elocation-id>915931</elocation-id>.<pub-id pub-id-type="pmid">35693938</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="cns70378-cit-0161">
<string-name>
<given-names>S.</given-names>
<surname>Watanabe</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ilieva</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Tamada</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010;Associated Membrane Collapse Is a Common Pathomechanism in SIGMAR1&#x02212; and SOD1&#x02212;Linked ALS</article-title>,&#x0201d; <source>Embo Molecular Medicine</source>
<volume>8</volume>, no. <issue>12</issue> (<year>2016</year>): <fpage>1421</fpage>&#x02013;<lpage>1437</lpage>.<pub-id pub-id-type="pmid">27821430</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="cns70378-cit-0162">
<string-name>
<given-names>T. A.</given-names>
<surname>Mavlyutov</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Epstein</surname>
</string-name>, <string-name>
<given-names>K. A.</given-names>
<surname>Andersen</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Ziskind&#x02010;Conhaim</surname>
</string-name>, and <string-name>
<given-names>A. E.</given-names>
<surname>Ruoho</surname>
</string-name>, &#x0201c;<article-title>The SIGMA&#x02010;1 Receptor Is Enriched in Postsynaptic Sites of C&#x02010;Terminals in Mouse Motoneurons. An Anatomical and Behavioral Study</article-title>,&#x0201d; <source>Neuroscience</source>
<volume>167</volume>, no. <issue>2</issue> (<year>2010</year>): <fpage>247</fpage>&#x02013;<lpage>255</lpage>, <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.02.022</pub-id>.<pub-id pub-id-type="pmid">20167253</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="cns70378-cit-0163">
<string-name>
<given-names>C.</given-names>
<surname>Taghibiglou</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>I. R.</given-names>
<surname>Mackenzie</surname>
</string-name>, <string-name>
<given-names>Y. T.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>N. R.</given-names>
<surname>Cashman</surname>
</string-name>, &#x0201c;<article-title>Sterol Regulatory Element Binding Protein&#x02010;1 (SREBP1) Activation in Motor Neurons in Excitotoxicity and Amyotrophic Lateral Sclerosis (ALS): Indip, a Potential Therapeutic Peptide</article-title>,&#x0201d; <source>Biochemical and Biophysical Research Communications</source>
<volume>413</volume>, no. <issue>2</issue> (<year>2011</year>): <fpage>159</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">21871872</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="cns70378-cit-0164">
<string-name>
<given-names>M. Y.</given-names>
<surname>Du</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>S. X.</given-names>
<surname>He</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sigma&#x02010;1 Receptor as a Protective Factor for Diabetes&#x02010;Associated Cognitive Dysfunction via Regulating Astrocytic Endoplasmic Reticulum&#x02010;Mitochondrion Contact and Endoplasmic Reticulum Stress</article-title>,&#x0201d; <source>Cells</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>197</elocation-id>.<pub-id pub-id-type="pmid">36611988</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="cns70378-cit-0165">
<string-name>
<given-names>S.</given-names>
<surname>Lattante</surname>
</string-name>, <string-name>
<given-names>G. A.</given-names>
<surname>Rouleau</surname>
</string-name>, and <string-name>
<given-names>E.</given-names>
<surname>Kabashi</surname>
</string-name>, &#x0201c;<article-title>TARDBP and FUS Mutations Associated With Amyotrophic Lateral Sclerosis: Summary and Update</article-title>,&#x0201d; <source>Human Mutation</source>
<volume>34</volume>, no. <issue>6</issue> (<year>2013</year>): <fpage>812</fpage>&#x02013;<lpage>826</lpage>.<pub-id pub-id-type="pmid">23559573</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="cns70378-cit-0166">
<string-name>
<given-names>M.</given-names>
<surname>Neumann</surname>
</string-name>, <string-name>
<given-names>L. K.</given-names>
<surname>Kwong</surname>
</string-name>, <string-name>
<given-names>E. B.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Phosphorylation of S409/410 of TDP&#x02010;43 is a Consistent Feature in all Sporadic and Familial Forms of TDP&#x02010;43 Proteinopathies</article-title>,&#x0201d; <source>Acta Neuropathologica</source>
<volume>117</volume>, no. <issue>2</issue> (<year>2009</year>): <fpage>137</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">19125255</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="cns70378-cit-0167">
<string-name>
<given-names>R.</given-names>
<surname>Stoica</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Paillusson</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Gomez&#x02010;Suaga</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>ALS/FTD&#x02010;Associated FUS Activates GSK&#x02010;3 to Disrupt the VAPB&#x02010;PTPIP51 Interaction and ER&#x02010;Mitochondria Associations</article-title>,&#x0201d; <source>EMBO Reports</source>
<volume>17</volume>, no. <issue>9</issue> (<year>2016</year>): <fpage>1326</fpage>&#x02013;<lpage>1342</lpage>.<pub-id pub-id-type="pmid">27418313</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="cns70378-cit-0168">
<string-name>
<given-names>J.</given-names>
<surname>Harley</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Hagemann</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Serio</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Patani</surname>
</string-name>, &#x0201c;<article-title>TDP&#x02010;43 and FUS Mislocalization in VCP Mutant Motor Neurons Is Reversed by Pharmacological Inhibition of the VCP D2 ATPase Domain</article-title>,&#x0201d; <source>Brain Communications</source>
<volume>3</volume>, no. <issue>3</issue> (<year>2021</year>): <elocation-id>fcab166</elocation-id>.<pub-id pub-id-type="pmid">34396115</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="cns70378-cit-0169">
<string-name>
<given-names>E. C.</given-names>
<surname>Genin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Abou&#x02010;Ali</surname>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Paquis&#x02010;Flucklinger</surname>
</string-name>, &#x0201c;<article-title>Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis</article-title>,&#x0201d; <source>Genes</source>
<volume>14</volume>, no. <issue>11</issue> (<year>2023</year>): <elocation-id>1981</elocation-id>.<pub-id pub-id-type="pmid">38002924</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="cns70378-cit-0170">
<string-name>
<given-names>M.</given-names>
<surname>Wiesenfarth</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Gunther</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Muller</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Clinical and Genetic Features of Amyotrophic Lateral Sclerosis Patients With C9orf72 Mutations</article-title>,&#x0201d; <source>Brain Communications</source>
<volume>5</volume>, no. <issue>2</issue> (<year>2023</year>): <elocation-id>fcad087</elocation-id>.<pub-id pub-id-type="pmid">37006326</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="cns70378-cit-0171">
<string-name>
<given-names>R. G.</given-names>
<surname>Cutler</surname>
</string-name>, <string-name>
<given-names>W. A.</given-names>
<surname>Pedersen</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Camandola</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Rothstein</surname>
</string-name>, and <string-name>
<given-names>M. P.</given-names>
<surname>Mattson</surname>
</string-name>, &#x0201c;<article-title>Evidence That Accumulation of Ceramides and Cholesterol Esters Mediates Oxidative Stress&#x02010;Induced Death of Motor Neurons in Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Annals of Neurology</source>
<volume>52</volume>, no. <issue>4</issue> (<year>2002</year>): <fpage>448</fpage>&#x02013;<lpage>457</lpage>.<pub-id pub-id-type="pmid">12325074</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="cns70378-cit-0172">
<string-name>
<given-names>M.</given-names>
<surname>Sanhueza</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Chai</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Smith</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Network Analyses Reveal Novel Aspects of ALS Pathogenesis</article-title>,&#x0201d; <source>PLoS Genetics</source>
<volume>11</volume>, no. <issue>3</issue> (<year>2015</year>): <elocation-id>e1005107</elocation-id>, <pub-id pub-id-type="doi">10.1371/journal.pgen.1005107</pub-id>.<pub-id pub-id-type="pmid">25826266</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="cns70378-cit-0173">
<string-name>
<given-names>B. C.</given-names>
<surname>Farmer</surname>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Walsh</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Kluemper</surname>
</string-name>, and <string-name>
<given-names>L. A.</given-names>
<surname>Johnson</surname>
</string-name>, &#x0201c;<article-title>Lipid Droplets in Neurodegenerative Disorders</article-title>,&#x0201d; <source>Frontiers in Neuroscience</source>
<volume>14</volume> (<year>2020</year>): <elocation-id>742</elocation-id>.<pub-id pub-id-type="pmid">32848541</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="cns70378-cit-0174">
<string-name>
<given-names>M. A.</given-names>
<surname>van Es</surname>
</string-name>, <string-name>
<given-names>P. W.</given-names>
<surname>van Vught</surname>
</string-name>, <string-name>
<given-names>H. M.</given-names>
<surname>Blauw</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Genetic Variation in DPP6 Is Associated With Susceptibility to Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Nature Genetics</source>
<volume>40</volume>, no. <issue>1</issue> (<year>2008</year>): <fpage>29</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">18084291</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="cns70378-cit-0175">
<string-name>
<given-names>Y. L.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Burg</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Neyrinck</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Disruption of MAM Integrity in Mutant FUS Oligodendroglial Progenitors From hiPSCs</article-title>,&#x0201d; <source>Acta Neuropathologica</source>
<volume>147</volume>, no. <issue>1</issue> (<year>2024</year>): <elocation-id>6</elocation-id>.<pub-id pub-id-type="pmid">38170217</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="cns70378-cit-0176">
<string-name>
<given-names>S.</given-names>
<surname>Watanabe</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Horiuchi</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Murata</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sigma&#x02010;1 Receptor Maintains ATAD3A as a Monomer to Inhibit Mitochondrial Fragmentation at the Mitochondria&#x02010;Associated Membrane in Amyotrophic Lateral Sclerosis</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>179</volume> (<year>2023</year>): <elocation-id>106031</elocation-id>.<pub-id pub-id-type="pmid">36736924</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="cns70378-cit-0177">
<string-name>
<given-names>S.</given-names>
<surname>Watanabe</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Murata</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Oka</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria&#x02010; Associated Membrane Collapse Impairs TBK1&#x02010;Mediated Proteostatic Stress Response in ALS</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>120</volume>, no. <issue>47</issue> (<year>2023</year>): <elocation-id>e2315347120</elocation-id>.<pub-id pub-id-type="pmid">37967220</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="cns70378-cit-0178">
<string-name>
<given-names>C.</given-names>
<surname>Cepeda</surname>
</string-name> and <string-name>
<given-names>X. P.</given-names>
<surname>Tong</surname>
</string-name>, &#x0201c;<article-title>Huntington's Disease: From Basic Science to Therapeutics</article-title>,&#x0201d; <source>CNS Neuroscience and Therapeutics</source>
<volume>24</volume>, no. <issue>4</issue> (<year>2018</year>): <fpage>247</fpage>&#x02013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">29582586</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="cns70378-cit-0179">
<string-name>
<given-names>A.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Lalonde</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Truesdell</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>New Avenues for the Treatment of Huntington's Disease</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>22</volume>, no. <issue>16</issue> (<year>2021</year>): <elocation-id>8363</elocation-id>.<pub-id pub-id-type="pmid">34445070</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="cns70378-cit-0180">
<string-name>
<given-names>T.</given-names>
<surname>Pringsheim</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Wiltshire</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Day</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Dykeman</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Steeves</surname>
</string-name>, and <string-name>
<given-names>N.</given-names>
<surname>Jette</surname>
</string-name>, &#x0201c;<article-title>The Incidence and Prevalence of Huntington's Disease: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Movement Disorders</source>
<volume>27</volume>, no. <issue>9</issue> (<year>2012</year>): <fpage>1083</fpage>&#x02013;<lpage>1091</lpage>.<pub-id pub-id-type="pmid">22692795</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="cns70378-cit-0181">
<string-name>
<given-names>S.</given-names>
<surname>Maity</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Komal</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Kumar</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Saxena</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tungekar</surname>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Chandrasekar</surname>
</string-name>, &#x0201c;<article-title>Impact of ER Stress and ER&#x02010;Mitochondrial Crosstalk in Huntington's Disease</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>23</volume>, no. <issue>2</issue> (<year>2022</year>): <elocation-id>780</elocation-id>.<pub-id pub-id-type="pmid">35054963</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="cns70378-cit-0182">
<string-name>
<given-names>L.</given-names>
<surname>Naia</surname>
</string-name>, <string-name>
<given-names>I. L.</given-names>
<surname>Ferreira</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Ferreiro</surname>
</string-name>, and <string-name>
<given-names>A. C.</given-names>
<surname>Rego</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Ca<sup>2+</sup> Handling in Huntington's and Alzheimer's Diseases &#x02010; Role of ER&#x02010;Mitochondria Crosstalk</article-title>,&#x0201d; <source>Biochemical and Biophysical Research Communications</source>
<volume>483</volume>, no. <issue>4</issue> (<year>2017</year>): <fpage>1069</fpage>&#x02013;<lpage>1077</lpage>.<pub-id pub-id-type="pmid">27485547</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="cns70378-cit-0183">
<string-name>
<given-names>L.</given-names>
<surname>Fao</surname>
</string-name> and <string-name>
<given-names>A. C.</given-names>
<surname>Rego</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial and Redox&#x02010;Based Therapeutic Strategies in Huntington's Disease</article-title>,&#x0201d; <source>Antioxidants and Redox Signaling</source>
<volume>34</volume>, no. <issue>8</issue> (<year>2021</year>): <fpage>650</fpage>&#x02013;<lpage>673</lpage>.<pub-id pub-id-type="pmid">32498555</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="cns70378-cit-0184">
<string-name>
<given-names>R.</given-names>
<surname>Aviner</surname>
</string-name>, <string-name>
<given-names>T. T.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>V. B.</given-names>
<surname>Masto</surname>
</string-name>, <string-name>
<given-names>K. H.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Andino</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Frydman</surname>
</string-name>, &#x0201c;<article-title>Polyglutamine&#x02010;Mediated Ribotoxicity Disrupts Proteostasis and Stress Responses in Huntington's Disease</article-title>,&#x0201d; <source>Nature Cell Biology</source>
<volume>26</volume>, no. <issue>6</issue> (<year>2024</year>): <fpage>892</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="pmid">38741019</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="cns70378-cit-0185">
<string-name>
<given-names>A.</given-names>
<surname>Hyrskyluoto</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Pulli</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>T&#x000f6;rnqvist</surname>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Ho</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Korhonen</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Lindholm</surname>
</string-name>, &#x0201c;<article-title>Sigma&#x02010;1 Receptor Agonist PRE084 Is Protective Against Mutant Huntingtin&#x02010;Induced Cell Degeneration: Involvement of Calpastatin and the NF&#x02010;&#x003ba;B Pathway</article-title>,&#x0201d; <source>Cell Death and Disease</source>
<volume>4</volume> (<year>2013</year>): <elocation-id>e646</elocation-id>.<pub-id pub-id-type="pmid">23703391</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="cns70378-cit-0186">
<string-name>
<given-names>W. J.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Petrilli</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mutant Huntingtin Binds the Mitochondrial Fission GTPase Dynamin&#x02010;Related Protein&#x02010;1 and Increases Its Enzymatic Activity</article-title>,&#x0201d; <source>Nature Medicine</source>
<volume>17</volume>, no. <issue>3</issue> (<year>2011</year>): <fpage>377</fpage>&#x02013;<lpage>382</lpage>.</mixed-citation></ref><ref id="cns70378-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="cns70378-cit-0187">
<string-name>
<given-names>J.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Moody</surname>
</string-name>, <string-name>
<given-names>C. K.</given-names>
<surname>Edgerly</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondrial Loss, Dysfunction and Altered Dynamics in Huntington's Disease</article-title>,&#x0201d; <source>Human Molecular Genetics</source>
<volume>19</volume>, no. <issue>20</issue> (<year>2010</year>): <fpage>3919</fpage>&#x02013;<lpage>3935</lpage>.<pub-id pub-id-type="pmid">20660112</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="cns70378-cit-0188">
<string-name>
<given-names>A. U.</given-names>
<surname>Joshi</surname>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Ebert</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Haileselassie</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Mochly&#x02010;Rosen</surname>
</string-name>, &#x0201c;<article-title>Drp1/Fis1&#x02010;Mediated Mitochondrial Fragmentation Leads to Lysosomal Dysfunction in Cardiac Models of Huntington's Disease</article-title>,&#x0201d; <source>Journal of Molecular and Cellular Cardiology</source>
<volume>127</volume> (<year>2019</year>): <fpage>125</fpage>&#x02013;<lpage>133</lpage>.<pub-id pub-id-type="pmid">30550751</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="cns70378-cit-0189">
<string-name>
<given-names>M. A.</given-names>
<surname>El&#x02010;Emam</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Sheta</surname>
</string-name>, <string-name>
<given-names>H. S.</given-names>
<surname>El&#x02010;Abhar</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Morin Suppresses mTORc1/IRE&#x02010;1&#x003b1;/JNK and IP3R&#x02010;VDAC&#x02010;1 Pathways: Crucial Mechanisms in Apoptosis and Mitophagy Inhibition in Experimental Huntington's Disease, Supported by In Silico Molecular Docking Simulations</article-title>,&#x0201d; <source>Life Sciences</source>
<volume>338</volume> (<year>2024</year>): <elocation-id>122362</elocation-id>.<pub-id pub-id-type="pmid">38141855</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="cns70378-cit-0190">
<string-name>
<given-names>A.</given-names>
<surname>Capizzi</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Woo</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Verduzco&#x02010;Gutierrez</surname>
</string-name>, &#x0201c;<article-title>Traumatic Brain Injury an Overview of Epidemiology, Pathophysiology, and Medical Management</article-title>,&#x0201d; <source>Medical Clinics of North America</source>
<volume>104</volume>, no. <issue>2</issue> (<year>2020</year>): <fpage>213</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">32035565</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="cns70378-cit-0191">
<string-name>
<given-names>M. D.</given-names>
<surname>Wiles</surname>
</string-name>, &#x0201c;<article-title>Management of Traumatic Brain Injury: A Narrative Review of Current Evidence</article-title>,&#x0201d; <source>Anaesthesia</source>
<volume>77</volume> (<year>2022</year>): <fpage>102</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">35001375</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="cns70378-cit-0192">
<string-name>
<given-names>M. M.</given-names>
<surname>Shi</surname>
</string-name>, <string-name>
<given-names>F. L.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Z. J.</given-names>
<surname>Chen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sigma&#x02010;1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury</article-title>,&#x0201d; <source>Frontiers in Cellular Neuroscience</source>
<volume>15</volume> (<year>2021</year>): <elocation-id>685201</elocation-id>.<pub-id pub-id-type="pmid">34658788</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="cns70378-cit-0193">
<string-name>
<given-names>R. R.</given-names>
<surname>Agrawal</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Larrea</surname>
</string-name>, <string-name>
<given-names>Y. M.</given-names>
<surname>Xu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Alzheimer's&#x02010;Associated Upregulation of Mitochondria&#x02010;Associated ER Membranes After Traumatic Brain Injury</article-title>,&#x0201d; <source>Cellular and Molecular Neurobiology</source>
<volume>43</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>2219</fpage>&#x02013;<lpage>2241</lpage>.<pub-id pub-id-type="pmid">36571634</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="cns70378-cit-0194">
<string-name>
<given-names>M. M.</given-names>
<surname>Shi</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>X. B.</given-names>
<surname>Min</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Activation of Sigma&#x02010;1 Receptor Alleviates ER&#x02010;Associated Cell Death and Microglia Activation in Traumatically Injured Mice</article-title>,&#x0201d; <source>Journal of Clinical Medicine</source>
<volume>11</volume>, no. <issue>9</issue> (<year>2022</year>): <elocation-id>2348</elocation-id>, <pub-id pub-id-type="doi">10.3390/jcm11092348</pub-id>.<pub-id pub-id-type="pmid">35566476</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="cns70378-cit-0195">
<string-name>
<given-names>H.</given-names>
<surname>Dong</surname>
</string-name>, <string-name>
<given-names>Y. F.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>Z. X.</given-names>
<surname>Ren</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sigma&#x02010;1 Receptor Modulates Neuroinflammation After Traumatic Brain Injury</article-title>,&#x0201d; <source>Cellular and Molecular Neurobiology</source>
<volume>36</volume>, no. <issue>5</issue> (<year>2016</year>): <fpage>639</fpage>&#x02013;<lpage>645</lpage>.<pub-id pub-id-type="pmid">26228028</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="cns70378-cit-0196">
<string-name>
<given-names>S.</given-names>
<surname>Gupta</surname>
</string-name>, <string-name>
<given-names>S. L.</given-names>
<surname>Cassel</surname>
</string-name>, <string-name>
<given-names>F. S.</given-names>
<surname>Sutterwala</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Dagvadorj</surname>
</string-name>, &#x0201c;<article-title>Regulation of the NLRP3 Inflammasome by Autophagy and Mitophagy</article-title>,&#x0201d; <source>Immunological Reviews</source>
<volume>329</volume>, no. <issue>1</issue> (<year>2025</year>): <elocation-id>e13410</elocation-id>, <pub-id pub-id-type="doi">10.1111/imr.13410</pub-id>.<pub-id pub-id-type="pmid">39417249</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="cns70378-cit-0197">
<string-name>
<given-names>Q. B.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Zheng</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>You</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Expression of Histone H1 in Rats With Traumatic Brain Injury and the Effect of the NLRP3 Inflammasome Pathway</article-title>,&#x0201d; <source>World Neurosurgery</source>
<volume>171</volume> (<year>2023</year>): <fpage>E286</fpage>&#x02013;<lpage>E290</lpage>.<pub-id pub-id-type="pmid">36509326</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="cns70378-cit-0198">
<string-name>
<given-names>U.</given-names>
<surname>Dirnagl</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Iadecola</surname>
</string-name>, and <string-name>
<given-names>M. A.</given-names>
<surname>Moskowitz</surname>
</string-name>, &#x0201c;<article-title>Pathobiology of Ischaemic Stroke: An Integrated View</article-title>,&#x0201d; <source>Trends in Neurosciences</source>
<volume>22</volume>, no. <issue>9</issue> (<year>1999</year>): <fpage>391</fpage>&#x02013;<lpage>397</lpage>.<pub-id pub-id-type="pmid">10441299</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="cns70378-cit-0199">
<string-name>
<given-names>N.</given-names>
<surname>Marklund</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Clausen</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Lewander</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Hillered</surname>
</string-name>, &#x0201c;<article-title>Monitoring of Reactive Oxygen Species Production After Traumatic Brain Injury in Rats With Microdialysis and the 4&#x02010;Hydroxybenzoic Acid Trapping Method</article-title>,&#x0201d; <source>Journal of Neurotrauma</source>
<volume>18</volume>, no. <issue>11</issue> (<year>2001</year>): <fpage>1217</fpage>&#x02013;<lpage>1227</lpage>.<pub-id pub-id-type="pmid">11721740</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="cns70378-cit-0200">
<string-name>
<given-names>H.</given-names>
<surname>Jayaram</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kolko</surname>
</string-name>, <string-name>
<given-names>D. S.</given-names>
<surname>Friedman</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Gazzard</surname>
</string-name>, &#x0201c;<article-title>Glaucoma: Now and Beyond</article-title>,&#x0201d; <source>Lancet</source>
<volume>402</volume>, no. <issue>10414</issue> (<year>2023</year>): <fpage>1788</fpage>&#x02013;<lpage>1801</lpage>.<pub-id pub-id-type="pmid">37742700</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="cns70378-cit-0201">
<string-name>
<given-names>P.</given-names>
<surname>Gharahkhani</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Jorgenson</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Hysi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Genome&#x02010;Wide Meta&#x02010;Analysis Identifies 127 Open&#x02010;Angle glaucoma Loci With Consistent Effect Across Ancestries</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2021</year>): <elocation-id>1258</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="cns70378-cit-0202">
<string-name>
<given-names>M.</given-names>
<surname>Nita</surname>
</string-name> and <string-name>
<given-names>A.</given-names>
<surname>Grzybowski</surname>
</string-name>, &#x0201c;<article-title>The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age&#x02010;Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults</article-title>,&#x0201d; <source>Oxidative Medicine and Cellular Longevity</source>
<volume>2016</volume> (<year>2016</year>): <elocation-id>3164734</elocation-id>.<pub-id pub-id-type="pmid">26881021</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="cns70378-cit-0203">
<string-name>
<given-names>J. H.</given-names>
<surname>Pham</surname>
</string-name> and <string-name>
<given-names>D. L.</given-names>
<surname>Stankowska</surname>
</string-name>, &#x0201c;<article-title>Mitochondria&#x02010;Associated Endoplasmic Reticulum Membranes (MAMs) and Their Role in Glaucomatous Retinal Ganglion Cell Degeneration&#x02010;a mini Review</article-title>,&#x0201d; <source>Frontiers in Neuroscience</source>
<volume>17</volume> (<year>2023</year>): <elocation-id>1198343</elocation-id>.<pub-id pub-id-type="pmid">37250427</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="cns70378-cit-0204">
<string-name>
<given-names>Y. T.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>Y. Q.</given-names>
<surname>Dai</surname>
</string-name>, <string-name>
<given-names>Y. J.</given-names>
<surname>Zhang</surname>
</string-name>, and <string-name>
<given-names>X. H.</given-names>
<surname>Sun</surname>
</string-name>, &#x0201c;<article-title>Olaparib, a PARP&#x02010;1 Inhibitor, Protects Retinal Cells From Ocular Hypertension&#x02010;Associated Oxidative Damage</article-title>,&#x0201d; <source>Frontiers in Cell and Developmental Biology</source>
<volume>10</volume> (<year>2022</year>): <elocation-id>925835</elocation-id>.<pub-id pub-id-type="pmid">36092711</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="cns70378-cit-0205">
<string-name>
<given-names>D. J.</given-names>
<surname>Hurley</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Normile</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Irnaten</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>O'Brien</surname>
</string-name>, &#x0201c;<article-title>The Intertwined Roles of Oxidative Stress and Endoplasmic Reticulum Stress in Glaucoma</article-title>,&#x0201d; <source>Antioxidants</source>
<volume>11</volume>, no. <issue>5</issue> (<year>2022</year>): <elocation-id>886</elocation-id>, <pub-id pub-id-type="doi">10.3390/antiox11050886</pub-id>.<pub-id pub-id-type="pmid">35624748</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="cns70378-cit-0206">
<string-name>
<given-names>K. R.</given-names>
<surname>Bhattarai</surname>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Riaz</surname>
</string-name>, <string-name>
<given-names>H. R.</given-names>
<surname>Kim</surname>
</string-name>, and <string-name>
<given-names>H. J.</given-names>
<surname>Chae</surname>
</string-name>, &#x0201c;<article-title>The Aftermath of the Interplay Between the Endoplasmic Reticulum Stress Response and Redox Signaling</article-title>,&#x0201d; <source>Experimental and Molecular Medicine</source>
<volume>53</volume>, no. <issue>2</issue> (<year>2021</year>): <fpage>151</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">33558590</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0207"><label>207</label><mixed-citation publication-type="journal" id="cns70378-cit-0207">
<string-name>
<given-names>J.</given-names>
<surname>Morena</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Gupta</surname>
</string-name>, and <string-name>
<given-names>J. C.</given-names>
<surname>Hoyle</surname>
</string-name>, &#x0201c;<article-title>Charcot&#x02010;Marie&#x02010;Tooth: From Molecules to Therapy</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>20</volume>, no. <issue>14</issue> (<year>2019</year>): <elocation-id>3419</elocation-id>.<pub-id pub-id-type="pmid">31336816</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0208"><label>208</label><mixed-citation publication-type="journal" id="cns70378-cit-0208">
<string-name>
<given-names>Y.</given-names>
<surname>Okamoto</surname>
</string-name> and <string-name>
<given-names>H.</given-names>
<surname>Takashima</surname>
</string-name>, &#x0201c;<article-title>The Current State of Charcot&#x02010;Marie&#x02010;Tooth Disease Treatment</article-title>,&#x0201d; <source>Genes</source>
<volume>14</volume>, no. <issue>7</issue> (<year>2023</year>): <elocation-id>1391</elocation-id>.<pub-id pub-id-type="pmid">37510296</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0209"><label>209</label><mixed-citation publication-type="journal" id="cns70378-cit-0209">
<string-name>
<given-names>B. A.</given-names>
<surname>McCray</surname>
</string-name> and <string-name>
<given-names>S. S.</given-names>
<surname>Scherer</surname>
</string-name>, &#x0201c;<article-title>Axonal Charcot&#x02010;Marie&#x02010;Tooth Disease: From Common Pathogenic Mechanisms to Emerging Treatment Opportunities</article-title>,&#x0201d; <source>Neurotherapeutics</source>
<volume>18</volume>, no. <issue>4</issue> (<year>2021</year>): <fpage>2269</fpage>&#x02013;<lpage>2285</lpage>.<pub-id pub-id-type="pmid">34606075</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0210"><label>210</label><mixed-citation publication-type="journal" id="cns70378-cit-0210">
<string-name>
<given-names>N.</given-names>
<surname>Bernard&#x02010;Marissal</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>van Hameren</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Juneja</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Altered Interplay Between Endoplasmic Reticulum and Mitochondria in Charcot&#x02010;Marie&#x02010;Tooth Type 2A Neuropathy</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>116</volume>, no. <issue>6</issue> (<year>2019</year>): <fpage>2328</fpage>&#x02013;<lpage>2337</lpage>.<pub-id pub-id-type="pmid">30659145</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0211"><label>211</label><mixed-citation publication-type="journal" id="cns70378-cit-0211">
<string-name>
<given-names>P.</given-names>
<surname>Zanfardino</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Longo</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Amati</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitofusin 2 Mutation Drives Cell Proliferation in Charcot&#x02010;Marie&#x02010;Tooth 2A Fibroblasts</article-title>,&#x0201d; <source>Human Molecular Genetics</source>
<volume>32</volume>, no. <issue>2</issue> (<year>2022</year>): <fpage>333</fpage>&#x02013;<lpage>350</lpage>, <pub-id pub-id-type="doi">10.1093/hmg/ddac201</pub-id>.</mixed-citation></ref><ref id="cns70378-bib-0212"><label>212</label><mixed-citation publication-type="journal" id="cns70378-cit-0212">
<string-name>
<given-names>A.</given-names>
<surname>Civera&#x02010;Treg&#x000f3;n</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Dom&#x000ed;nguez</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mart&#x000ed;nez&#x02010;Valero</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mitochondria and Calcium Defects Correlate With Axonal Dysfunction in GDAP1&#x02212;Related Charcot&#x02010;Marie&#x02010;Tooth Mouse Model</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>152</volume> (<year>2021</year>): <elocation-id>105300</elocation-id>.<pub-id pub-id-type="pmid">33582224</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0213"><label>213</label><mixed-citation publication-type="journal" id="cns70378-cit-0213">
<string-name>
<given-names>J.</given-names>
<surname>R&#x000f6;nkk&#x000f6;</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Molchanova</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Revah&#x02010;Politi</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Dominant Mutations in ITPR3 Cause Charcot&#x02010;Marie&#x02010;Tooth Disease</article-title>,&#x0201d; <source>Annals of Clinical and Translational Neurology</source>
<volume>7</volume>, no. <issue>10</issue> (<year>2020</year>): <fpage>1962</fpage>&#x02013;<lpage>1972</lpage>.<pub-id pub-id-type="pmid">32949214</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0214"><label>214</label><mixed-citation publication-type="journal" id="cns70378-cit-0214">
<string-name>
<given-names>F.</given-names>
<surname>Rizzo</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Bono</surname>
</string-name>, <string-name>
<given-names>M. D.</given-names>
<surname>Ruepp</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Combined RNA Interference and Gene Replacement Therapy Targeting MFN2 as Proof of Principle for the Treatment of Charcot&#x02010;Marie&#x02010;Tooth Type 2A</article-title>,&#x0201d; <source>Cellular and Molecular Life Sciences</source>
<volume>80</volume>, no. <issue>12</issue> (<year>2023</year>): <fpage>373</fpage>.<pub-id pub-id-type="pmid">38007410</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0215"><label>215</label><mixed-citation publication-type="journal" id="cns70378-cit-0215">
<string-name>
<given-names>F.</given-names>
<surname>Urano</surname>
</string-name>, &#x0201c;<article-title>Wolfram Syndrome: Diagnosis, Management, and Treatment</article-title>,&#x0201d; <source>Current Diabetes Reports</source>
<volume>16</volume>, no. <issue>1</issue> (<year>2016</year>): <elocation-id>6</elocation-id>.<pub-id pub-id-type="pmid">26742931</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0216"><label>216</label><mixed-citation publication-type="journal" id="cns70378-cit-0216">
<string-name>
<given-names>V.</given-names>
<surname>Gorgogietas</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Rajaei</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Heeyoung</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>GLP&#x02010;1R Agonists Demonstrate Potential to Treat Wolfram Syndrome in Human Preclinical Models</article-title>,&#x0201d; <source>Diabetologia</source>
<volume>66</volume>, no. <issue>7</issue> (<year>2023</year>): <fpage>1306</fpage>&#x02013;<lpage>1321</lpage>.<pub-id pub-id-type="pmid">36995380</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0217"><label>217</label><mixed-citation publication-type="journal" id="cns70378-cit-0217">
<string-name>
<given-names>C.</given-names>
<surname>Rouzier</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Moore</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Delorme</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Novel CISD2 Mutation Associated With a Classical Wolfram Syndrome Phenotype Alters Ca<sup>2+</sup> Homeostasis and ER&#x02010;Mitochondria Interactions</article-title>,&#x0201d; <source>Human Molecular Genetics</source>
<volume>26</volume>, no. <issue>9</issue> (<year>2017</year>): <fpage>1599</fpage>&#x02013;<lpage>1611</lpage>.<pub-id pub-id-type="pmid">28335035</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0218"><label>218</label><mixed-citation publication-type="journal" id="cns70378-cit-0218">
<string-name>
<given-names>L.</given-names>
<surname>Crouzier</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Danese</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Yasui</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Activation of the Sigma&#x02010;1 Receptor Chaperone Alleviates Symptoms of Wolfram Syndrome in Preclinical Models</article-title>,&#x0201d; <source>Science Translational Medicine</source>
<volume>14</volume>, no. <issue>631</issue> (<year>2022</year>): <elocation-id>eabh3763</elocation-id>.<pub-id pub-id-type="pmid">35138910</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0219"><label>219</label><mixed-citation publication-type="journal" id="cns70378-cit-0219">
<string-name>
<given-names>M.</given-names>
<surname>Callens</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Loncke</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Bultynck</surname>
</string-name>, &#x0201c;<article-title>Dysregulated Ca<sup>2+</sup> Homeostasis as a Central Theme in Neurodegeneration: Lessons From Alzheimer's Disease and Wolfram Syndrome</article-title>,&#x0201d; <source>Cells</source>
<volume>11</volume>, no. <issue>12</issue> (<year>2022</year>): <elocation-id>1963</elocation-id>.<pub-id pub-id-type="pmid">35741091</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0220"><label>220</label><mixed-citation publication-type="journal" id="cns70378-cit-0220">
<string-name>
<given-names>M.</given-names>
<surname>Cagalinec</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Liiv</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Hodurova</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome</article-title>,&#x0201d; <source>Plos Biology</source>
<volume>14</volume>, no. <issue>7</issue> (<year>2016</year>): <elocation-id>e1002511</elocation-id>.<pub-id pub-id-type="pmid">27434582</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0221"><label>221</label><mixed-citation publication-type="journal" id="cns70378-cit-0221">
<string-name>
<given-names>M.</given-names>
<surname>Zatyka</surname>
</string-name>, <string-name>
<given-names>T. R.</given-names>
<surname>Rosenstock</surname>
</string-name>, <string-name>
<given-names>C. X.</given-names>
<surname>Sun</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Depletion of WFS1 Compromises Mitochondrial Function in hiPSC&#x02010;Derived Neuronal Models of Wolfram Syndrome</article-title>,&#x0201d; <source>Stem Cell Reports</source>
<volume>18</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>1090</fpage>&#x02013;<lpage>1106</lpage>.<pub-id pub-id-type="pmid">37163979</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0222"><label>222</label><mixed-citation publication-type="journal" id="cns70378-cit-0222">
<string-name>
<given-names>S. E.</given-names>
<surname>Wiley</surname>
</string-name>, <string-name>
<given-names>A. Y.</given-names>
<surname>Andreyev</surname>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Divakaruni</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Wolfram Syndrome Protein, Miner1, Regulates Sulphydryl Redox Status, the Unfolded Protein Response, and Ca<sup>2+</sup>Homeostasis</article-title>,&#x0201d; <source>Embo Molecular Medicine</source>
<volume>5</volume>, no. <issue>6</issue> (<year>2013</year>): <fpage>904</fpage>&#x02013;<lpage>918</lpage>.<pub-id pub-id-type="pmid">23703906</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0223"><label>223</label><mixed-citation publication-type="journal" id="cns70378-cit-0223">
<string-name>
<given-names>Z. Q.</given-names>
<surname>Shen</surname>
</string-name>, <string-name>
<given-names>Y. L.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>Y. C.</given-names>
<surname>Teng</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>CISD2 Maintains Cellular Homeostasis</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta&#x02010;Molecular Cell Research</source>
<volume>1868</volume>, no. <issue>4</issue> (<year>2021</year>): <elocation-id>118954</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.bbamcr.2021.118954</pub-id>.<pub-id pub-id-type="pmid">33422617</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0224"><label>224</label><mixed-citation publication-type="journal" id="cns70378-cit-0224">
<string-name>
<given-names>B.</given-names>
<surname>Delprat</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Maurice</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Delettre</surname>
</string-name>, &#x0201c;<article-title>Wolfram Syndrome: MAMs' Connection?</article-title>,&#x0201d; <source>Cell Death and Disease</source>
<volume>9</volume> (<year>2018</year>): <elocation-id>364</elocation-id>.<pub-id pub-id-type="pmid">29511163</pub-id>
</mixed-citation></ref><ref id="cns70378-bib-0225"><label>225</label><mixed-citation publication-type="journal" id="cns70378-cit-0225">
<string-name>
<given-names>M.</given-names>
<surname>Liiv</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Vaarmann</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Safiulina</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>ER Calcium Depletion as a Key Driver for Impaired ER&#x02010;to&#x02010;Mitochondria Calcium Transfer and Mitochondrial Dysfunction in Wolfram Syndrome</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>15</volume>, no. <issue>1</issue> (<year>2024</year>): <elocation-id>6143</elocation-id>.</mixed-citation></ref><ref id="cns70378-bib-0226"><label>226</label><mixed-citation publication-type="journal" id="cns70378-cit-0226">
<string-name>
<given-names>K.</given-names>
<surname>Ahuja</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Vandenabeele</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Nami</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Deep Phenotyping Study in Mouse and iPSC Models to Understand the Role of Oligodendroglia in Optic Neuropathy in Wolfram Syndrome</article-title>,&#x0201d; <source>Acta Neuropathologica Communications</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2024</year>): <elocation-id>140</elocation-id>.<pub-id pub-id-type="pmid">39198924</pub-id>
</mixed-citation></ref></ref-list></back></article>